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ABSTRACT
The production of the Bacillus subtilis /3-glucanase enzyme was 
examined in the yeast Saccharomyces cerevisiae. The ability of 
the bacterial signal peptide to translocate and secrete the 
enzyme was analysed and compared to the yeast a-factor signal 
peptide. A truncated version of the signal was also examined as 
was the effect of complete removal of the signal sequence. 
Glycosylation of the /3-glucanase enzyme in the yeast secretory 
pathway was examined using both Western blots and activity gels 
and the effects of glycosylation on /3-glucanase production was 
assessed. A second bacterial enzyme, /3-glucuronidase, was also 
examined for its potential use as a reporter enzyme in yeast 
expression and secretion systems. This work included attempts 
to secrete the enzyme, the definition of its active site, 
investigation of its potential for use in translational fusion 
experiments and the generation of a polyclonal antibody to the 
E.coli /3-glucuronidase enzyme.
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CHAPTER 1 
INTRODUCTION
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(1.1) Heterologous protein production in yeast: an overview.
S . cerevisiae has many advantages as a host for the production 
of proteins of commercial value. The high cell densities 
reached in fermentations, using simple media, has made it an 
ideal organism for applications at an industrial level. In 
addition, the rapid progress being made in characterizing 
S . cerevisiae at biochemical and molecular levels and the ease 
with which the organism can be manipulated genetically, has 
greatly enhanced its potential in this respect.
There are a wide range of systems available for introducing, 
expressing and maintaining foreign genes in yeast, some of 
which are outlined below. The production and isolation of a 
particular protein however, goes beyond the successful 
maintenance and expression of the gene. A major problem 
encountered is insolubility of the gene product in the yeast 
cytoplasm. This problem is also associated with intracellular 
production in the bacterial host, E.coli and can result in the 
recovery of malfolded, biologically inactive material. Other 
factors such as protein instability and degradation can also 
affect recovery levels. Some of these problems and possible 
solutions are discussed in the remainder of this initial 
section. The potential of improving both recovery levels and 
product quality, by directing heterologous proteins through the 
secretory pathway is also examined.
(1.1.1) Yeast expression systems.
A number of vector systems are available for the introduction 
and maintenance of exogenous genes in S .cerevisiae. These 
include autonomously replicating plasmids which are maintained 
at high, medium or low copy numbers and integrating vectors 
whose copy number can also be controlled to a certain extent. 
The most widely used autonomously replicating vectors are based 
on the native 2/j.m circle plasmid (Hartley and Donelson, 1980 ) . 
These vectors include the 2\j> origin and REP3 regions required 
for maintaining copy number and partitioning fidelity (Jayaram 
et al 1985). Copy number is controlled by the REP1, REP2 and 
FLP functions which are provided by endogenous 2n circles in
2
cir+ hosts (Wu et al 1987) . 2/i based vectors are maintained at 
relatively high copy numbers (20-40 copies/cell) and stability 
is high under selective growth conditions. Autonomously 
replicating sequences (ARS), derived from chromosomal elements 
have also been included into vectors and although higher copy 
numbers are achieved, this is at the expense of stability and 
partitioning fidelity, even with selective growth conditions 
(Murray and Szostak, 1983).
Methods of increasing copy number and maintaining stability of 
2p, based vectors have been developed. The introduction of the 
leucine defective (leu-d) gene as a selectable plasmid marker 
maintains a higher than average number of plasmid copies per 
cell. This is due to the inefficiency of the leu2 defective 
promoter which reduces transcription levels of the gene. High 
copy number is required to allow cell growth in leu2 
auxotrophic strains (Erhart and Hollenberg, 1983). Along a 
similar line, the TPI1 (triose phosphate isomerase) gene from 
S z .pombe, which is not expressed well in S .cerevisiae, has been 
introduced into vectors for propagation in tpi 1 mutants. High 
copy number is maintained to ensure that adequate levels of TPI 
are produced to allow cell growth (Thim et al, 1986)
One copy of a plasmid can be stably maintained by the 
introduction of a yeast centromeric sequence (CEN) into an ARS 
or 2/x based plasmid. CEN plasmids are maintained at 1-2 copies 
per haploid genome and confer stability onto unstable vector 
systems such as ARS based plasmids (Tschumper and Carton,
1983). The advantages of maintaining low copy numbers come into 
play when for example, the protein of interest is toxic to the 
host.
More rigid control of copy number can be achieved by directing 
an expression cassette (ie. promoter and heterologous gene) 
into the yeast genome using integrating vectors (Smith et al,
1985). Integrating vectors lack replication origins and can be 
directed to any part of the genome by carrying at least one 
portion of a yeast gene to provide homology. In this way the 
heterologous sequences are maintained in the genome without the 
need for selective growth conditions. Multiple integration
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events can be achieved by directing the vector to Ty element«,
S sequences or rDNA genes which are present in the genome at >
1 copy (Melnick et al, 1990; Fuj ii et al, 1990). It has been 
shown that some secreted proteins can be produced at higher 
levels and secreted with greater efficiencies when the 
expression/secretion cassette is integrated into the genome. 
Prochymosin and urinary plasminogen activator are secreted 
almost 4 times as efficiently under these conditions compared 
to levels secreted when expressed on autonomously replicating 
multicopy vectors (Smith et al, 1985; Melnick et al, 1990).
This suggests; that very high expression levels are not 
necessarily ideal for heterologous protein secretion.
The expression level of a gene can also be controlled by the 
choice of promoter. Constitutive promoters such as ADH1 
(Ammerer, 1983), PGK1 (Hitzeman et al 1982) and GAPDH1 (Bitter 
and Egan, 1984) have been cloned, characterised and used for 
the expression of heterologous genes. These promoters 
transcribe their natural products at levels of >1% of total 
cell mRNA and protein. However, transcription of heterologous 
DNA in autonomously replicating vectors is not as efficient 
using these promoters as transcription of the natural gene. 
PGK1 for example is highly expressed in yeast, accounting for 
up to 5% of total cell protein and mRNA. Proteins produced from 
fusions to the cloned promoter sequence however result in much 
lower yields (Mellor et al, 1985). Even PGK produced in this 
manner is transcribed at lower than normal levels.
Inducible promoters are particularly useful in yeast expression 
systems in that high cell densities can be reached before the 
expression of the product is switched on. Many inducible 
promoters depend on the carbon source. The GAL1 and GAL.LO 
promoters are tightly repressed in glucose medium but rapidly 
induced when galactose is introduced as a carbon source 
(Johnson and Davis, 1984). Changing the growth medium however, 
is not necessarily ideal in many industrial situations and the 
ADH2 promoter is more useful in this respect (Yu et al, 1989). 
ADH2 is turned off in the presence of glucose. The gradual 
depletion of glucose from the medium during cell growth can be
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exploited to allow expression from this promoter to occur 
naturally, late in the growth cycle.
Transcriptional initiation from yeast promoter sequences 
usually occurs between 11 and 160 nucleotides from the
translational initiation codon, (AUG). The average length of 
the 5' untranslated region is 52 nucleotides (Cigan and
Donahue, 1987). Fusions to foreign genes however, usually
results in lengthening the 5' non-coding region with the
introduction of foreign sequences, often derived from 
restriction sites used in manipulating the various components 
of the expression cassette. Within the above range, the length 
of the leader region does not appear to affect translation 
efficiency of heterologous transcripts in yeast. However, the 
sequence content of this non-coding region can be of major
importance.
Examination of leader sequences of highly expressed genes shows 
them to be largely void of secondary structure (Cigan and
Donahue, 1987). The introduction of regions of dyad symmetry
into the 5' region of HIS4 was shown to cause a reduction in 
translation to <5% of wild type levels (Cigan et al, 1988).
Yeast appears to be sensitive even to single G and C 
nucleotides in this region and in the absence of secondary 
structure, the presence of Gs and Cs can have a detrimental 
effect on translation. This is thought to be due to intra and 
intermolecular interactions in this region of the transcript. 
The marked absence of Gs and abundance of As in the 5' 
untranslated leaders of yeast genes is a reflection of this 
effect (Cigan and Donahue, 1988).
Another feature affecting translation efficiency in yeast is 
the importance of the first AUG initiation codon. Studies 
examining preferred leader regions have shown that translation 
is initiated preferentially at the first AUG encountered by the 
ribosome. The introduction of out of frame AUG codons 5' of the 
initiator in HIS4 was found to reduce translation to less than 
20% of normal levels (Donahue and Cigan, 1987). With the 
definition of ideal sequences arising out of the extensive 
analyses of Cigan and Donahue outlined briefly above, there is
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definite potential for optimizing leader regions of foreign 
genes in order to maximize translation efficiency. Increased 
production levels of various foreign proteins in yeast has been 
observed when the 5' non-coding sequences are replaced either 
with yeast sequences or optimized leaders (Kniskern et al, 
1986; Bitter and Egan, 1988).
(1.1.2) Heterologous protein stability.
A protein that can be produced in yeast cytoplasm in a soluble 
active form, can be recovered in quantities exceeding the 
levels produced in many secretion systems (Sabin et al, 1989). 
However, there are additional problems associated with 
intracellular expression and production of proteins apart from 
those already described. A major problem is instability of the 
foreign gene product in the yeast cytoplasm and this can depend 
on the nature of the N-terminus of the protein. The N-terminal 
formylated methionine residue of cytoplasmic proteins in E.co.li 
is always removed by the action of MAP (methionine 
aminopeptidase) (Ben-Bassat et al. 1987). In eukaryotes,
including S .cerevisiae, this methionine is not always removed 
and when it is retained, it may or may not be modified by 
acylation. Removal of the initiator methionine is dependant on 
the identity of the adjacent amino acid residue. Once exposed, 
this amino acid in turn may be acylated (Bradshaw, 1989). These 
modifications are often essential for biological activity of 
proteins. For proteins that are normally cytoplasmic residents, 
intracellular production in yeast will usually result in 
processing according to the general rules. However, secretory 
proteins rarely have N-terminal methionine residues in their 
mature sequences and may be processed incorrectly when produced 
in the cytoplasm.
For the production of proteins for pharmaceutic and therapeutic 
use, an authentic gene product identical to the naturally 
occurring counterpart is usually required. Removal of an 
unwanted initiator methionine can occur naturally in vivo. This 
can also be achieved by chemical treatment with cyanogen 
bromide or enzymatically using the cloned E.coli MAP protein.
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In yeast, the identity of the penultimate residue then exposed 
can be vital in determining the stability of proteins in the 
cytoplasm and can be responsible for targeting a protein for 
degradation by the ubiquitin degradation pathway.
Ubiquitin is a 76 amino acid protein involved in the 
recognition system of protein degradation pathways in 
eukaryotic cells (Ozykaynak et al. 1987). Although the exact
mechanism of its action is poorly understood, ubiquitin is 
known to form conjugates with a variety of intracellular 
proteins and targets abnormal or damaged proteins for 
proteolysis. Ubiquitin is processed by a specific protease that 
recognizes the carboxyl terminal Arg-Gly-Gly sequence. The 
specific processing of ubiquitin has been exploited to examine 
the effects of various N-terminal amino acids on protein 
stability in the yeast cytoplasm.
Ubiquitin was fused to the N-terminal of /3-galactosidase with 
the Arg-Gly-Gly cleavage site separating the two proteins 
(Bachmair et al, 1986). Fusions were arranged so that different 
residues were present at the N-terminus of the /3-galactosidase 
protein after processing by ubiquitinase. These fusions were 
efficiently processed by this enzyme and the processed 
^-galactosidase examined for stability. Amino acids Met, Ser, 
Gly, Val, Pro, Cys, Ala, Thr were identified as stabilizing 
residues, giving /9-galactosidase a half-life of up to 30 hours. 
Amino acids Glu, Gin, Asp, Asn, He, Leu, Phe, Trp, Tyr, His, 
Lys, Arg were shown to be destabilizing when present at the 
N-terminal of ¡3-galactosidase, exhibiting half-lives of 30 
minutes or less.
The definition of this N-end rule has allowed the choice of 
appropriate fusions to maximize stability of heterologous 
proteins in yeast. The ubiquitin fusion system can be used to 
produce active stable proteins with authentic N-termini. Human 
7IFN (interferon) and a^PI (proteinase inhibitor) have been 
produced in yeast using this system (Sabin et al, 1989). In
some cases, increased levels of a heterologous protein have 
been reported when produced as a ubiquitin fusion (Ecker et al, 
1989) .
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An additional problem associated with the recovery of 
heterologous proteins from the yeast cytoplasm, is degradation 
by the action of cellular proteases. This can present a 
problem, not only for cytoplasmically produced proteins, but 
also in assaying the intracellular pool of proteins directed to 
the secretory pathway. The complement of vacuolar proteases, 
particularly proteases A and B (PrA and PrB) and 
carboxypeptidases Y and S (CpY and CpS) are the major source of 
the proteolysis problem in yeast. These proteases complex with 
cytosolic inhibitors when released from the vacuole during cell 
lysis procedures. In many cases however, the nature of the 
lysis solutions and assaying procedures promote release of the 
proteases from their inhibitors, rendering them fully active 
(Jones, 1984). The presence of SDS, increased temperatures and 
pH can have this effect (Ulane and Cabib, 1976; Zubenko et al, 
1979). Certain precautions, such as the use of protease 
inhibitors like PMSF and EDTA can alleviate the problem to some 
extent. However, a genetic approach to the protease problem has 
proved more successful.
PEP4 is the structural gene encoding the PrA precursor. This 
protein activates the other vacuolar proteases PrB and CpY on 
transfer into the vacuole (Ammerer et al, 1986). Disruption of 
PEP4 by the introduction of nonsense codon (pep4-3 mutants) has 
a pleiotropic effect on vacuolar hydrolases. PrA production is 
eliminated and the levels of PrB and CpY are significantly 
reduced. However, PrB can still cause problems even in a pep4 
mutant. The prbl mutation eliminating the PrB protein 
altogether, has also been isolated and the use of a double 
mutant (pep4-3 prbl) is recommended where proteolysis is a 
major concern.
(1.1.3) Improving production by secretion.
Many of the problems associated with intracellular production 
of heterologous proteins in yeast can be avoided by directing 
the protein through the secretory pathway. Producing proteins 
in the yeast culture medium, relatively free of contaminating 
host proteins, greatly eases purification procedures and is a
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major advantage over the popular bacterial host, E.coli. In the 
reducing environment of the ER, disulphide bond formation 
occurs more readily than in the cytoplasm and this is of major 
importance for maintaining solubility and in some cases, 
biological activity. Protein glycosylation in the secretory 
pathway can contribute to product solubility and biological 
activity of mammalian proteins in particular. In addition, by 
generating the correct fusions, secretion can allow the 
generation of authentic N-termini and the secretory pathway can 
afford foreign proteins protection from the action of cellular 
proteases.
Two proteins, prochymosin and human serum albumin (HSA), are 
examples of success (Smith et al, 1985; Etcheverry et al, 
1986). In both cases, attempts to produce the protein 
intracellularly in yeast resulted in low yields of largely 
insoluble and inactive material. Secretion however allowed 
soluble, correctly folded, fully active protein to be 
recovered. Directing the human growth hormone (hGH) through the 
secretory pathway has also led to increased recovery levels by 
up to 300 fold (Brake et al, 1984).
Although the secretion of foreign proteins in yeast is not 
without its o'm particular problems, many of which will become 
apparent, detailed characterization of the yeast secretory 
process has gone a long way in helping to overcome many of 
these. A better understanding of secretion has also been 
invaluable in working towards optimizing heterologous protein 
production in yeast.
Protein translocation across membrane structures is a process 
common to prokaryotic and eukaryotic cells. All cells produce 
proteins that must be transported from their site of synthesis 
to various subcellular organelles and compartments, or out into 
the cell medium, in order to perform their specific functions. 
Uncovering the molecular mechanisms involved in selective 
protein transport and sorting has been the subject of intensive 
research over the last 20 to 25 years. The rest of this review 
will attempt to cover the substantial progress that has been 
made in the area of protein transport through eukaryotic
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secretory systems. Much of the information that has allowed 
characterization of the yeast secretory process has come from 
analysis of secretion in bacterial and mammalian cells. 
Emphasis will be placed on the developments made in eukaryotes 
and relevant aspects of the bacterial secretory process will 
also be discussed. Finally, a short summary of the initial 
successes in the area of heterologous protein secretion in 
S .cerevisiae is also included.
(1.2.0) Introduction to the secretory process.
Although bacterial cells do not have distinct organelles they 
are compartmentalised to a certain extent. In the gram negative 
bacterium E.coli, for example, the cytoplasm is surrounded by 
an inner and an outer membrane, separated by the periplasmic 
space. Proteins are transported from the cytoplasm to both 
membranes and to the periplasm by what is believed to be a 
common export pathway (Ito et al. 1981). Eukaryotic cells on 
the other hand, are compartmentalised to a much higher degree. 
To understand the complexities of the mechanisms that 
control eukaryotic protein transport, one must consider that 
apart from directing soluble proteins through the secretory 
pathway, the secretory process is also involved in cell surface 
assembly and in the assembly of subcellular organelles (Erikson 
and Blobel, 1985; Rome et al. 1979; Shore et al. 1979). In
addition, proteins produced in the cytoplasm must be 
transported to the nucleus, the mitochondrion and chloroplasts, 
while others are inserted into cellular and subcellular 
membranes. The molecular mechanisms by which cells sort and 
traffic proteins to their various destinations are being 
gradually uncovered. The process however is far from fully 
understood.
Most of the initial information about protein translocation 
into and transport across membranes came from genetic evidence 
in prokaryotes (Benson et a l . 1975) and from biochemical
studies in eukaryotic cell free systems (Walter et a l . 1984).
Studies on protein localisation in these systems has allowed 
the identification of a large number of components involved in
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the secretory process. A notable outcome of this work was the 
realisation that the mechanisms involved have been conserved to 
some extent between these groups. Bacteria have been shown to 
export eukaryotic secretory proteins (Talmadge et al. 1980) and 
in turn, eukaryotic cells can secrete certain bacterial 
proteins (Weidmann et al. 1984).
With eukaryotic cell free translation and translocation 
systems, extrapolation to in vivo situations is difficult. The 
lower eukaryote yeast, has a secretory system very similar to 
that of higher eukaryotic cells (Schekman et al. 1982). In 
contrast to mammalian cells it is easily manipulated 
genetically and therefore has the additional advantage of 
allowing in vitro assays to be backed up at a molecular level 
by the creation of mutants. For these reasons the potential of 
yeast as an organism to examine and identify components and 
steps involved in eukaryotic protein secretion has been 
realised. Several yeast genes have been cloned covering various 
steps and components involved in the secretory process and 
yeast has become a useful test system for translocation and 
transport analysis.
(1.2.1) The secretory pathway of eukaryotic cells.
The eukaryotic secretory pathway was defined by following the 
intracellular route taken through cells by pulse labeled 
proteins using electron microscope autoradiography and cell 
fractionation techniques (Jamieson and Palade, 1967a; 1967b;
1968). This pioneering work was carried out in pancreatic 
exocrine cells which are specialised for secretion. Secretory 
proteins were shown to be first sequestered into the lumen of 
the endoplasmic reticulum (ER). From there they enter the cis 
face of the Golgi apparatus via ER-membrane derived vesicles. 
The proteins are concentrated in secretory vesicles which are 
released from the trans side of the Golgi. These vesicles fuse 
with appropriate membranes, releasing the proteins into their 
correct subcellular location or out into the cell medium 
(Palade, 1975).
In yeast the secretory pathway was defined by the isolation of
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a series of secretion defective mutants (Novick and Schekman,
1979). Yeast, unlike pancreatic cells is not specialised for 
secretion. Precursors are present in relatively low 
concentrations and the secretory organelles are fewer in number 
compared to secretory cells of higher eukaryotes. These 
features however, make yeast a sensitive system for examining 
protein secretion as the consequences of disruption of the 
secretory process are pronounced.
Cytological analyses have shown that secretion is limited to 
the growing bud surface of the yeast cell wall and is an 
essential function involved in cell growth (Linnemans et al, 
1977). The first secretion defective (sec) mutants were 
isolated as conditional lethal growth mutants of S .cerevisiae 
(Novick and Schekman, 1979). These temperature sensitive 
mutants were screened for defects in protein secretion by 
assaying for a block in secretion of the invertase enzyme 
(Novick et al 1980). At the non-permissive temperature (37°C) 
the block in secretion of invertase, an enzyme which is 
normally secreted to the periplasmic space, is accompanied by 
an intracellular accumulation of active enzyme. Another feature 
of these sec mutants is that they accumulate exaggerated 
secretory organelles at the stage in the pathway where the 
block occurs. This can be observed in electron micrograph thin 
sections of cells. Also, in most cases, the defect in secretion 
is reversible and normal growth and secretion is restored on 
returning the cells to the permissive temperature (25°C). 
Initially, 192 of these mutants (classed as secA) were isolated 
and were classified into 23 complementation groups.
Another set of mutants (secB) were also isolated in these 
studies. These secB mutants are temperature sensitive for 
growth but do not accumulate active secretory proteins at the 
non permissive temperature. SecB mutants define four 
complementation groups and two in particular, sec53 and sec59, 
have been characterised in detail (Ferro-Novick et al. 1984). 
Sec53 and sec59 accumulate inactive forms of invertase and acid 
phosphatase (another yeast secretory protein) and the defect 
has been shown to affect the glycosylation process.
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The generation of double secretory mutant strains and their 
characterization with regard to invertase accumulation and 
organelle morphology, allowed the order of events in the yeast 
secretory pathway to be defined (Novick et al. 1981). In
theory, a double mutant will accumulate the intermediate prior 
to the first block encountered in the pathway. Using this 
approach, the yeast secretory pathway was shown to closely 
resemble that of higher eukaryotes. ER accumulating mutants are 
epistatic to Golgi and secretory vesicle mutants and in turn, 
Golgi mutants are epistatic to secretory vesicle mutants. Many 
of the mutants isolated in these studies and other isolated 
since, have been analysed in detail. In some cases the genes 
have been cloned, the protein products identified and functions 
assigned. Studies of the sec mutants and double mutants,plus 
work on the glycosylation of yeast secretory proteins and 
vacuolar mis-sorting mutants (Esmon et al. 1981; Stevens et al. 
1982) can be combined to give a diagrammatic representation of 
the route taken by secretory proteins in yeast (Fig.1.1).
Figure (1.1) The secretory pathway of yeast as defined by sec 
mutant analysis (Schekman, 1982).
Fig. / .  Secretory and vacuolar protein transport pathways in yeast. N: nucleus; NM: nuclear membrane, 
ER: endoplasmic reticulum; SFC: wild-type f^ enc; VA C: vacuole; V: vesicle; PM: plasma membrane, C W. 
cell wall; C P Y: A/ Kd mature carboxypeptidase Y; pi CPY: a 67  Kd pro-enzyme form oftPY; p2 C I  V a 
b'J Kd pre-enzyme Jorni of CPY.
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(1.2.2) The signal hypothesis.
The first suggestion that secretory proteins themselves contain 
information for selectivity in the export process came with the 
development of cell free translation systems (Milstein et 
3.1.1972; Schecter et al. 1975). Immunoglobulin light chains,
when translated In vitro, were shown to be produced in a larger 
form than was finally secreted. These precursors had short 
amino terminal extensions and it was suggested that this series 
of amino acids might contain information that could direct the 
protein to the ER membrane.
This was later confirmed with the development of an assay that 
could directly measure protein transport across and interaction 
with membrane structures (Blobel and Dobberstein, 1975a;
1975b). In this assay, canine pancreatic microsomes were added 
to cell free translation systems and the translation of
immunoglobulin light chains was examined.. The microsomes, if 
present during protein synthesis, were shown to sequester newly 
made precursors of immunoglobulin light chains and process them 
to their correct size. These amino terminal extensions were 
termed signal peptides (also referred to as signal sequences or 
leader peptides).
In 1975, Blobel and Dobberstein proposed the signal hypothesis. 
This is a model proposing the a series of molecular events
accounting for the co-translational transfer of secretory 
proteins across the ER membrane. According to the early model, 
the signal peptide is the basis for selectivity of proteins for 
export through the secretory pathway. As the signal emerges 
from the ribosome, it is recognised and bound by specific 
receptors in the ER membrane, directing the nascent protein
across the lipid bilayer via a putative pore or tunnel. The 
signal peptide is removed during or after transfer yielding the 
mature protein in the lumen of the ER (Fig.1.2).
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Figure (1.2) The early signal hypothesis
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The cell free transport assays developed by Blobel and 
Dobberstein allowed the isolation of some of the essential 
components of the transport machinery proposed in the early 
signal hypothesis. Using biochemical purification and 
fractionation techniques, two components were isolated, the 
signal recognition protein (srp) and srp receptor or docking 
protein (Walter and Blobel, 1980, 1981; Meyer and Dobberstein,
1980) . Srp was shown to bind the signal peptide as it emerges 
from the ribosome putting a halt on further translation. It was 
proposed that the srp-polypeptide-ribosome complex then 
interacts with the membrane bound srp receptor, translation 
resumes, the signal peptide is cleaved and the protein is 
translocated (Fig.1.3). The srp and docking protein are 
released leaving the processed form of the secretory protein 
residing in the lumen of the ER. Models describing 
translocation into the ER are being continuously updated as 
more information about the components involved is uncovered. 
Recent developments are discussed in section 1.4.
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Figure (1.3) The signal hypothesis. 
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(1.3) Characterizing eukaryotic and prokaryotic signal 
peptides.
After the isolation of the first eukaryotic signal peptide, it 
soon emerged that prokaryotic secretory proteins are also 
produced in precursor forms with signal sequences similar to
eukaryotes (Inouye and Beckwith, 1977). The similarities 
between the two systems, despite the differences in
complexities, soon became apparent. Eukaryotic and prokaryotic 
signals are functionally interchangeable. The E.coli secretory 
protein, /3-lactamase, can be synthesised in a eukaryotic cell
free translation system and is efficiently translocated into
dog pancreatic microsomes (Muller et al. 1982). Srp has been
shown to interact directly with this bacterial signal peptide 
effecting its translocation and when microinjected into Xenopus 
oocytes, it is efficiently processed and secreted into the cell 
medium (Weidmann et al. 1984).
This functional interchangeability is successful in vivo also. 
The Bacillus a-amylase enzyme, for example, is secreted in 
yeast using its own signal peptide (Ruohonen et al. 1987).
Similarly in bacterial cells, some eukaryotic proteins can be 
secreted (Talmadge et al. 1980). Also, signal peptides can
direct cytosolic proteins to the secretory pathway. The
eukaryotic globin protein for example, when fused to the 
/3-lactamase signal peptide is translocated into microsomal
vesicles (Lingappa et al. 1984) and in E.coli, the LamB
(receptor for phage lambda) signal peptide targets 
/3-galactosidase to the cell membrane (Emr et al. 1980; Emr and 
Silhavy, 1980). Signal sequences therefore play an central role 
in protein export. They are necessary for directing proteins to 
the bacterial or ER membrane, a role that appears to be 
conserved to some extent between two evolutionarily diverse 
groups.
(1.3.1) Physical disection of signal peptides.
Although signal peptides perform conserved functions, 
systematic comparisons of amino acid sequences from prokaryotes 
and eukaryotes reveal no overall consensus sequences or
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absolute amino acid requirements (von Heijne 1984a, 1984b;
Perlman and Halvorsen, 1983). Furthermore, signal peptides 
differ in length as well as in amino acid composition. These 
comparisons however, reveal that all signal peptides conform to 
an overall tripartite structure of three structurally distinct 
domains : a positively charged amino terminal domain
(N-domain), a central hydrophobic core (H-domain) and a polar 
carboxyl terminus (C-domain) which contains the cleavage site.
In a study comparing 118 eukaryotic and 32 prokaryotic signal 
peptides, von Heijne (1985) attempted to ascertain by 
statistical analysis, if there were limitations to the 
variations that could occur within these domains. The study 
reemphasises the variations that do occur but also suggests 
that minimal requirements for the distinct regions may exist. 
Briefly, comparison of the sequences showed that the length of 
the N-region can vary considerably but that the overall net 
charge does not. On average, in prokaryotes anyway, the mean 
charge is approximately +1.7. In the hydrophobic core there are 
no sequence restraints and the choice of hydrophobic amino acid 
in this region is random. The minimum length of the H-domain is 
7 - 8  residues and this region spans from positions -6 to -13 
and -7 to - L4 in eukaryotes and prokaryotes respectively. 
Extremes and exceptions do exist. Human pancreatic polypeptide 
and C .diptheriae toxin for example, have H-domains of 15 and 16 
amino acids, and, the H-region of human choriogonadotrophin 
/3-subunit signal peptide has 9 residues, 7 of which are 
leucine.
The cleavage site at the C-terminus is the least variable of 
the three. The length seldom varies from 5 amino acids in 
eukaryotes and 6 in prokaryotes. Also, certain sequence 
restraints are adhered to in that particular amino acids are 
preferred at particular positions in the cleavage site (section 
1.3.4). These observations highlight the degeneracy of signal 
peptides at an amino acid level. However, they also underline 
the physical organisational pattern that signal sequences 
adhere to. The potential importance of these structural domains 
in maintaining signal function and the possible role of each in
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the translocation process has been investigated.
(1.3.2) Disruption of the hydrophobic domain.
Extensive studies of signal peptide mutants have shown that 
disruption of the structural domains can affect leader peptide 
function with varying degrees of severity. In vitro mutagenesis 
of the H-domain of prokaryotic and eukaryotic signal peptides 
has generated mutants that significantly affect protein 
secretion. Hydrophobic regions of polypeptides have the 
potential to form cc-helices, a thermodynamically preferred 
conformation in the non-polar environment of the lipid bilayer. 
It has been suggested that this region of the signal peptide 
interacts directly with the membrane during translocation 
(Wickner et al. 1980; Engleman, 1981). For this reason, a great 
deal of attention has focused on disruption mutants in the 
H-core of signal sequences.
Analysis of E.coli secretory protein mutants has shown that 
disruptions to the H-domain can severely affect secretion. 
Mutations of the lamB signal peptide, were isolated by 
constructing a fusion between it and /?-galactosidase, a protein 
not normally secreted by this organism (Emr and Silhavy, 1980; 
Emr et al. 1980). Overexpression of this hybrid gene in E.co.li 
results in ¡3-galactosidase being directed to the cytoplasmic 
membrane, effectively jamming the normal export system. Because 
secretion is blocked, the cell cannot secrete its own enzymes 
and is prevented from using maltose as a carbon source (maltose 
sensitive). Mutations that alter secretion of the hybrid 
protein and therefore relieve jamming of the membrane result in 
normal secretion patterns and a maltose resistant phenotype. 
The mutations isolated in this manner, disrupting the function 
of the lamB signal peptide, all map to a group of 4 amino acids 
in the hydrophobic core. Some introduce a charged residue in 
the region while others yield various deletions. Similar 
results are obtained when /3-galactosidase is fused to the 
signal peptide of another secretory protein, the maltose 
binding protein (MBP), in E.coli (Bedoulle et al. 1980).
In eukaryotes, the yeast secretory protein invertase has been
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used for similar analyses. S .cerevisiae produces two types of 
invertase enzyme. Both are encoded by separate mRNA transcripts 
synthesized from a common gene, SUC2 (Perlman et al. 1982). The 
cytoplasmic form is constitutively produced and transcription 
of the secreted form is glucose repressed. When grown on 
sucrose as a carbon source, the secreted form is transcribed 
and the enzyme is produced in the precursor form with a signal 
peptide that directs the enzyme to the secretory pathway 
where it is transported to the periplasmic space.
Deletion of 4 amino acids in the H-region of the signal 
peptide, reducing it from 8 to 4 residues, resulted in 
accumulation of active enzyme in the cytoplasm (Perlman et al.
1986). Western blot analysis revealed that the mutant enzyme, 
now located in the cytoplasm, was not glycosylated and retained 
its signal peptide. This indicates that the enzyme had no 
interaction with the ER membrane. (Disruption of the invertase 
signal peptide cleavage site alone, inhibiting signal 
processing does not interfere with translocation (Schauer et 
al.1985).
Along a similar line, human lysozyme is efficiently secreted 
and processed in yeast when fused to a synthetic signal peptide 
constructed to optimise the H-region (Yamamoto and Kikuchi
1989). In this signal, 8 contiguous leucine residues make up 
the hydrophobic core. Leucine was chosen for this purpose 
because of its hydrophobic nature and its disposition toward 
forming a-helical structures (Chou and Fasman, 1978). Reduction 
of this core to just 6 leucine residues resulted in a decrease 
in secretion efficiency to 40% compared to the 8 leucine 
sequence.
Overall, mutant leader peptides seem to have varying effects on 
translocation efficiency. In bacteria, point mutations and 
substitutions, sometimes affecting only one amino acid can have 
drastic consequences blocking secretion completely. In 
eukaryotes however, mutations that intefere with signal 
function and block secretion tend to be large deletions or 
rearrangements (Perlman et al. 1986; Gething and Sambrook,
1982). In some cases, as outlined above, partial signal
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function is retained. In bacteria also, deletions in the 
H-region of the outer membrane lipoprotein (lpp) of E.coli 
disrupt secretion to different extents, some deletions having 
more pronounced effects than others (Inouye et al. 1984).
Certain mutations therefore, even in this highly conserved core 
retain the ability to translocate proteins, albeit with lower 
efficiencies.
To investigate the extent that alternate sequences can function 
as signal peptides, Kaiser (1987) adapted the secretion of 
invertase in yeast as a model test system. The invertase signal 
peptide was removed and replaced with random peptide sequences 
derived from human genomic DNA. 20% of these random sequences 
were shown to contain some signal function, allowing the 
secretion of invertase, reflected by the ability of these cells 
to grow on sucrose. Although the sequences secreted invertase 
with different efficiencies (only a small amount of secreted 
enzyme is required for growth on sucrose), all allowed a 
proportion of the enzyme to be translocated into the lumen of 
the ER where core glycosylation took place. Sequence 
comparisons to non-functional isolates showed the functional 
ones to be enriched in hydrophobic residues and depleted in 
charged amino acids.
Revertants of the non-functional, secretion defective isolates 
generated in this study were also examined (Preuss and 
Botstein, 1989). The revertants were selected by their ability 
to grow on sucrose as a sole carbon source after treatment with 
the mutagen ethylmethylsulphate (EMS), or with ultra violet 
(UV) irradiation. Spontaneous revertants were also isolated. 
Sequencing the revertant leaders showed that the mutations 
allowing secretion were all point mutations that either 
introduced hydrophobic residues or deleted charged residues in 
the N-terminal random sequences.
Kaisers experiments demonstrate the broad range of sequences 
that can function, however inefficiently, as signal peptides 
allowing targeting and translocation to the ER membrane. The 
hydrophobic domain is clearly important and the functional 
sequences isolated in the above studies resemble known signal
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peptides in this respect. This region has a potential role in 
membrane targeting as well as interacting with the ER membrane 
itself. However, the specificity of the export process is 
unlikely to depend on the presence of a hydrophobic domain 
alone, especially considering that most proteins contain 
hydrophobic sequences. The inefficiency of the sequences 
isolated in Kaisers experiments underline this.
The conservation of overall signal peptide structure, as 
already mentioned, goes further than the presence of this 
hydrophobic domain. A positively charged amino terminus and the 
cleavage site region are equally well conserved (von Heijne, 
1985). The roles of these domains in the translocation process 
and overall signal function and their interaction with each 
other have also been considered.
(1.3.3) The hydrophillic domain: the role of positively charged 
amino acids.
The genetic selections used to generate signal peptide mutants 
in vivo, some of which have been described, all yielded 
disruptions mapping to the hydrophobic domain. In no case were 
alterations to the hydrophillic N-domain of the signal peptide 
obtained that resulted in a secretion defective phenotype. The 
hydrophillic domain however is a conserved feature in all 
signal peptides and in prokaryotes, secretory proteins carry a 
net positive charge in this region (von Heijne 1984a).
The potential importance of these charged residues and their 
possible role in prokaryotic signal function, was first 
proposed in the "loop model" for protein translocation (Inouye 
and Halegoua, 1982). According to this model, the N-terminal of 
the signal peptide does not leave the cytoplasm. The basic 
amino acids in this region are proposed to interact with the 
acidic groups in the phospholipids of the bacterial cytoplasmic 
membrane, anchoring it in the cytoplasm and allowing the 
hydrophobic core to loop into the membrane. The electrochemical 
potential that exists across the bacterial cytoplasmic 
membrane, which is negatively charged on the cytoplasmic side, 
would promote this type of interaction (Li et al. 1988).
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Oligonucleotide site-directed mutagenesis has generated 
mutations mapping to the hydrophillic N-domain of prokaryotic 
and eukaryotic signal peptides. A lot of interest has focussed
on positively charged amino acids in this region. Although the
N-termini of all prokaryotic signal peptides contain at least 
one basic amino acid, evidence suggests that this feature is
not absolutely required for signal function. Removal of the 3 
basic residues in the maltose binding protein (MBP) of E.coll, 
for example, has no effect on export of the protein (Puziss et 
al. 1989). Similarly, when the 2 lysine residues are removed
from the prolipoprotein signal peptide, no discernable effect 
on translocation is observed (Vlasuk et al. 1983). However, a
net charge of at least +1 is required to obtain correct
processing when this signal peptide is fused to /3-lactamase 
(Lunn et al. 1987). The introduction of net negative charges in 
the N-domain of prolipoprotein and MBP does affect
translocation, decreasing the kinetics of the process
considerably (Vlasuk et al. 1983; Pusiss et al. 1989).
Translocation takes place, but at a slower rate compared to the 
wild type sequences.
These observations have led to the suggestion that the N-domain 
of the signal peptide plays a facilitative role in 
translocation. The presence of positive charges, while not 
absolutely necessary, may act to improve the efficiency of the 
whole process. The exact function of these charged residues
however remains unclear. Although it has not been proved 
conclusively, cross-linking studies suggest that the SecA 
protein, a cytoplasmic component of the E.coll secretory 
pathway that is essential for translocation, interacts with the 
positive charges in the OmpA signal peptide (Akita et al.
1990). The extent of the interaction is dependant on the number 
of positive charges present in the hydrophillic domain. The 
SecA protein also interacts with other known secretory pathway 
components and could therefore mediate interactions between the 
signal peptide and other components involved (Fandl et a.l.
1988). PrlD2 supressor strains can partially rescue the 
phenotype of MBP N-domain mutants (Puziss et al. 1989). The
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prlD2 supressor strain, which is allelic to SecA (Fikes and 
Bassford, 1989), has no effect on hydrophobic core mutations 
and it is possible that SecA interacts more strongly with the 
hydrophillic section of the signal peptide.
In yeast, a potential role for the hydrophillic domain of 
signal peptides is less easy to define. Not all yeast signal 
peptides exhibit a net positive charge in the N-domain (Kaiser 
and Botstein, 1986) and the ER membrane does not contain a 
general electrochemical potential. None of the random sequences 
generated by Kaiser (1987) that promoted translocation of 
invertase, contained hydrophillic segments or positive charges. 
In contrast to this, with a similar experiment carried out in 
E.coli, most of the functional leader peptides derived from 
random sequences did contain a net positive charge preceding 
the hydrophobic domain (Zhang and Broome-Smith, 1989).
The signal peptide of the yeast secretory protein alpha-factor, 
has an arginine residue at position 3 in the pre-region. The 
position of this positively charged residue rather than it's 
presence appears to be an important feature in the functioning 
of this leader peptide (Green et al. 1989). Replacement of this 
amino acid with a neutral phenylalanine residue, has no effect 
on secretion. Misplacement of the positive charge by one 
position however, has a significant effect, reducing 
translocation efficiency by up to 70%.
Green (1989) proposes that misplacement of the positive charge 
in the a-factor pre-region may adversely affect interactions of 
the protein precursor with molecular chaperones such as heat 
shock proteins (hsps) (section 1.4.4), or a similar interaction 
with other components of the secretory pathway. It has also 
been suggested that this charged residue may be important in 
intramolecular interactions with a series of 3 contiguous 
acidic amino acids in the mature region of the a-factor protein 
(at positions 7-9). Transposition of the charged residue could 
promote or destroy an electrostatic interaction in this region, 
resulting in a reduction in translocation efficiency.
The interaction of positive charges in the mature sequence of 
prokaryotic secretory proteins and the N-domain of signal
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peptides has been investigated. A net positive charge at the 
extreme N-terminus of chicken triosephosphate isomerase, when 
fused to the E.coll lamB signal peptide, has a detrimental 
effect on translocation of the protein (Andrews e C  al. 1989; 
Summers and Knowles, 1989). As the positive charges are moved 
further away from the N-terminus, by the insertion of lamB 
sequences, the blocking effect weakened. The introduction of 
positive charges into this region of the mature alkaline
phosphatase sequence results in a similar defect in
translocation efficiency (Li et al. 1988). A study of
prokaryotic signal peptides (von Heijne, 1986) shows that in 
most cases there is a net negative or neutral charge in the
area including the C-domain and the extreme N-terminus of the
mature sequences of secretory proteins. This characteristic may 
have evolved to avoid the detrimental effects positive charges 
can have on translocation of certain proteins. No such pattern 
is observed however, in the majority of eukaryotic secretory 
proteins.
The potential importance of the N-domain in the folding of
secretory precursors has been mentioned. Positive charges in
this region of yeast secretory proteins appears to be important 
in some cases only. Signal peptides, having evolved with a 
specific protein, will presumably be optimised for the 
translocation needs of that particular molecule, taking into 
account its charged regions, folding characteristics and 
conformational requirements. In many cases, the particular
properties of some signal peptides or the requirements of 
certain proteins to achieve translocation only become apparent 
when specific characteristics are modified, or in heterologous 
fusion experiments.
It seems likely that the N-domain is important in improving the 
efficiency of the translocation process. With the exception of 
hsps, specific components that interact with this region have 
yet to be identified in yeast. The recent identification of 
proteins involved in early tranlocation events in the yeast 
secretory pathway (section 1.4.2) may reveal more information 
about protein interactions in this region.
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(1.3.4) The signal peptide cleavage site.
The C-terminal of signal peptides, containing the cleavage 
site, is the only region where the conservation of amino acid 
sequences is observed. A statistical analysis of sequences 
around the cleavage site of prokaryotic and eukaryotic leader 
peptides shows that certain patterns of amino acids are 
preferred in this region. (von Heijne, 1983, Perlman and 
Halvorsen, 1983). These studies have revealed that small 
neutral amino acids predominate at positions -1 and -3 
(position -1 being defined as one amino acid upstream of the 
actual cleavage site), and that aromatic residues are strictly 
avoided at these positions but are present at position -2. More 
extensive analyses show that alanine is the preferred residue 
at -1 and -3 and, that an order of preference exists for other 
acceptable amino acids at these positions (von Heijne, 1983).
A general model has been proposed for how signal peptides 
maintain their cleavage specificity (von Heijne, 1984b). This 
model incorporates the position of the last residue of the 
H-domain (occurring at position -6 in eukaryotes and -7 in 
prokaryotes). The end of the H-domain defines a window of 
potential cleavage sites that compete for access to the signal 
peptidase. Cleavage occurs at the most probable site defined by 
the observed amino acid preferences revealed in the study 
outlined above. Although this model is based on statistical 
analysis of known signal sequences, a study of approximately 
300 eukaryotic, prokaryotic and viral leader peptides (Watson
1984), showed that for 74% of viral and eukaryotic proteins, 
cleavage occurred at the site with the highest processing 
probability. 11% of these proteins were cleaved at the second 
most likely site. For prokaryotic signal sequences, 39% of 
actual cleavage sites were as predicted with 15% at the second 
most likely site.
Analysis of signal sequence termini shows that in many cases 
greater than one potential cleavage site exists and in vivo 
cleavage heterogeneity does occur. Bovine growth hormone for 
example, is processed at an alanine residue in 65% of case/3, 
the remaining 35% of cleavage events occurring one position
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upstream (Lingappa et al. 1977). Human interferon when produced 
in yeast is processed at more than one site (Hitzeman et al.
1983) , and cleavage of rat prolactin can be forced to take 
place at a less favourable site by replacing one amino acid at 
the ideal cleavage site (Hortin and Boime, 1981).
(1.4) Proteins that interact with signal peptides.
(1.4.1) The signal recognition particle (Srp) and Srp receptor. 
The first components of the eukaryotic secretory pathway 
identified to be involved in sequestering secretory proteins, 
were the srp and srp receptor (section 1.2.2). Disassembly, 
fractionation and reconstitution experiments (summarized by 
Seigel and Walter, 1988a), have allowed the detailed 
characterization of mammalian srp and its functions. Srp is 
made up of 6 polypeptides and a 7SL RNA molecule. The complex, 
which is held together by protein/protein and protein/RNA 
interactions, is arranged into 4 units consisting of 2 dimers 
(p9/14 and p68/72) and 2 monomers (pl9 and p54).
Srp recognizes the signal peptide of a nascent secretory 
protein as it emerges from the ribosome (Walter and Blobel,
1981). The specificity of this recognition and binding is 
dependant on nascent chain length. The efficiency of srp 
directed targeting drops dramatically as polypeptides emerging 
from the ribosome exceed approximately 140 amino acids in 
length (Siegel and Walter, 1988b). Translation arrest, which 
occurs after binding to the signal peptide and ribosome and 
which is a characteristic feature of membrane targeting in 
higher eukaryotes, is associated with the p9/14 dimer subunit 
of srp (Siegel and Walter, 1988a). Photocrosslinking 
experiments show that the 54kDa polypeptide of srp specifically 
binds signal peptides of various secretory proteins (Kurzchalia 
et al. 1986; Krieg et al. 1986). Sequence analysis of this
polypeptide reveals that it is made up of 2 domains, a G-domain 
which has the potential to bind GTP, and an M-domain, rich in 
methionine residues (Romisch et al. 1989; Bernstein et al.
1989). This protein also shares homology with the srp receptor
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which is present on the ER membrane.
Proteins sharing homology with parts of the mammalian srp have
been identified in E.coli and yeast (S.cerevisiae and
Sz.pombe). In yeast, the genes were isolated on the basis of 
their sequence homology to the p54 subunit of mammalian srp and 
predict protein sequences that are 50% identical to the
mammalian counterpart (Hann et al. 1989). The yeast proteins
contain a G-domain and an M-domain and although no functions 
have been designated as of yet, they represent the first
evidence of srp related proteins in yeast. In E.coli, a 4.I5S 
RNA molecule which specifically binds a 48kDa (p48) protein has 
been identified (Ribes et al. 1990). The mammalian srp
component, p54, can also bind this RNA in a complex that can 
functionally replace the 4.5S RNA/p48 complex to promote 
translocation of /3-lactamase in E.coli. Also the mammalian 7S 
RNA species can functionally replace the E.coli 4.5S RNA. This 
E.coli 4.5S RNA and p48 are thought to be structural and 
functional homologues of the mammalian species and are involved 
in the transloocation of at least some of E.coli's secretory 
proteins.
Srp has a close affinity for its receptor in the ER membrane. 
Interaction with the srp receptor results in displacement of 
srp from the nascent chain/ribosome complex, a process which 
involves GTP hydrolysis (Connolly and Gilmore 1989). This
interaction results in transfer of the signal peptide to the ER 
membrane where it is found in close proximity to a 34kDa
integral membrane protein known as the signal sequence receptor 
protein (ssr) (Weidmann et al. 1989). The ssr protein is a
constituent of the protein environment where secretory proteins 
are transferred through the membrane. Antibodies raised against 
the protein inhibit translocation across microsomal membranes 
in vitro (Hartmann et al. 1989) and it seems likely that this
protein forms part of a putative translocation complex in the
ER membrane. Further investigations should reveal more
information about the nature of this complex and the mechanisms 
by which translocation, after the targetting event, is
achieved.
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(1.4.2) Proteins involved in the yeast translocation event.
Genetic selections have been used to isolate components of the 
yeast secretory process (section 1.2). None of the temperature 
sensitive, secretion defective (sec) mutants isolated in these 
initial studies however, uncovered steps in the early 
translocation stage of secretion. The earliest acting mutants 
isolated in this screen were the glycosylation mutants 
affecting proteins after translocation into the ER 
(Ferro-Novick et al. 1984).
A more refined assay, developed to specifically target 
translocation events (described in detail in Fig.1.4), resulted 
in the the identification of three genes SEC61, SEC62 and SEC(53 
(Deshaies and Schekman, 1987; Rothblatt et al. 1989). In vivo 
and in vitro studies show that at the non-permissive 
temperature, these temperature sensitive mutants block 
transport of secretory and vacuolar proteins into the ER 
(Deshaies and Schekman, 1987 and 1989) and accumulation of 
unprocessed precursors occurs in the cytoplasm. Interestingly, 
all three mutants isolated in this screen encode products that 
are membrane associated, no yeast equivalents of srp-like 
components were identified, although Sec61 is a possible 
candidate.
Initially Sec62 was shown to be an integral membrane protein 
(Deshaies and Schekman, 1989 and 1990) and sequence analysis of 
SEC63 reveals that the gene product has a potential membrane 
spanning domain (Sadler et al. 1989). Antibodies to the Sec<52 
protein were used to investigate the nature of the protein's 
association with the ER membrane (Deshaies et a l .  1991'). 
Immunoprécipitations using this antibody on solubilised 
membranes, showed that Sec62 is associated with Sec61 and Sec(33 
in the ER membrane, comprising a multisubunit membrane 
associated complex. Furthermore, Sec61 appears to have a labile 
association with this putative complex, suggesting a potential 
intermediary role, possibly involved in targetting. Two other 
proteins of molecular weights 31.5 and 28kDa were precipitated 
along with this complex. Based on molecular weight comparisons, 
these proteins were tentatively proposed to be comparable to 2 
subunits of the mammalian ssr protein. It is likely that this
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complex is involved in the actual translocation of secretory 
proteins at this site in the ER membrane. Further 
manipulations, including reconstitution experiments, may 
uncover the mechanism by which proteins are translocated across 
membrane structures in yeast, the details of which have proved 
elusive in the less easily manipulated mammalian systems.
Figure (1.4) Selection of translocation mutants in yeast 
(taken from Deshaies et al, 1989).
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The His4 protein (His4p) converts histidinol to histidine and 
is normally a cytoplasmic protein. When modified with a signal 
peptide, His4p is targeted to the ER. Cells expressing this 
fusion fail to grow on minimal medium supplemented with 
histidinol, due to the inability of the substrate to gain 
access to the ER. By selecting for mutants that could grow on 
histidinol, temperature sensitive mutants that disrupted 
translocation of His4p to the ER:were isolated.
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(1.4.3) The importance of conformation for translocation
competence.
A series of cytosolic proteins have emerged as essential 
components of the eukaryotic and prokaryotic secretory process, 
interacting with secretory precursors to promote translocation 
across the ER and cytoplasmic membranes. Proteins from 
bacterial, mammalian and yeast cells have been identified that 
are involved in binding secretory precursors to promote and 
maintain an unfolded, translocation competent state. These 
proteins are termed chaperones.
Evidence for the unfolded state was first shown for the import 
of mitochondrial precursors (Eliers and Schatz, 1986).
Pre-secretory proteins in bacterial and eukaryotic cells also 
exhibit similar conformational requirements for translocation. 
In E.coli, evidence for the unfolded state comes from the 
examination of pre-secretory forms of OmpA and MBP (Crooke and 
Wickner, 1987; Randall and Hardy, 1986). Both of these proteins 
are sensitive to protease digestion in their presecretory forms 
only, suggesting a loosely folded conformation. In some cases, 
artificial denaturation, using urea, can render pre-proteins 
competent for translocation in vitro without the addition of 
cytosolic extracts (Sanz and Meyer, 1988). Dilution of the urea 
results in renaturation of the protein and is accompanied by a 
loss of translocation competence.
In cells where translocation has been artificially blocked, 
pre-MBP remains in a loosely formed conformation for up to 10 
minutes (Randall and Hardy, 1986). The factor involved in 
maintaining the unfolded conformation of pre-MBP is the SecB 
protein (Collier et al. 1988). SecB strains exhibit a severe 
defect in export of MBP, and pre-MBP isolated from secB 
strains was shown to be in a tightly folded, protease resistant 
form (Kumamoto et al. 1988). Purified SecB can prevent the 
formation of protease resistant pre-MBP in vitro and can also 
block the refolding of artificially denatured pre-MBP (Collier 
et al. 1988; Liu et al. 1988). SecB can also maintain proOmpA 
in a translocation competent state in vitro (Lecker et al. 
1989). In vivo however, secB strains are not defective in OmpA
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export and sec B cell extracts can still promote OmpA 
translocation in vitro (Kumamoto et al. 1989). Another 
chaperone protein, trigger factor, has been shown to 
specifically interact with proOmpA to promote translocation in 
much the same: way as SecB (Crooke and Wickner 1987) . This
evidence suggests that there are several chaperone proteins 
involved in protein export and that different ones are specific 
for different proteins.
Eukaryotic cells also appear to require the presence of 
molecular chaperones and it has been suggested that srp may act 
as such in mammalian cells. Srp can replace trigger factor to 
stabilise proOmpA for translocation across bacterial, yeast and 
mammalian membrane structures (Sanz and Meyer, 1988). It is 
also functional in promoting prepro a-factor translocation into 
yeast microsomes (Crooke et al. 1988). Dénaturation of these 
proteins prior to the addition of srp was required to allow 
translocation. This correlates with the co-translational
targeting role of srp in vivo and the general idea that
chaperones are likely to bind precursors as they are 
synthesized rather than actively unfolding the completed 
proteins.
(1.4.4) Unfolding in yeast: the role of heat shock proteins.
In yeast, genetic and biochemical evidence suggests that 
members of the heat shock family of proteins (hsps) play a role 
in promoting translocation competence in pre-secretory proteins 
(Chirico et al. 1988). When prepro-a-factor is produced in 
wheat germ lysate, it can only be translocated into yeast
microsomes if yeast cytosolic extract is added. Fractionation 
of the extract showed that this activity is associated with 2 
yeast hsps, SSAl and SSA2 (members of the 70kDa hsp family). 
The effect can also be achieved if the protein is denatured
before addition of the yeast membranes. This reinforces the 
idea that proteins must be unfolded in order to be translocated 
in yeast. The involvement of these proteins is backed up at a 
genetic level in that ssal mutants accumulate a-factor, 
carboxypeptidase-Y and mitachondrial precursors in unprocessed,
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untranslocated forms (Werner-Washburner et al. 1987).
The in vitro evidence involving fully formed a-factor, suggests 
that hsps can act in a post-translational capacity. It has been 
proposed that these proteins may act as "unfoldases", possibly 
using energy derived from ATP hydrolysis to actively unfold 
protein precursors before translocation (Rothman and Kornberg,
1986). Hsps have also been implicated in post-translational 
translocation in mammalian cells (Zimmerman et al. 1988) and in 
E.coli where the GroEL protein has been shown to interact with 
/3-lactamase to promote its translocation (Kusukawa et al. 
1989).
(1.4.5) Characterization of signal peptidases.
Two E.coli signal cleavage enzymes have been identified, leader 
peptidase or SP1 (Zwizinski and Wickner 1980) and lipoprotein 
peptidase or SP11 (Tokunaga et al. 1982). Both signal
peptidases are integral membrane proteins with molecular masses 
of 36 and 18kDa respectively. Repression of leader peptidase 
function results in accumulation of unprocessed precursors in 
the E.coli periplasm (Dalbey and Wickner, 1985) This suggests 
that in E.coli, while signal peptidase is not essential for 
translocation, retention of the signal peptide inhibits the 
release of secretory proteins into the periplasm.
Signal peptidases of higher eukaryotic cells appear to be more 
complex. Canine and avian signal peptidases have been isolated 
as multisubunit complexes (Evans et al. 1986; Baker and Lively,
1987). Canine microsomal signal peptidase consists of 6 
polypeptides and hen oviduct signal peptidase exists as a 
heterodimer. Two of the canine and one of the avian subunits 
are glycosylated and share sequence homologies (Shelness et al.
1988). Despite the differences in complexities, the substrate 
specificities of prokaryotic and eukaryotic signal peptidases 
are remarkably similar and both enzymes cleave eukaryotic and 
prokaryotic signal peptides at the correct cleavage sites 
(Watts et al. 1983; Muller et al. 1982). The extra subunits of 
the vertebrate enzyme complex may provide additional functions 
associated with increasing the efficiency or cleavage
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specificity of the signal cleavage process in vertebrates 
(Randall and Hardy, 1989).
Disruption of signal peptide cleavage sites in yeast secretory 
proteins results in retention of the signal peptide. 
Translocation of the mutant protein is not affected. 
Replacement of an alanine residue with valine at position -1 in 
the secreted form of invertase inhibits cleavage and the 
unprocessed form of the enzyme is translocated into the lumen 
of the ER (Schauer et al. 1985). Although translocation is 
achieved, the mutant invertase accumulates in the ER and 
further secretion is delayed. This has been shown to be a 
result of insolubility of this form of invertase in the lumen 
of the organelle, combined with a possible association between 
the mutant protein and the ER membrane via the signal peptide 
(Schauer et al. 1985). Another yeast secretory protein, acid
phosphatase, is also transiently retained in the ER when signal 
cleavage is inhibited (Haguenauer-Tsapis et al. 1986).
A mutation to the yeast signal peptidase would presumably mimic 
this phenotype of delayed secretion patterns. One of the yeast 
temperature sensitive sec mutants, secll, was shown to 
transport invertase and acid phosphatase at severely reduced 
rates (Bohni et al. 1988). At the restrictive temperature,
secll cells accumulate core glycosylated acid phosphatase and 
invertase with their signal peptides still intact. The SEC11 
gene was cloned and shown to encode an 18.8kDa integral 
membrane protein with one potential glycosylation site. The 
mass of the protein is very similar to the avian and canine 
glycosylated subunits described and although it does not share 
exact sequence homologies with the canine subunit, the two 
proteins have similar arrangements of hydrophillic and 
hydrophobic domains (Shelness et al. 1988). The SEC11 gene
product is essential for signal peptidase activity in yeast. At 
this stage it is not clear if the yeast signal peptidase, as it 
is now referred to, acts as part of a complex. Also it is not 
known if the Secll protein is responsible for the actual 
cleavage event. A method has been developed for the 
solubilisation of microsomal membranes retaining signal
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peptidase activity and should allow further characterisation of 
the Secll protein (Ya Deau and Blobel, 1989).
(1.5.0) Sorting signals in the secretory pathway.
In addition to secretory proteins, the ER contains proteins 
bound for membrane structures, proteins en route to the Golgi 
and proteins destined to remain in the ER itself. A large 
number of these ER proteins interact with incoming proteins 
allowing them to fold and mature before being passed on (Pelham
1989) . An intriguing question which arises out of studying this 
transport process, is how the cell sorts these proteins. What 
distinguishes ER resident proteins from those that are to be 
passed on and how are proteins targeted to their final 
destinations?. Also, in the Golgi, how are proteins destined 
for vacuolar compartments diverted from the bulk flow of 
protein traffic into vacuole specific vesicles? While the 
question of protein sorting in the secretory pathway of
eukaryotic cells is far from fully understood, the 
investigation of two sorting events has allowed some insights 
into the mechanisms involved and the types of signals used.
(1.5.1) Retention In the ER.
Proteins enter the ER in an unfolded state (section 1.4). In 
order to be transported further, refolding, assembly and ER
modifications must first take place. In mammalian cells, an ER 
protein known as BiP (binding protein) was found associated 
with malfolded secretory proteins that were blocked from 
further transport in the ER of mammalian cells (Gething et al, 
1986). Enhanced expression of the protein was observed under 
conditions that promote the accumulation of unfolded or mutant 
proteins (Kozutsumi et al, 1986). BiP was also found to be
transiently associated with wild type forms proteins in the ER 
(Bole et al, 1986). It was proposed that BiP, and possibly
other ER proteins, could be involved in monitoring the folding 
of secretory proteins, allowing correct assembly, folding and 
modifications to take place before further transport
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(Normington et al 1989).The yeast homologue of BiP acts in a 
similar fashion to its mammalian counterpart (Rose et al 1989; 
Normington et al 1989). Expression of yeast BiP is induced when 
secretory proteins accumulate in the ER, such as in seec'. 53 
mutants or after treatment with tunicamycin (section 1.6).
The identification of BiP and other ER resident proteins such 
as PDI (protein disulphide isomerase), has allowed some insight 
into ER sorting mechanisms. Comparison of BiP and PDI sequences 
reveals a common carboxyl terminus of four amino acids, KDEL 
(Munro and Pelham, 1987). Removal of this KDEL sequence results 
in secretion of the proteins (Mazzarella et al 1990). The 
addition of the tetrapeptide to the C-terminal of secretory 
proteins, results in their accumulation in the ER (Pelham,
1988). Experiments with S.cerevisiae BiP and PDI proteins have 
yielded similar results, although in this organism the 
retention signal differs to the mammalian by one amino acid ie.
HDEL instead of KDEL (Hardwick et al 1990). In Sz.pombe, the
sequence is ADEL while K.lactls recognizes both DDEL and HDEL 
(Inhohara et al, 1989; Lewis et al, 1990).
In S.cerevisiae, secretory proteins tagged with HDEL accumulate
in the ER, having acquired modifications known to occur in 
early Golgi compartments (Dean and Pelham, 1990) (see section 
1.6 for glycosylation of secretory proteins). This observation 
led to a model for retention based on retrieval. It was 
proposed that ER proteins can leave the ER in secretory 
vesicles but are retrieved by interaction with a putative 
membrane bound receptor. This receptor would bind the HDEL 
sequence and return the proteins to the ER via a special set of 
transport vesicles.
This receptor (the ERD2 gene product) was identified in yeast 
by the isolation of mutants that failed to retain secretory 
proteins tagged with the HDEL retention sequence (Semenza et al
1990). The gene was shown to encode a membrane spanning 
protein, the expression levels of which control the capacity of 
the retention system. This gene was also cloned from K.lactis. 
(Lewis et al 1990). S .cerevisiae, carrying the K.lactis ERD2 
gene, recognises both HDEL and DDEL sequences, demonstrating
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that this receptor specifically recognizes the retention
signal. The human homologue of ERD2 has also been identified 
and the gene product localised to a post-ER Golgi-lilce 
compartment (Lewis and Pelham, 1990). While the available
evidence supports a model of retrieval for ER retention in 
higher and lower eukaryotes, the exact nature of the
interactions between signal and receptor and the process of 
retrieval are not fully understood.
(1.5.2) Vacuolar sorting signals.
The second major sorting step that has attracted much
investigation is the diversion of proteins from the Golgi into 
secretory vesicles bound for the lysosome. In mammalian cells, 
tagging of acid hydrolyses with mannose-6-phosphate (Man-6-P) 
has been shown to signal targeting of these proteins (Sly and 
Fischer,1982).
The yeast equivalent of the lysosome is the vacuole, an acidic 
compartment containing numerous hydrolytic enzymes. Studies on 
proteins directed to the vacuole has led to an understanding of 
some of the requirements for targeting in S .cerevislae. 
Carboxypeptidase-Y (CpY) is the best studied of these vacuolar 
hydrolases. It is produced as an inactive precursor (proCpY) 
and undergoes glycosylation in the ER before sorting occurs at 
the level of the Golgi (Hasilik and Tanner, 1978; Stevens et al 
1982). In the vacuole, CpY is converted to its mature active 
form by the action of another vacuolar protease proteinase A 
(PrA) , the product of the PEP4 gene (Ammerer et al 1986) . 
Glycosylation is not involved in protein sorting to the vacuole 
in yeast and inhibition of glycosylation has no effect on 
localisation of CpY (Schwaiger et al 1982).
Fusion experiments involving portions of the proCpY N-terminal 
and yeast invertase, showed that the propeptide of CpY can 
direct invertase to the vacuole (Bankaitis et al 1986). This 
fusion protein, when expressed on a low copy number plasmid, 
targeted invertase to the vacuole with < 2% being secreted to 
the cell surface. Increasing the copy number resulted in up to 
20% of the invertase being secreted, suggesting that the
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targeting system is saturable. This is also the case when wild 
type CpY is overexpressed in S.cerevisiae (Stevens et al 1986). 
Deletion studies and site directed mutagenesis of CpY 
identified four contiguous amino acids (QPRL), at positions 24 
-27 in the pro-region of the signal sequence, to be responsible 
for targeting of CpY to the vacuole (Vails et al 1987) . Similar 
analyses with the other vacuolar hydrolase proteinase A (PrA), 
demonstrated that the pro region of this peptide can also 
target CpY to the vacuole (Klionski et al 1988). Sequence 
analysis of PrA, however, did not reveal a QPRL motif or any 
other similarities to CpY in this region, suggesting that 
greater than one recognition signal may exist.
The CpY-invertase fusion was used to isolate potential 
receptors involved in the targeting process. In a sue strain, 
mutants missorting the CpY-invertase fusion to the cell surface 
were isolated on the basis of their ability to grow on sucrose 
as a sole carbon source. A large number of mutants, defining 47 
complementation groups, were identified using this screen 
(Bankaitis et al 1986; Banta et al 1988). One mutant in 
particular, vpsl5 (producing a mutant protein kinase) has been 
analysed in detail. Study of this enzyme, which exhibits 
phosphorylating and autophosphorylating activities, has led to 
the suggestion that phosphorylation may play a role in the 
regulation of vacuolar recognition and sorting events in 
S.cerevisiae (Herman et al, 1991).
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(1.6.0) N-linked glycosylation of eukaryotic proteins.
Secretory proteins passing through the ER membrane, acquire 
asparagine-linked (N-linked) core oligisaccharide chains which 
are subsequently modified and extended in the Golgi. Studies in 
yeast using mutants defective in secretion and glycosylation 
have proved invaluable in characterising the individual steps 
involved in assembly, transfer and modification of these 
oligosaccharides.
The assembly of oligosaccharide chains onto yeast and mammalian 
glycoproteins involves a large number of transfer reactions. 
This core oligosaccharide is assembled in both cases on a 
phosphorylated dolichol glycolipid (P-Dol), in the ER membrane. 
The core unit is made up of 14 sugars (3 glucose, 9 mannose and 
2 N-acetylglucosamine residues), Glc^MangGlcNAc^, which are 
transferred to the polypeptide chain via an N-glycosidic bond 
to asparagine (Asn) residues. In both _yeast and mammalian 
cells, this Asn residue is a substrate when it occurs within 
the sequence Asn-X-Ser/Thr, where X can be any amino acid 
except proline (Lehle and Bause, 1984). The pathway for 
assembly and transfer of this core oligosaccharide is similar 
in both systems. The differences lie in the trimming and 
addition reactions that are initiated in the ER and completed 
in the Golgi.
Much of the initial information about core glycosylation has 
come from investigations in mammalian cells. Yeast however, has 
confirmed this model with the isolation of alg (asparagine 
linked glycosylation) mutants that have allowed further 
characterisation of the individual steps. The assembly, 
transfer and trimming of the yeast oligosaccharide core is 
summarized below in sections (1.6.1) and (1.6.2) and in Figure
(1.5) (Deshaies et al 1989).
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Figure (1.5) Assembly of the core oligosaccharide on the ER 
membrane, transfer onto the protein and trimming of the core. 
(Taken from Deshaies et al, 1989)
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(1.6.1) Core oligosaccharide assembly.
The first step in the pathway involves the addition of 
GlcNAc-l-P from UDP-GlcNAc to P-Dol on the ER membrane. This 
initial step is inhibited by the antibiotic tunicamycin (Lehle 
and Tanner, 1976). Prolonged incubation of yeast cells in 
tunicamycin is lethal and the transferase gene (ALG7), 
responsible for the addition of this first GlcNAc residue was 
isolated from a genomic library on the basis of its tunicamycin 
resistant phenotype (Rine et al 1983; Barnes et al 1984). The 
second GlcNAc is then added to the growing oligosaccharide 
chain before transfer of the first mannose residue. This first 
mannose residue is transferred from GDP-mannose by the action 
of /3-l,4 mannosyltransferase, encoded by ALG1. This gene and 
the other ALG genes, with the exception of ALG7, were isolated 
by their ability to complement alg mutants. These mutants were 
generated using a mannose suicide selection screen whereby
glycosylation mutants survive due to their reduced ability to
3incorporate H-mannose (Huffaker et al 1982) .
The algU mutant was shown to accumulate a spectrum of 
oligosaccharide intermediates containing 1 to 8 mannose 
residues (Huffaker and Robbins, 1983). Due to the broad range 
of incomplete oligosaccharide units linked to the dolichol 
carrier observed in this mutant, it seemed likely that the ALG4 
gene product would play a more indirect role in mannose 
addition than for example a transferase. The sec53 temperature 
sensitive mutant, defective in secretion and glycosylation of 
invertase and a-factor glycoproteins, was shown to be allelic 
to algh (Ferro-Novick et al 1984; Feldman et al 1987). Detailed 
analysis of the sec53 mutant at permissive (25°C) and 
non-permissive (37°C) temperatures in cell free translocation 
and glycosylation systems, has allowed characterization of the 
sec53 defect (Kepes and Schekman, 1988). Extracts and membranes 
from sec53 cells were shown to accumulate a-factor precursors 
with 0,1,2 and 3 core oligosaccharide units. Rescue of this 
phenotype and full glycosylation of the a-factor protein cou.Ld 
be stimulated by the addition of wild type cell extract. 
Enhanced stimulation was observed using the cell extract of
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these cells carrying the SEC53 gene on a multicopy plasmid. 
Supplementing sec53 membranes with GDP-mannose also stimulated 
glycosylation and it was proposed that the mutant was defective 
in the phosphomannomutase activity responsible for converting 
Man-6-P to Man-l-P in vivo. This was confirmed by examination 
of the SEC53 gene product in a surrogate bacterial host 
(S. typhimurium) where the host and yeast phosphomannomutase 
activities could be distinguished (Kepes and Schekman, 1988). 
After the addition of the first 01-4,mannose residue, four 
additional mannose sugars are added in various linkages (a-1,6; 
a-1,3; and a-1,2), from GDP-mannose donors (see Fig.1.5). Two 
mutants, alg2 and sec59 have been implicated in effecting this 
step (Huffaker and Robbins, 1983; Bernstein et al 1989). algl 
mutants accumulate incomplete oligosaccharides containing 1 or 
2 mannose residues and are temperature sensitive for growth. 
sec59 also produces a discrete set of incomplete core units 
ranging from 5 to 6 mannose additions. Accumulated invertase 
and a-factor isolated from sec 59 cells at the restrictive 
temperature, contain incomplete core units that are sensitive 
to cleavage by endoglycosidase H (EndoH). This is unusual as 
the normal Man,.intermediate is EndoH resistant, as are the alg3 
intermediates which accumulate at the next stage of assembly 
(see below). GDP-mannose and Dol-P are not limiting in sec59
cell extracts when tested in an in vitro translocation /
glycosylation system and it has been suggested that SEC59 may 
encode a mannosyltransferase (Huffaker and Robbins 1983; 
Bernstein et al 1989) .
These initial steps in core unit assembly are believed to take 
place on the cytoplasmic side of the ER membrane. Evidence for 
translocation of the lipid linked oligosaccharide to the 
luminal face of the ER comes from experiments in mammalian 
cells (Snider and Rogers, 1984). Fibroblasts, treated with
concanavalin A show that the oligosaccharides carrying 1 to 6 
mannose sugars are on the cytoplasmic face while those with 
more than 5 additions are oriented toward the lumen.
Algl mutants define the next step in core assembly.
Man,_GlcNAc2-PP-Dol assembled oligosaccharides accumulate in
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this mutant and the incomplete precursors are transferred to 
secretory proteins in the lumen of the ER (Huffaker and 
Robbins, 1983). Membranes from alg3 mutants synthesize 
Dol-P-Man, the sugar donor for the transfer of the final 4 
mannose units and it is likely that this mutant is also 
defective in the transfer reaction.
The final step in assembly is the addition of 3 glucose 
residues to the core. ALG6 encodes the glucosyltransferase 
responsible for the addition of the first a-1,3 linked glucose
while the ALG8 gene product transfers the final two (Runge and
Robbins, 1986). In both mutants, transfer of underglucosylated 
core units to the secretory peptides still occurs. The ALG5 
gene has also been defined in its role at this stage of 
assembly (Runge et al 1984) . alg5 mutants are defective in 
synthesis of the Glc-P-Dol donor and affects oligosaccharide 
assembly indirectly, in much the same way as sec53 (algW) .
Membranes from alg5 cells synthesize complete Glc^Man^GlcNAc^ 
chains only when Glc-P-Dol is added exogenously.
(1.6.2) Transfer and trimming of the core oligosaccharide.
The completed core is transferred to the polypeptide in the 
lumen of the ER by an oligosaccharide transferase that has been 
identified in both mammalian and yeast cells (Kaplan et al
1987; Sharma et al 1981). Under glucosylated donor core units 
can also be transferred to secretory polypeptides although less 
efficiently than fully glucosylated units. Even severely 
truncated donors can be transferred, as has been discussed 
above with some of the alg mutations.
After transfer, extensive trimming reactions in mammalian cells 
leaves only 3 mannose residues in the core unit. This is 
subsequently extended by the addition of sialic acid, galactose 
or N-acetylglucosamine (Kornfield and Kornfield, 1985). In 
yeast a-glucosidase I (encoded by the GLSI1 gene ) and 
a-glucosidase II are responsible for the sequential removal of 
the 3 glucose residues and an a-1,2 mannosidase removes the 
mannose residues (Byrd et al 1982). Analysis in secl8 strains 
show that these modifications occur in the lumen of the ER,
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before transport to the Golgi (Esmon et al 1984) . (sec'.L8 
mutants accumulate secretory proteins in the ER due to 
disruptions in vesicle fusion events between the ER and Golgi 
apparatus (Eakle et al 1988)). Secretory proteins accumulating 
at the restrictive temperature in this mutant are predominantly 
glycosylated with oligosaccharides containing 8 mannose and no 
glucose residues. Also, in a glslsecl& double mutant, the 
accumulation of Glc_Man0GlcNAc0 shows that removal of the two
J O  /
types of sugars are independent.
In contrast to mammalian glycoproteins, yeast glycoproteins are 
extensively modified by large numbers of mannose residues. 
These outer chain addition reactions occur after transfer of 
proteins to the Golgi (Esmon et al 1981) . The removal of the 
glucose sugars is not necessary for outer chain addition and 
elongation although removal of the a-1,2 mannose may be (Tsai 
et al 1984).
(1.6.3) Elongation in the Golgi.
Elongation of the core unit has been characterized using 
mutants defective in the addition of outer chain mannose 
residues. The cell wall of S .cerevisiae is made up of 
mannoproteins that are characterized by the presence of a-1,3 
linked mannose units. a-1,3 mannose sugars are highly 
immunogenic and cells mixed with antiserum raised against these 
sugars cause the cells to agglutinate. The mnn (mannan 
defective) mutants were isolated on the basis of their 
inability to agglutinate due to defects in the cell surface 
glycoproteins (Ballou et al 1973; Ballou and Raschke, 1974). 
Although the mutants were isolated as cell wall glycan mutants, 
the disruptions affect all proteins in the N-linked 
glycosylation system.
Initial steps in the addition of mannose extensions were 
elucidated by analysis of modifications to secreted invertase 
(Trimble and Atkinson, 1986). Outer chain addition is initiated 
by the transfer of an a-1,6 mannose to the a-1,6 backbone chain 
of the core by an unidentified a-1,6 mannosyltransferase. 
Elongation occurs when a different a-1,6 mannosyltransferase
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extends the core by the addition of outer chains to this 
initiation residue (Fig. 1.6). This step is defined by the mwi9 
mutation which lacks this specific mannosyltransferase (Tsai et 
al 1984). In wild type cells, glycoproteins can have up to 15 
of these outer chains extending from the N-linked core. Side 
chain additions, defined by other mnn mutants are also 
indicated in Fig.(1.6). wnn9 mutants are less viable than both 
wild type and outer chain mutant strains, suggesting that outer 
chain synthesis is essential for cell growth.
Figure (1.6) Extension of inner core oligisaccharide with 
mannose side chains (the initiation mannose added to the a,1-6 
backbone chain is marked with an asterix). (from Kurkuruzinslca 
et al, 1987)
x = 1-15 (number of outer cores that can be added).
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More recent analysis of the structure of mannose additions in 
wnn9 mutants, suggests that the elongation reaction may stem 
from a different point in the core than previously suggested 
for invertase (Hernandez et al 1989) . The discovery that the 
a-1,6 mannose residue previously proposed to be the initiation 
point for elongation is phosphorylated in mnn9 glycoproteins, 
precludes it as the point of the first mannose addition and 
therefore for elongation. An alternative structure is proposed 
in Fig.(1.7), suggesting that elongation extends from the a-1,3 
mannose as indicated. While the possibility remains that 
different structures may occur in different glycoproteins, this 
proposal is more conducive with the observation that initiation 
and elongation are two separate events and are promoted by the 
action of two distinct mannosyltransferases with different 
specificities.
Figure (1.7). Outer chain addition extends from the a,1-3 
mannose in mnn9 glycoproteins (the invertase a,1-6 mannose
residue now phosphorylated is indicated with asterix).
(Hernandez et al. 1989).
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(1.6.4) Glycosylation of yeast secretory proteins.
Much of the information on the yeast glycosylation process was 
obtained by studying glycosylation patterns of proteins 
naturally secreted by S.cerevlsie. These studies have allowed 
some insight Into the role of glycosylation in the secretion 
and maturation of proteins through the secretory pathway. 
Invertase for example, accumulates as an inactive, ER membrane 
bound precursor at the restrictive temperature in sec53 and 
sec59 cells (Ferro-Novick et al 1984). On return to the
permissive temperature, the protein appears to refold, becomes 
partially active again and is secreted. The majority of 
secreted invertase exists as an octamer (Esmon et al 1987) . 
Assembly of this octamer and its localization in the yeast 
periplasmic space is related to glycosylation of the enzyme. 
Octamers are not formed when invertase is synthesized in the 
presence of tunicamycin and secretion of the enzyme is
inhibited under these conditions. Small amounts of invertase 
dimers are released from the cell wall when cells are washed 
with buffer or /3-mercaptoethanol. Release of the octameric form 
of the enzyme is only achieved with cell wall disruption. This
has also been shown for other periplasmic proteins such as acid
phosphatase and a-galactosidase.
Studies on a-factor production in yeast has also been 
characterized in glycosylation defective mutants. a-factor 
production involves a series of complex processing reactions 
which are summarized in Figure (1.8) (Bussey, 1988). Three 
copies of the a-factor protein are synthesized as a larger 
precursor of 165 amino acids, 85 of which comprise the signal 
sequence (Julius et al 1983) . The first 20 residues (the 
pre-region) are removed by signal peptidase on translocation 
into the ER, leaving the three copies of a-factor attached to 
the 65 amino acid pro-region. This pro-region has 3 
glycosylation sites at positions 23, 57 and 67. Studies in
secl8 mutants show that this region is core glycosylated in the 
ER. Removal of the pro-peptide occurs in the Golgi, by the 
action of a specific peptidase, KEX2 (Julius et al 1984a). 
Further processing requires the action of two additional
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peptidases, the STE13 and KEX1 gene products (see Fig.1,8 for 
details)
Secretion of a-factor is blocked in sec59 and sec53 mutants at 
the non-permissive temperature. Incomplete and unglycosylated 
forms of the protein precursor accumulate in the ER, 
correlating glycosylation with secretion efficiency. The effect 
of blocking secretion with tunicamycin is more pronounced at 
30°C and 37°C, compared to 25°C, suggesting that inhibition of 
secretion may be related to folding of the precursor protein 
(Julius et al 1984b).
Figure (1.8) Processing of prepro-a-factor (Bussey, 1988).
P R E P R O - a  -  F A C T O R
K E X  2 d i b o i i c  * r * d o p r o t e o » »
I
SP
N -  t e r m i n a l  p r o c e » » in g  
d i p a p t i d y l  a m i n o p a p t i d o « *
STE13 STE 13
11
KEX 1
|  C - t # r m i n o l  p r o c » » » in g  
CQfbo*yp*p*idai« B -  l i t ( *  a c t i v i t y
(3*1
4 8
(1.7.0) The secretion of heterologous proteins in S.cerevisiae. 
The first proteins to be secreted in yeast, human interferon 
q-1 and interferon a-2, were directed by their natural signal 
peptides (Hitzeman et al, 1983). These heterologous signal
peptides however, were processed by signal peptidase at greater 
than one site and heterogeneous products were recovered from 
the medium. Human serum albumin (HSA) on the other hand, also 
secreted using its own signal peptide, is correctly processed 
by the KEX2 cleavage enzyme when produced in yeast (Etcheverry 
et al,1986; Bathurst et al, 1987). This human signal peptide is 
surprisingly efficient, more efficient than many homologous 
secretion signals (Sleep et al, 1990) and has also been used to 
secrete other heterologous proteins.
As well as its use as a signal peptide in yeast, the HSA 
protein, with its signal sequence still intact, has been used 
in fusion studies. Secretion and glycosylation of invertase was 
achieved with the HSA protein and signal peptide fused to its 
3’ end. Stomatostatin has also been produced in yeast when 
fused to HSA (Hitzeman et al, 1990). These experiments
demonstrate the potential of using heterologous signals, not 
only to secrete heterologous proteins, but also (by fusing to 
the heterologous protein itself) for stabilizing and secreting 
smaller proteins in yeast. Other heterologous signal peptides 
have been shown to direct their natural products through the 
yeast secretion system with varied efficiencies. Human and 
wheat a-amylases are secreted using their native signal 
sequences, although at a lower efficiency compared to HSA 
(Nakamura et al, 1986). al antitrypsin on the other hand,
cannot be secreted using its native signal peptide (Rothstein 
et al, 1987).
Homologous yeast signal sequences from yeast secretory 
proteins, fused to the mature portions of heterologous genes 
are widely used to direct secretion. The invertase signal 
sequence efficiently directs secretion of HSA, prochymosin and 
interferon a2, among others (Etcheverry et al, 1986; Smith et 
al, 1985; Chang et al, 1986). The a-factor signal peptide is
also widely used in the production of heterologous proteins.
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The a-factor prepro-region was shown to secrete IFNal more 
efficiently than the IFN signal peptide (Singh et al, 1984).
However, in this case the Glu-Ala repeats that occur after the 
Lys-Arg KEX2 cleavage site were retained in a large proportion 
of the secreted material. Attempts to produce this protein by 
direct fusion to the Lys-Arg site, resulted in inefficient 
cleavage by KEX2 (Zsebo et al, 1986) showing that heterologous 
sequences in the fusions can affect cleavage specificity in 
homologous signal peptides in some cases. Direct fusion to the 
Lys-Arg site of the a-factor prepro-region however, has 
resulted in efficient processing and secretion in most other 
cases (Ernst et al, 1986; Guisez et al,1990 Loison et al, 1988; 
Shaw et al, 1988 are examples).
A comparison of a number of signal sequences and their ability 
to secrete HSA has been carried out (Sleep et al, 1990). In
this study the HSA signal, the a-factor signal and the killer 
toxin signal from K.lactis (Stark and Boyd, 1986) were compared 
along with two fusion signal peptides. These fusions comprised 
the HSA signal with 5 amino acids around the cleavage site 
replaced by the KEX2 cleavage site of a-factor and the killer 
toxin signal with its last 13 amino acids replaced by the same 
a-factor sequence (Sleep et al, 1990). Results show that both
fusion peptides were more efficient at secreting HSA than any 
of the other 3. The natural HSA signal was more efficient than 
both a-factor and killer toxin, which was the least efficient 
of the series.
These observations show that it is difficult to predict how 
well a particular protein will be secreted by a homologous or 
heterologous signal peptide. The heterologous protein in this 
case, was most efficiently secreted using its natural signal 
peptide. However, the HSA signal was improved by inserting 
a-factor signal sequences, as was the killer toxin signal 
peptide. Other heterologous sequences have not been efficient 
in directing secretion of their native products and the 
introduction of a yeast signal has proved more successful. 
Different signals therefore, appear to work with varied 
efficiencies when fused to different proteins. The efficiency
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of a particular signal peptide is likely to be related to its 
structural interaction with the heterologous protein itself and 
the overall interaction of the new combination with the 
secretory apparatus as a whole.
To summarize, in attempting to improve secretion levels of a 
heterologous protein in yeast, there are several parameters 
which can be altered and improved. Different signal peptides 
can be assessed to give the most efficient and correctly 
processed products. Further improvements in recovery levels can 
be sought by optimizing expression either by the choice of 
promoter or type of expression vector and translational 
efficiency can be optimized by choosing appropriate leader 
regions. Host strains can be manipulated to minimize 
proteolysis and supersecreting strains, which exhibit increased 
secretion efficiencies, have also been generated (Smith et al, 
1985). These strains, including the sscl (or pmr1) mutation, 
appear to enhance secretion by overcoming in some way what is 
thought to be the rate limiting step in protein transport, ie. 
the ER to Golgi transfer step.
Other mutant strains can manipulate the glycosylation levels of 
heterologous proteins, eg. mnn9 mutants (section 1.6). 
Mammalian proteins, when produced in yeast, are often 
glycosylated to a far greater extent than in their normal 
hosts. This arises out of the fundamental differences in the 
glycosylation processes of higher and lower eukaryotes. 
Hyperglycosylation can cause problems for mammalian proteins, 
particularly those of potential therapeutic use in humans. This 
is due to problems that arise in the immuno genic ity of the 
characteristic extended mannose chains of proteins produced in 
yeast (Melnick et al, 1990; Kurkuruzinski et al, 1987). 
Attempts to minimize this problem have included the alteration 
of the acceptor sequences by site directed mutagenesis to 
completely inhibit glycosylation and the production of the 
protein in glycosylation mutant strains such as mnn9 (Myaj iina 
et al, 1986; Ernst et al, 1987; Melnick et al, 1990). This 
approach has proved successful in the secretion of human 
a-antitrypsin in yeast (Moir and Dumais, 1987).
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CHAPTER 2 
MATERIALS AND METHODS
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(2.1) Materials
Except where stated all chemicals were from Sigma Corporation, 
BDH and Reidel de Haen and were of AnalaR grade. Restriction 
enzymes, DNA ligase, Klenow polymerase, calf intestinal
phosphatase and pUC19 DNA were from Boehringer Mannheim and 
Bethsheda Research Labs. (BRL). /?-glucanase antiserum was a 
gift from Dr. E. Gormley, Trinity College, Dublin.
(2.2) Table of strains.
S.eerevisiae Source
DBY746 D.C.U. stocks.
Mata,secl8-1,ura3-52,leu2-3,-112,suc2. Univ. of California,
Mata,his-Al,l e u2-3,-112,ura3-52,trpl-289a.
RSY11 R. Schekman,
RSY12
Mata.sec53 - 6,ura3-52,leu2-3,-112.
RSY45
Mata,seel-1,ura3- 52,Ieu2- 3,-112,trpl-289.
Berkeley, U.S.A.
Mata,sst2-1,rme,ade2-1,ural,his6.metl
RC631 V.Bugeja, Maynooth 
College.
MD50
Mata,pep4-3,leu2- 3,leu2-112. J.R.Dickinson, Univ. 
of Wales, Cardiff.
E .coli
JA221
F',recAl,l e uB6,crpA5,hsdMT,hsdR ,lacY,x y l .
D.C.U. stocks
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( 2 . 3 ) Table of plasmids
(A). Yeast expression vectors:
pAAH5 Adhl promoter, LEU2 marker 
/{indili cloning site.
Ammerer, G. (1983)
pAH9 pAAH5 derivatives, ATG start
pAHIO sites in 3 frames, no yeast
pAH21 terminator sequences.
Ammerer, G. (1983)
pVT102U Adhl promoter, URA3 marker. Vernet et al (1987)
(B) . Plasmids used in /3-glucanase constructs:
pJG106 /3-glucanase gene plus full 
signal in pUC8.
T . Ryan, D .C .U .
pJG104 /3-glucanase gene minus 
signal in pUC8. 
pJG104a 104 with //indili linker 
in Smal site. 
pJG104b 104 with //indili linker 
in EcoRI site. 
pJGl04c 104b with //indili linker 
in Smal site.
T . Ryan, D .C .U . 
This study
p69A
p69B
p69D
pJG317
MFal (a:-factor) gene, signal 
and promoter in Yepl3.
MFccl promoter and signal in 
YEpl3, //indlll cloning site. 
p69B derivative, BamHI linker 
inserted into Hindlll.
Kurjan and 
Herskowitz, (1982)
T . Ryan, D .C .U .
/3-gLucanase gene, full bacterial T. Ryan, D.C.U.
signal in pAAH5.
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pJG205 /3-glucanase gene, truncated T. Ryan, D.C.U.
bacterial signal in pAAH5.
pJG314 ß-glucanase gene, a-factor promoter 
and promoter (in p69D).
pGS4 a-factor signal peptide on
SamHI/tfindlH fragment in 
pBR322 derivative.
Shaw et al, (1988)
pUGS4 a-factor signal from pGS4 in
pUC19.
This study
pJGS4 /3-glucanase gene in pJGS4.
pVT314 /3-glucanase gene, a-factor signal 
and Adhl promoter.
pJB/34 /3-glucanase minus signal in
pAH9 (pJB/31, same construct 
with gene reversed). 
pJBC55A /3-glucanase minus signal in
pAAH5.
pRB155 Yeast /3-actin gene in YEp24, Shortle et al, 
(1982).
C. Plasmids used in B-glucuronidase constructs:
pRAJ260 /J-GUS gene in pEMBL7. Jefferson et al,
(1986).
pRAJ260a pRAJ260 with ffindlll in £coRI site. This study
pJBU7 /3-GUS gene in pAAH5.
pGUSl,2,3 /3-GUS gene in 3 reading frames, T. Kavanagh 
in Smal/EcoRI of pUC19. T.C.D.
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pGUSla pGUSl,2,3 with Hindlll
2a, 3a linker in £coRI site
pGUSlb pGUSla with //indill linker in EcoRI.
pGUS2c pGUS2 with Clal linker in Smal site.
This study
pGUSa6 /3-GUS gene in p69B, pGUSlb fragment.
pAl6.1 /3-GUS deletion in pUC19.
pAl6.9 /9-GUS deletion in pUC19.
pJGUS6.1 /3-glucanase//3-GUS fusion 
(plus bacterial signal). 
pJGUS4.1 /3-glucanase/)3-GUS fusion 
(minus signal peptide).
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All media was autoclaved at 151bs/in for 15 minutes.
( 2 . 4 )  Media
2
LB (Luria Broth)
This media was used for routine culturing of E.coli 
Bacto-tryptone lOg
Yeast extract 5g
NaCl lOg
H O  to 112
pH 7.5
For solid media Oxoid no.l agar was added (13g/l). 
YEPD
Complex media for routine culturing of yeast.
Yeast extract lOg
Bacto-peptone 20g
D-glucose 20g
H O  to 11
2
For solid media Oxoid no.l agar was added (20g/l).
MYGP
Complex media for culturing strains YT53 and YT54.
Malt extract 3g
Yeast extract 3g
Bacto-peptone 5g
D-glucose 20g
H O  to 11
2
For solid media Oxoid no.l agar was added (20g/l).
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Yeast minimal medium
This synthetic medium was used for the selective growth of 
yeast auxotrophic strains carrying plasmids. Appropriate amino 
acid additions were made after autoclaving (see table below for 
details of stock solutions and working concentrations).
Difco yeast nitrogen base 6.7g
D-glucose1 20.Og
2Succinic acid 10.Og
NaOH2 6.Og
H O  to 11
2
For solid media Oxoid no.1 agar was added (20g/l).
1.For liquid medium 50ml per litre 40% D-glucose was added 
after autoclaving.
2 .Growth media for strains harbouring plasmids expressing 
/9-glucanase were buffered to pH6.3 with succinic acid and NaOH.
Amino acids :
Stock solutions Volume added Final conc.
per litre mg/ml.
2.0%(w/v) L-histidine 1.0ml 20.0
1.5%(w/v) L-leucine 2.0ml 30.0
3.0%(w/v) L-lysine 1.0ml 30.0
0.25%(w/v) Uracil 8.0ml 20.0
0.4%(w/v) L-tryptophan 5.0ml 20.0
2Stock solutions were sterilised by autoclaving at 151bs/in 
for 15 mins. L-tryptophan was stored in the dark at 4°C.
(2.5) Antibiotics
For selective growth of transformed E.coli strains, appropriate 
antibiotics were added to media after autoclaving.
Ampicillin stock solutions (25mg/ml) were made in sterile H^O 
and used at a working concentration of 40/jg/ml for solid media 
and 35/ig/ml for broths.
Tetracycline hydrochloride stock solutions (10mg/ml) were made 
up in 50% ethanol and stored in the dark at -20°C. The working
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concentration used was lOug/ml.
Chloramphenicol stock solutions (50mg/ml) were made up in 100% 
ethanol, stored at -20°C and used at a working concentration of 
50 /¿g/ml for amplification of ColEl plasmids.
(2.6) Growth conditions and storage of strains.
E.colL strains were grown at 37°C. Short term storage was on 
agar plates at 4°C. Long term storage was in 50% glycerol or 
15% DMSO at -70°C.
Yeast strains were grown at 30°C (25°C for secretion mutants). 
Short term storage was on agar plates at 4°C. Long term storage 
was in 50% glycerol or 20% DMSO at -70°C.
(2.7) Buffers and Solutions.
Buffers for DNA manipulations:
TE buffer: lOmM Tris.HCl, pH8.0
ImM EDTA, pH8.0
Ligation buffer: 200mM Tris.HCl, pH7.6
lOOmM MgClz 
lOmM ATP 
lOOmM DTT
DTT was stored as a 500mM stock at -20°C and added separately 
to ligation reactions.
Restriction buffers:
Buffers were supplied by the manufacturers and used according 
to their recommendations.
Nick translation buffer: 50mM Tris.HCl, pH7.2
lOmM MgSO^
ImM DTT 
500ug/ml BSA
STE buffer: lOmM Tris.HCl, pH8.0
lOOmM NaCl 
lOmM EDTA
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2X Bal31 buffer: 40mM Tris.HCl, pH7.2
25inM MgCl2 
25mM CaCl
2
2mM EDTA 
1.2M NaCl
RNase (DNase free):
RNaseA (lOrag/ml) was dissolved in lOmMTris.HCl (pH7.5), 15mM 
NaCl; heated to 100°C for 15 minutes .allowed to cool slowly to 
room temperature and stored at -20°C.
Phenol/chloroform mix:
lOOg of phenol (AnalaR grade) was disolved in 100ml chloroform 
with 4.0ml isoamylalcohol and 0.8g 8-hydroxyquinoline. The 
phenol mix was stored under lOOmM Tris.HCl, pH7.5, at 4°C in 
the dark.
Buffers for agarose gel electrophoresis: 
lOx TBE: 0.89M Tris. borate
0.89M Boric acid 
0.02M EDTA 
pH8.3
50x TAE: 2.0M Tris. borate
242g Glacial acetic acid 
100ml 0.5M EDTA 
pH8.0
5x Bromophenol blue: 0.25%(w/v) Bromophenol blue
25% Ficoll (type 400)
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Solutions for isolation of DNA from agarose:
Sodium iodide solution:
90.8g Nal was disolved in 100ml H20 . The solution was filtered 
through Whatman no. 1 filter paper, 15g of Na^O^ was added 
and the solution stored at 4°C in the dark.
Ethanol wash solution: 50% Ethanol
lOOmM NaCl
lOmM Tris. HC1, pH7.5 
ImM EDTA
This solution was stored at -20°C.
Solutions for preparation of RNA:
All solutions for preparation of RNA were made up in DEPC 
(diethyl polycarbonate) treated H20 .
DEPC treatment:
DEPC (0.1%) was added to distilled ^0, allowed to stand for 20 
mins. at room temperature and autoclaved for 20 mins. at 
151b/in2 to remove the DEPC.
Letts buffer: 0.1M LiCl
0.1M EDTA
0.01M Tris.HCl pH7.4 
0.02% SDS
5x Formamide running buffer: 0.1M MOPS (pH7.0)
40mM Sodium acetate 
5mM EDTA
Solutions for Northern blotting and hybridisation:
20x SSC: 175.3gNaCl
88.2g Tri-sodium acetate
H 0 to 11 2
pH 7.0
6 1
MPrehybridisation buffer: 6X SSC
2x Denhardts reagent 
0.1% SDS
100/ig/ml Salmon sperm DNA
50x Denhardts reagent: 5.0g Ficoll
5.0g Polyvinylpyrrolidone 
5.Og BSA
H O  to 11
2
Buffers for dialysing yeast extracts:
5x PBS: 5.45g KH P0°  2 *
10.7g Na HPO
°  2  h
45.Og NaCl
H 0 to 11 2
Preparation of dialysis tubing:
Appropriate lengths of tubing were boiled for 15 mins. in lOmM 
EDTA, rinsed and boiled for 15 mins. in distilled H^ O.
Solutions for preparation of yeast extracts: 
lOx Lysis buffer: 50mM NaPO , pH7.0* k
lOmM EDTA
0.1% Triton X-100
0.1% Sarkosyl
lOmM /?-mercaptoethanol
PMSF:
PMSF was made up freshly as a lOmM stock in 2-propanol and used 
as required.
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DNS (3,5-dinitrosalicylic acid) solution for measuring 
/3-glucanase activity: 5 . Og DNS
l.Og Phenol 
0.25g Na S03
lOOg Sodium potassium tartrate 
2% NaOH
11 total volume
Buffers for polyacrylamide gel electrophoresis (PAGE):
SDS electrophoresis buffer: 25mM Tris. HC1, pH8.3
192mM Glycine 
0.1% SDS
Solubilisation buffer: lOOmM Dithiothreitiol (DTT)
80mM Tris. HC1, pH6.8
10% (w/v) Glycerol
2.0% (w/v) SDS
0.2% (w/v) Bromophenol blue
Coomassie blue stain:
0.5% Coomassie brilliant blue in acetic acid : water : methanol 
( 1  : 1 0  : 8 ) .
Destain solution: Acetic acid : water : methanol (1 : 10 : 8)
Solutions for Western blotting:
Transfer buffer: (per litre)
3.03g Tris. base 
14.4g glycine 
200ml methanol
TBST buffer: 150mM NaCl
lOmM Tris. HC1, pH8.0
0.05% Tween-20
Blocking solution: TBST with 1% (w/v) BSA
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AP (alkaline phosphatase) buffer: lOOmM Tris. HC1, pH9 . 5
lOOmM NaCl 
5mM MgClz
NBT stock: NBT (nitroblue tetrazolium), 50mg/ml in 70%
N ,N-dimethylformamide.
BCIP stock: BCIP (5-bromo-4-chloro-3-indolyl phosphate),
50mg/ml in 100% N,N-dimethylformamide.
AP colour development solution: 10ml AP buffer
66ul NBT stock 
33ul BCIP stock
NBT was added to the AP buffer and mixed. BCIP was then added 
and mixed. The solution was made up freshly from stocks before 
use.
(2.8) Transformation of E.coli 
Preparation of competent cells:
100ml of LB was innoculated with 1.0ml of an overnight culture
of JA221 and grown at 37°C with aeration to an OD run of 0.3
600
to 0.4. The culture was chilled on ice for 30 mins and cells
were harvested by centrifugation at 10,000rpm for 10 mins at
4°C. The cells were washed in half the original volume of ice
cold 50mM MgCl2 and resuspended in half the original volume of
50mM CaCl . After incubation on ice for 30 mins, the cells were 
2
harvested as before and resuspended in one tenth the original 
culture volume of 50mM CaCl .
7.
Transformation of competent cells:
Plasmid DNA (up to 250ng) was added to 200ul aliquots of 
competent cells in an eppendorf and incubated on ice for 
60 mins. The cells were heat-shocked by placing them at 420C 
for exactly 2 mins and returned to ice immediatly. 0.8ml of LB 
was added and the samples incubated at 37°C to allow expression 
of the plasmid encoded antibiotic resistant marker gene. The 
cells were plated in 200ul aliquots on LB agar containing the
6 4
appropriate selective antibiotic and incubated overnight at 
37 °C.
(2.9) Transformation of S .cerevisiae.
Preparation of yeast competent cells :
100ml of YEPD was innoculated with 50^1 of an overnight culture 
of S . cerevisiae '"'and grown at 30°C with agitation to an OD600nm 
of 0.7. The cells were harvested at room temperature by 
centrifugation at 5,000 rpm. After 2 washes in half the 
original culture volume of TE, pH 7.5, the cells were 
resuspended in one tenth the original culture volume of lOOmM 
LiAc and incubated at 30°C with agitation for 60 mins. The 
cells were harvested as before and resuspended in the same 
volume of lOOmM LiAc. Routinely, 10ml samples of culture were 
used yielding 1.0ml competent cells.
l. When preparing and transforming competent cells of of 
S .cerevisiae secretion defective mutants, growth and incubation 
temperatures were 25°C.
Transformation of yeast competent cells:
Plasmid DNA (0. l/ig-10/ig) was added to 300^1 competent cells. 
0.7ml of 50% P E G aooo was added, mixed gently by inversion and 
incubated at 30°C for 60 mins. The cells were then placed at 
42°C for 5 mins and plated directly onto selective media.
(2.10) Generation of yeast spheroplasts.
Cells were grown in YEPD to OD =0.7, harvested and washed b  600
twice in 1.2M sorbitol. One tenth volume of zymolyase (3mg/ml) 
was added and the cells shaken (150 rpm) at 30°C for 60 mini;. 
Spheroplast formation was monitored by adding a sample to H^0 
and following the drop in ODgoQ readings as the cells lyse.
(2.11) Small scale isolation of DNA from E.coli.
Two methods for isolating small amounts of plasmid DNA were 
generally employed:
Method 1 (Birnboim and Doly 1979):
Cells were grown overnight at 37°C in LB with appropriate 
antibiotics. 1.5ml was pelleted by centrifugation and the
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supernatant removed completely. The pellet was resuspended in
100 /¿I of Solution 1 and left on ice for 5 mins. 200^1 of
Solution 2 was added mixed, by inversion and incubated on ice
for 10 mins. 150/il of Solution 3 was added, mixed by inversion
and the sample left on ice for 5 mins. After centrifugation at
10,000 rpm for 5 mins, 400/il of the supernatant was removed to
a fresh tube. An equal volume of phenol/chloroform was added,
vortexed and spun . The aqueous layer was removed to a fresh
tube and 0.8ml of ice cold ethanol was added. The sample was
allowed to stand at room temperature for 10 mins. The DNA was
pelleted by centrifugation at 10,000 rpm for 10 mins and the
pellet washed in 70% ethanol. The DNA was dried under vacumn
and resuspended in 30-50/il TE, pH 8.0. 5/il RNaseA (lOmg/ml) was
added and the DNA stored at 4°C.
Solution 1:
1.0ml 0. 5M Glucose
1.0ml 0.1M EDTA
0.25ml 1M Tris.HC1,pH8.0
7.75ml H 0 
2
Solution 2: (made freshly every month and stored at RT)
2.0ml IN NaOH
1.0ml 10% SDS
7 .0ml HO 
2
Solution 3: (3M Potassium acetate)
To 60ml of 5M potassium acetate, 11.5ml of glacial acetic acid
and 25ml of H 0 were added.
2
Method 2 (Holmes and Quigley 1981) :
Cells were grown overnight at 37°C on LB agar containing the 
appropriate antibiotics. A patch of growth was transferred to 
an eppendorf using a sterile cocktail stick. The cells were 
resuspended by vortexing in 300/il STET buffer. 20pl lysozyme 
(lOmg/ml) was added and the samples were allowed to stand at RT 
for 10 mins. The samples were placed in a boiling water bath
for 60 seconds, centrifuged at 10,000 rpm for 5 mins. and the
supernatant removed to a fresh tube. An equal volume of
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isopropanol was added and the samples incubated at -20°C for 30 
mins. The DNA pellet was washed with ether, dried and
resuspended in 30-50/il TE buffer, pH 8.0. 5/xl of RNaseA 
(lOmg/ml) was added and the DNA stored at 4°C .
STET buffer: 8% w/v Sucrose
5% w/v Triton X-100
50mM EDTA
50mM Tris.HCl, pH 8.0
(2.12) Large scale preparation of plasmid DNA from E . c o l i .
250ml of LB (with the appropriate antibiotic addition) was 
innoculated with 1ml of an overnight culture of E . c o l i ,  and 
grown at 37°C with shaking to an OD600nm of 0.8.
Chloramphenicol (1.0ml of 50/ig/ml stock) was added to allow 
plasmid amplification and the cells were returned to 37°C for a 
further 12 to 16 hours.
Cells were harvested by centrifugation (10,000 rpm, 10 mins at 
4°C) and resuspended in 2.0 ml sucrose solution. The cell
suspension was transferred to a screw cap Beckman polycarbonate 
50iTi tube and 0.4ml of lysozyme (20mg/ml in 0.25M Tris.HCl, pH 
8.0) was added. After incubation on ice for 5 mins, 0.8ml of 
0.25M EDTA was added, the cells mixed by inversion and 
incubated on ice for a further 10 mins. Triton-mix (3.2ml) was 
added, mixed and left on ice for 15 mins. When cell lysis was 
evident (indicated by an increase in viscosity of the mixture) 
the samples were centrifuged at 40,000 rpm for 20 mins at 4°C. 
The cleared lysate was removed to a 10ml tube and 6.7g of 
caesium chloride was added and mixed gently at room
temperature. The solution was transferred to a 20ml Beckman 
quickseal polyallomer tube and 180/il of ethidium bromide 
(lOmg/ml) was added. The total solution weight was brought to 
14. lg using lOmM EDTA, pH 8.0. The tube was filled to the top 
with mineral oil heat sealed and centrifuged at 50,000 rpm for 
24hrs at 18°C. The plasmid band was visualised by ultra violet 
transillumination and extracted from the tube using a sterile 
18 guage needle and 1ml syringe.
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Ethidium bromide was removed from the sample by extracting with 
isopropanol saturated with 20X SSC. The DNA was dialysed 
against TE pH 8.0 for at least 12 hrs with 3 changes of buffer. 
DNA was concentrated by ethanol precipitation.
Sucrose solution: 25% Sucrose
50mM Tris.HCl, pH 8.0 
Triton Mix: 5.0ml 20% Triton X-100
12.5ml 0.25M EDTA
2.5ml 1.0M Tris.HCl, pH 8.0
(2.13) Separation of DNA molecules by agarose gel 
electrophoresis:
Agarose gels were made up and run at constant voltage in IX TAE 
or TBE buffer. 5X bromophenol blue dye was added to the samples 
before loading. Gels were stained in ethidium bromide (5/ug/ml)
for 20 mins, destained in H O  for 10 mins and DNA was
2
visualised by UV transillumination.
Gels were photographed using Kodak TriX-pan 35mm film. The film 
was developed with Kodak Universal developer (1/8 v/v in 
distilled H20) for 10 mins at 20°C and fixed in Kodafix (1/4 
v/v in distilled ^0) for 10 mins. Printing was on Kodak 
photographic paper using the above developer and fixer mixes.
(2.14) General DNA manipulations.
Restriction digestions:
Restriction buffers were supplied by the manufacturers and used 
under the recommended conditions. When restricted DNA was 
required for further manipulations it was cleaned up by 
extraction with phenol/chloroform and ethanol precipation or 
was passed through a sepharose column.
Ethanol precipitations:
For the routine precipitation of DNA l/10th volume of 3M sodium 
acetate and 2 volumes of ethanol were added. After incubation 
at -20°C for at least 60 mins, the DNA was recovered by 
centrifugation at 10,000 rpm for 20 mins, the pellet washed 
once in 70% ethanol, dried under vacumn and resuspended in TE 
at the required pH.
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Filling in 5' overhangs on DNA restricted DNA fragments: 
Restricted DNA was incubated in IX Klenow buffer, 2mM dNTPs and 
1 unit of Klenow polymerase (lunit/^1) for 1 hour at 22°C. The 
reaction was stopped by heating to 70°C for 5 mins. Conditions 
were then adjusted for further manipulations.
Dephosphorylation of DNA:
1 unit of calf intestinal phosphatase (CIP) was added at the 
end of a restriction digest and the sample incubated at 370C 
for 20 mins. The reaction was stopped by heating to 65°C for 5 
mins after the addition of l/10th volume 10X STE, 10mm EDTA and 
l/20th volume 10% SDS (added to denature the enzyme). The DNA 
was then extracted with phenol/chloroform and ethanol 
precipated.
Addition of linkers:
Phosphorylated DNA linkers were ligated to blunt ended DNA in 
IX LKB. Spermidine (final concentration of lOmM) and T^  ligase 
(lUnit) were added and the reaction carried out at 22°C for (SO 
mins. lUnit T ligase was added and the reaction left at 12°C 
0/N .
Ligations:
Ligations were carried out at 12-14°C 0/N in IX LKB using 1U T^  
DNA ligase. Vector and insert DNAs were mixed in a ratio of 
approx. 1:10.
(2.15) Bal31 digestions.
Linearised DNA (30/ig) disolved in TE pH 7.2, was mixed in an
equal volume of 2x Bal31 buffer (total volume was usually
200/j1) . Bal31 enzyme (2.5 units) was added and the reaction
incubated at 30°C. At appropriate time points, 20/il samples
were removed into 2/il 0.25M EGTA on ice to stop the reaction.
2+Because EGTA is a strong chelator of Ca ions it does not 
inhibit restriction enzymes. Time points could therefore be 
analysed by restriction digestion directly after Bal31 
deletion. For further manipulations,the DNA was cleaned up 
using sepharose CL6B columns.
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(2.16) Sepharose CL6B columns (pers.comm. T. Kavannagh,TCD).
For cleaning up DNA preparations and changing buffer conditions 
samples were spun through mini-sepharose columns. The columns 
were prepared as follows : A hole was pierced in the base of a 
0.75ml eppendorf. A small amount of glass beads (40 mesh) was 
placed in the tube to cover the hole and 0.5ml of 70% sepharose 
was added. The tube was placed in a 1.5ml eppendorf and spun at 
1,500 rpm for exactly 2 mins. The liquid was removed from the 
large eppendorf and 20-50/il TE buffer added to the top of the
column. The column was spun as before. This washing procedure
was repeated once more. The column was then placed in a fresh, 
sterile 1.5ml eppendorf and the DNA added to the top of the
column, the column spun and the DNA collected in the sterile
1.5ml eppendorf. In order to avoid increasing or decreasing the 
volume of the DNA the timing and speed of each spin was kept 
identical in each case.
(2.17) Isolation of DNA fragments from agarose.
The glass beads were prepared by T. Ryan (D.C.U.).
The DNA was separated by agarose gel (TAE) electrophoresis. The 
fragment of interest was cut out of the gel using a clean 
blade. The gel slice was chopped into small pieces, weighed and 
sodium iodide solution was added (2ml/g agarose). The sample 
was vortexed and incubated at 55°C for 5 mins or untill the 
agarose had disolved. 1-2/j1 of glass bead slurry was added, the 
sample vortexed and left on ice for 5 mins. The beads were spun 
at high speed for 10 secs and the supernatant removed. The 
glass bead pellet was washed 3 times in 50^1 ice cold ethanol 
wash solution, spinning for 10 secs between each wash. The 
pellet was resuspended in 10-20/il TE, pH 8.0, and the DNA 
allowed to elute from the beads at 55°C for 3 mins. The beads 
were then spun and the eluate removed into a sterile eppendorf. 
This elution step was repeated to ensure maximum recovery of 
DNA.
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(2.18) Plate assay to detect /3-glucanase activity.
Yeast strains producing /3-glucanase were grown on selective 
minimal media containing 0.05% lichenan. The medium was 
buffered using succinic acid and NaOH (section 2.7). 
Extracellular /3-glucanase activity was detected by direct 
staining with congo red dye (0.1%). Intracellular activity was 
released by lysing the cells with a hot agar overlay containing 
0.05% lichenan. The overlay was allowed to solidify and the 
plates incubated 0/N at 37-45°C. /3-glucanase activity was 
detected by staining with congo red dye (0.1%).
To assay cell supernatants and extracts, 6mm wells were cut in 
buffered agar plates containing 0.05% lichenan. The plates were 
incubated 0/N at 37-45°C. To obtain clearer halos, plates were 
destained by rinsing in 1M NaCl.
(2.19) DNS assay for measuring /3-glucanase activity.
The DNS assay (Hiller et al. 1960) was used to accurately
quantify /3-glucanase activity. This assay measures the levels 
of reducing sugars produced by the enzyme from the /i-glucan 
substrate. In order to ensure accurate quantitation of activity 
in cell supernatants, glucose present in the growth medium was 
removed before assaying, by dialysis. 2.0-5.0ml samples of 
supernatant were dialysed against PBS at 4°C for 12-16 hrs. The 
buffer was changed at least 3 times during that period. The 
substrate /3-glucan was prepared by boiling /3-glucan (1% w/v) in 
0.1M sodium phosphate buffer, pH6.5 (section 2.7).
Assay: 1.0ml of substrate was prewarmed to 45°C for 10 mins
before the addition of 1.0ml enzyme sample. Each sample was 
mixed by vortexing and incubated at 45°C for 20 mins exactly. 
The reaction was stopped by cooling under running water for 15 
secs, and the addition of 3.0ml DNS solution. Blanks were 
prepared by mixing 1.0ml substrate, 1.0ml enzyme sample and 
3.0ml DNS solution. All samples were boiled for 15 mins exactly 
and cooled under running water. 5.0ml H^O was added and the 
absorbance at 540nm measured against the stopped blanks. The 
amount of reducing sugars present was read from a standard 
curve prepared using glucose standards.
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(2.20) Preparation of yeast cell extracts for DNS assays.
5 X 107 cells were harvested by centrifugation (5,000 rpm, 5 
mins) and resuspended in IX lysis buffer (section 2.7), 10 rnM 
PMSF. Lysis was typically carried out in a volume of 5.0ml. 
l.Og glass beads was added and the cells were vortexed for 3 
mins (6 X 30 second bursts with 30 seconds on ice between each 
burst) . The cell debris was spun out and the cleared lysate 
removed to a fresh tube. For smaller preparations, volumes were 
adjusted appropriately. (In this procedure, 40 mesh glass beads 
were used for lysing the cells).* see end of '"eth°ds s e c t i o n  CP 9  78)
(2.21) Separation of proteins by polyacrylamide gel 
electrophoresis (PAGE).
Preparation of running gel:
8% 10% 15%
Acrylamide:bis-
acrylamide (29:1) 5.30ml 7 .00ml 10.30ml
1.87M Tris.HCl.pH 8.8 4.20ml 4.20ml 4.20ml
10% SDS 0.12ml 0.12ml 0.12ml
10% Ammonium persulphate 0.10ml 0.10ml 0.10ml
TEMED 0.02ml 0.02ml 0.02ml
H 0 2 11.10ml 9.40ml 6.10ml
Preparation of stacking gel (3%) :
Acrylamide:bis -acrylamide 2.50ml
0.5M Tris.HCl, pH 6.8 1.20ml
10% SDS 0.10ml
10% Ammonium persulphate 0.10ml
TEMED 0.10ml
H 0 2 7.50ml
(2.22) Preparation of yeast cell extracts and supernatants for 
PAGE.
Yeast cells were lysed as per section 2.20. 1.0ml samples of
extract and supernatant were dialysed 0/N against ImM NaPO^, pH 
7.0, freeze dried and resuspended in IX solubilisation buffer 
(20-100/il). Samples were boiled for 3 mins before loading.
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(2.23) Western blotting procedure.
Transfer of proteins to nitrocellulose:
Following electrophoresis, proteins were transferred to 
nitrocellulose using a Bio-Rad transfer cell. Gels were 
equilibrated in transfer buffer (section 2.7) for 20 mins 
before transfer. The transfer unit was assembled as follows: 
the fibre pads, Whatmann paper and nitrocellulose were soaked 
in transfer buffer . A fibre pad was placed on the cathode 
panel of the gel unit. A piece of Whatmann no. 2 paper, cut to 
the size of the gel was placed on top. This was followed by the 
gel, a sheet of nitrocellulose, another piece of Whatmann paper 
and the second fibre pad. The unit was closed and placed in the 
transfer tank. Transfer was carried out in transfer buffer at
30V,0.1A 0/N or at 60V, 0.21A for 4 hrs. A small stirring bar
was used to circulate the buffer throughout transfer in order 
to improve heat transfer and ensure a homogenous pH throughout 
the tank. Efficiency of transfer was monitored by the use of 
pre-stained markers (Sigma). After transfer was complete, the
membrane was used directly for binding to antibodies or
was sealed in plastic and stored at 4°C. At no stage was the 
membrane allowed to dry out.
Binding of primary antibody and secondary enzyme-conjugated 
antibody to blotted proteins:
The membrane was submerged and rinsed in TBST. The TBST was 
replaced with blocking solution and incubated at room 
temperature with gentle agitation for 30-60 mins. The blocking 
solution was decanted and replaced with TBST (O.lml/cnO 
containing the primary antibody (20/xl for /3-glucanase) . After 
inbcubation at room temperature for 60 mins, the membrane was 
washed 3 times in TBST (5-10 mins per wash). The membrane was 
transferred to TBST containing a 1:7,500 dilution of 
anti-rabbit IgG alkaline phosphatase (AP) conjugate for 
/3-glucanase, or anti-rat IgG AP conjugate for /3-glucuronidase. 
This was incubated for 60 mins at room temperature and washed 3 
times in TBST (5-10 mins per wash).
Development of AP colour reaction:
The membrane was blotted dry on filter paper and transferred to
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10ml of AP colour development solution (prepared as described 
section 2.7). Colour development was continued until bands of 
the desired intensity appeared. The reaction was stopped by 
rinsing for several minutes in distilled H^O. The membrane was 
air dried and stored, sealed in plastic.
(2.24) /3-glucanase activity gel.
Yeast cell extracts and supernatants were prepared and 
subjected to SDS PAGE as described in sections 2.21 and 2.22. 
After electrophoresis, the gel was renatured in 50mM NaPO , 1% 
SDS for 60 mins at room temperature. The gels were agitated 
gently and the renaturation buffer changed at least 3 times 
during incubation. The gel was then placed on top of a second 
acrylamide gel containing 0.15% lichenan (buffered with 
Succinic acid and NaOH) , and left at 25°C for 24hrs. The 
lichenan gel was stained in congo red dye. Destaining was in 1M 
NaCl. Bands of /?-glucanase activity appeared as white on a red 
background. To obtain a clearer background, the lichenan gel 
was made from a stock solution of lichenan (0.3%), that had 
been boiled in ^ 0  for lOmins. The insoluble lichenan particles 
were spun out of the solution before adding to the 
polyacrylamide gel.
(2.25) Isolation of RNA from S .cerevisiae.
Total RNA was isolated from yeast using a method adapted from 
Sherman et al. (1986).
In order to minimize RNase activity during the isolation of RNA 
the following precautions were taken. All solutions (section
2.7) used in this procedure were made up in DEPC treated H^O
2and autoclaved at 151b/in for 15 mins. Glassware and glass 
beads were washed in 3M HC1 and baked at 180°C for 8 hrs before 
use. Plasticware was rinsed in chloroform and autoclaved before 
use.
Cells were grown in appropriate media to an OD600nm of 
approximately 1.0. 100ml of cells were harvested by
centrifugation at 5,000 rpm for lOmins at 4°C and resuspended 
in 2.0ml Letts buffer. The cell suspension was transferred to a
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15ml corex tube containing 8g glass beads (40 mesh) and 2inl 
phenol/chloroform that had been equilibrated with Letts buffer. 
The cells were lysed by vortexing for 3 mins (6 x 30 sec.
bursts with 30 secs intervals on ice between each burst). 2. Oinl 
Letts buffer was added, the sample mixed by vortexing and spun 
for 5 mins at 8,000 rpm at 4°C. The aqueous layer was removed 
and the sample extracted 3 times with phenol/chloroform The RNA 
was precipitated in 0.1% 5M LiCl and 2 volumes ice cold 
absolute ethanol and incubated at -20°G for at least 3 hrs. 
Total RNA was harvested by centrifugation at 10,000 rpm for 10 
mins at 4°C. The pellet was washed in 80% ethanol, air dried 
and resuspended in 1.0-1.5ml DEPC treated H^O. RNA 
concentrations were estimated at 0D260nm.
(2.26) Formaldehyde gel electrophoresis.
RNA molecules were separated on formaldehyde gels before 
blotting onto nitrocellulose.
(a) Preparation of formaldehyde gel: For a 200ml gel (1.2%),
2.4g agarose was boiled in 124ml DEPC treated H^O and allowed 
to cool to 60°C. 40ml 5X formaldehyde buffer (section 2.7) and 
36ml 37% formaldehyde was added and the gel allowed to set at 
room temperature.
(b) Preparation of RNA samples for loading: For a total sample
volume of 2 0 f j . l, 4/il 5X formaldehyde buffer, 5/tl f ormamide, 2)j , l
37% formaldehyde and 1/il ethidium bromide (lmg/ml) were mixed 
in an eppendorf. Up to 8/jg of RNA was added. A separate sample 
containing 4/il 5X bromophenol blue and 4^1 H^O and no RNA was 
also prepared as a marker for running the gel. The samples were 
heated to 65°C for 10 mins before loading.
The gel was run at 3V/cm in IX formaldehyde buffer for 4-6hrs 
until the dye had reached half way down the gel.
(2.27) Transfer of RNA to nitrocellulose.
After staining, the gel was soaked in 0.05N NaOH to partially 
hydrolyse the RNA, rinsed in DEPC treated H^0 and soaked in 20X 
SSC for 45 mins.
Bi-directional transfer of RNA to nitrocellulose: An 8cm high
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stack of paper towels was placed on a glass plate. Two pieces 
of Whatmann no. 2 paper, soaked in 2X SSC and cut to the 
dimensions of the gel, were placed on top. A sheet of 
nitrocellulose, soaked in 20X SSC was placed on top of the 
filter paper. This was followed by the gel, a second presoaked 
sheet of nitrocellulose, 2 pieces of Whatmann paper (soaked in 
2X SSC) , an 8cm stack of paper towels and finally a glass 
plate. To ensure even transfer the stack was inverted 4 times 
in the first 30mins and transfer allowed to continue for 12hrs. 
After transfer, the towels and Whatmann paper were removed and 
the positions of the wells marked on the nitrocellulose. The 
nitrocellulose filters were washed in 6X SSC at room 
temperature and allowed to air dry for approximately 60 mins. 
The gel was stained again in ethidium bromide to assess 
efficiency of transfer. The filters were placed between 2 
sheets of Whatmann No.l paper, baked for 2hrs. at 80°C and 
stored at room temperature sealed in plastic.
(2.28) Random primer labelling of DNA.
Random primer labelling of probe DNA was carried out using a 
Promega "Prime a gene" kit.
25ng of DNA was denatured by heating to 100°C for 2 mins and
transferred to ice. The DNA was mixed with 10/il 5X Labelling 
buffer, 2/il 500/iM dNTPs and 2/il lmg/ml acetylated BSA. 5/il
32[a P] dATP and 5/il Klenow polymerase were added and the volume 
made up to 50/il with ^0. The reaction was mixed gently and
incubated at room temperature for 60 mins. The reaction was 
terminated by heating to 100°C for 2 mins and chilled on ice. 
2/il 0. 5M EDTA was added and the labelled, denatured probe DNA 
was used dire'ctly for hybridisation to RNA filters.
(2.29) Hybridisation of probe to RNA blots.
The baked filter was floated on the surface of 6X SSC until 
wet, submerged and allowed to soak for 2 mins. The filter was 
then placed in a plastic bag and pre-hybridisation mix (section
2.7) added to volume of 0.2ml/cm2 nitrocellulose. The bag was 
resealed, eliminating as much air as possible and placed at
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68°C for 2 hrs with shaking. After pre-hybridisation, the probe 
was added to the filters, the bag resealed and hybridisation 
allowed to take place at 68°C for 16-24 hrs. After 
hybridisation, the filters were washed for 20 mins at room 
temperature for 20 mins in IX SSC, 0.1% SDS. This was followed 
by 3 washes of 20 mins each in 0. 2X SSC, 0.1% SDS at 68°C. 
After washing, the filter was air dried for 60 mins, sealed in 
plastic and exposed to X-ray film (Kodak 0M84) with 
intensifying screens at -70°C for up to 1 week. The films were 
developed in Kodak LX24 developer for 5 mins at room 
temperature. Fixing was in Kodak FX40 fixer, 2 X 2  mins at room 
temperature. The films were rinsed in water and allowed to dry.
(2.30) /3-glucuronidase assays.
Spectrophotometric assay:
Samples of yeast cell extracts and supernatants were incubated 
in IX reaction buffer (section 2.28) and ImM p-nitrophenyl 
glucuronide (PNPG) in a total volume of 1.0ml at 37°C. The 
reaction was stopped by the addition of 0.4ml 2. !5M
2 - amino,2-methyl propanediol at intervals of 30, 60 and 90 mins 
for any one assay (samples were prepared in triplicate) . The 
absorbance at 450nm was measured against a substrate blank for 
each time point and a standard curve for each sample was 
constructed (OD450nm vs. time). The amount of /3-glucuronidase 
in a sample was calculated. One unit of ¡3-glucuronidase enzyme 
is defined as the amount that will produce 1.0 nmole of 
p-nitrophenol per minute at 37°C. The molar extinction 
coefficient of p-nitrophenol is 14,000. In a total volume of 
1.4ml, an absorbance of 0.01 is equivalent to 1.0 nmole of 
product. 1.0 nmole of product is equivalent to 5.Ong of 
¡3- glucuronidase enzyme.
Flourimetric assay:
E.colL strains expressing /3-glucuronidase from multicopy 
plasmids were identified by spraying colonies growing on agar 
plates with linM MUG (4-methyl umbelliferyl glucuronide). Plates 
were then incubated for 30 mins. at 37 C and viewed by UV 
transillumination.
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(2.31) /3-glucuronidase activity gel.
SDS polyacrylamide gels were renatured in IX reaction buffer 
(50mM NaPO pH 7.0, 0.1% Triton X-100, lOmM EDTA, lOinM
/3-mercaptoethanol) for 60 mins at room temperature with gentle 
agitation. The buffer was changed at least 3 times during this 
period. The renatured gel was transferred to IX reaction buffer 
containing 0.5mM MUG (4-methyl umbelliferyl /3-D-glucuronide) 
and incubated at 37°C for 30 mins. The gel was washed in 0. 2M 
NaCO^ to stop the reaction and to enhance fluorescence. 
/3-glucuronidase activity was viewed by UV transillumination and 
appeared as fluorescent bands.
(2.32) Incorporation of Mata cells into MYGP agar.
-2RC631 cells were grown to an OD =1.0 units. 1.0ml of a 10600
dilution of the cells was added to 10ml of molten MYPG agar (at 
45°C), mixed and poured into a petri dish. The agar was allowed 
to set at room temperature before use.
* Cell lysis was monitored microscopically and was 
standardised using the Bradford assay for measuring 
total cell protein. Based on the total protein / 
dried weight ratios obtained, efficient cell lysis 
was achieved routinely.
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CHAPTER 3 
RESULTS
Section 3.1
Analysis of /3-glucanase production and secretion in
S .cerevisiae.
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(3.1) Introduction.
Endo (1-3), (1-4) -/3 -D -glucahase, from B.subtilis (from now
on referred to as simply /3-glucanase) , hydrolyses ¿3-1,4 
glucosidic bonds provided they are adjacent to a >3-1,3 
glucosidic bond. These type of bonds comprise the major type of 
linkages in the glucans of malt and barley cell wall endosperm. 
In the brewing process, these glucans are normally degraded by 
endogenous barley and malt /3-glucanase enzymes. However, the 
high temperatures associated with mashing and kilning 
procedures destroys these enzymes and this can result in the
glucans being extracted in the wort. The presence of high
molecular weight glucans in the wort can ultimately cause a
reduction in beer quality. The B.subtilis /3-glucanase enzyiae 
cleaves the same /3-l,4 linkages and produces a similar range of 
products from malt and barley /3-glucans as the cereal enzymes. 
The B.subtilis gene was cloned with the intention of producing 
a yeast strain that could hydrolyse these excess /3-glucans 
during the fermentation process (Cantwell and McConnell 1983). 
The cloned gene has a coding sequence of 726bp (app.l),
producing a protein of 242 amino acids (Murphy et al. 1984). 
This sequence includes a signal peptide of 26 -28 amino acids. 
The signal sequence is characteristic of most signal peptides 
in that it includes a short hydrophillic domain of six amino 
acids, followed by a hydrophobic sequence. The signal ends with 
two potential cleavage sites as shown below (Fig.3.1). A 
useful feature of the cleavage site is the presence of a DdeI 
site which allows the convenient separation of signal and 
mature sequences during manipulations.
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(pJG317) (pJG205) (pJG314)
1 17 27
ATG-.............. ATG.........GCT - ACT - GCC - TCA- GCT - CAA. .* * * * * * *
Ddel
1 17 26 27 28
ATG.............. ATG..........GCT - ACT - GCC - TCA - GCT - CAA. .
Ala-Thr-Ala-Ser-Ala-Lys.. 
4- -!■
Potential signal
cleavage sites
Figure (3 .1) . Features of the /3-glucanase signal peptide.
The entire /3-glucanase gene, including its signal peptide and 
terminator sequence, were inserted into the BamHI site of pUC8 
(T.Ryan, D.C.U.). This plasmid, pJG106, has formed the basis 
for many of the manipulations to follow and is shown in 
app.(3). The /3-glucanase gene in its entirety can be removed on 
a BamHI or tfindlll fragment.
The /3-glucanase gene was expressed in S .cerevisiae under 
control of the a-factor promoter and signal peptide sequence in 
pJG314. (Fig.3.2) (T. Ryan, D.C.U.). To generate this
construct, the /3-glucanase gene was removed from its signal 
peptide sequences at the DdeI site, BamHI linkers were added 
and the gene inserted into the BamRI site of p69D (a derivative 
of p69A, see app.(2) for details) (Kurjan and Herskowitz, 
1982), generating an in-frame fusion with the a-factor signal 
peptide. When transformed into DBY746, pJG314 was shown to
secrete /3-glucanase into the yeast cell medium.
In addition to pJG314, two further constructs pJG317 and 
pJG205, were made. pJG317 contains the entire /9-glucanase gene, 
including the bacterial signal peptide, under AD H1 promoter
control in pAAH5 (Fig. 3.3). Using this construct, it was shown 
that the heterologous Bacillus signal sequence also secretes
the /3-glucanase enzyme in S.cerevisiae (T. Ryan, D.C.U.).
The /3-glucanase signal peptide has a second ATG start site (at
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amino acid position 17) , in frame with the initiation codon. 
The gene including the signal peptide from this second ATG, was 
introduced into S.cerevisiae under control of the ADH1 promoter 
in pAAH5 (Cantwell et al. 1986). This plasmid, pJG205
(Fig.3.3), was also shown to produce and secrete the enzyme 
despite its truncated signal sequence. Initial investigations 
suggested, that in terms of secretion of the enzyme in 
S .cerevisiae, pJG317 and pJG205 were more efficient than pJG314 
(T.Ryan, pers. comm.). In fermentation trials, an ale and lager 
brewing strain transformed with pJG205(l) (pJG205 modified by
the insertion of the CUP1 dominant selectable marker), also 
secreted the enzyme in sufficient quantities to significantly 
reduce the levels of /3-glucan during the fermentation process 
(Cantwell et al. 1985).
The work presented here was undertaken to examine in more 
detail the production and secretion of the B.subtilis 
/3-glucanase enzyme in S.cerevisiae using these three plasmids. 
Of particular interest was to determine whether the 
extracellular levels of activity observed in pJG317 and pJG205, 
were due to translocation into and transport through the 
conventional yeast secretory pathway, rather than simply due to 
cell lysis or leakage. Also, it was hoped to examine the 
efficiency of the bacterial signal and assess its potential for 
use as a general secretion sequence for heterologous protein 
production in yeast. Examination of the Bacillus protein 
product, with respect to processing and modification, was also 
carried out. The difficulties associated with rapid 
quantitation of /3-glucanase levels prompted the investigation 
of another heterologous protein, /3-glucuronidase (an E.coli 
enzyme), and its potential for development as a reporter enzyme 
for S.cerevisiae.
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Summary of plasmid constructs:
CONSTRUCT PROMOTER SIGNAL PEPTIDE
pJG205 ADH1 Truncated ^-glucanase
pJG317 ADH1 Complete /3-glucanase
pJG314 a-factor a-factor
NOTE: Except where indicated, pJG317, pJG205 and pJG314, refers 
to these plasmids transformed into DB746.
Figure (3.2) pJG314
pJG 314
p-glucanase ^
\  ^
\  /
n
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Figure (3.3). pJG317 and pJG205
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(3.2) The /3-glucanase plate assay.
The plate assay for detecting /3-glucanase activity (section 
2.18), which was developed to screen for E.coli cells producing 
the enzyme (Cantwell and McConnell 1983), can also be used to 
identify and monitor ¿3-glucanase production in yeast cells. The 
substrate lichenan (from Usnea barbata), included in plates at 
a concentration of 0.05%, is composed of glucans with both 
¿3-1,3 and 1,4 linkages. These linkages are specifically broken 
down by the Bacillus /3-glucanase, producing a halo visible on 
staining with congo red dye (0.1%). Non-selective media such as 
YEPD and MYGP, containing lichenan, stain with congo red. 
Minimal medium however, must be buffered in order to detect 
extracellular /3-glucanase production under selective growth 
conditions (section 2.4).
Intracellular and extracellular levels of ¿3-glucanase activity 
were compared in pJG317, pJG205 and pJG314 using the plate 
assay (Figure 3.4). This qualitative assessment suggests that 
all three constructs produce similar overall levels of the 
enzyme, with a slightly larger halo in pJG205 at an 
intracellular level. The extent of this increase in activity is 
demonstrated quantitatively in section (3.4) and reflects the 
limitations of the plate assay at high concentrations of 
/3-glucanase.
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Figure (3.4).
(a) Extracellular levels of /3-glucanase activity detected by 
direct staining with congo red.
(b) Intracellular levels of activity were released using a hot 
agar overlay and stained with congo red.
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(3.3) The DNS assay for measuring /3-glucanase activity. 
/9-glucanase hydrolyses the substrate /3-glucan, to produce 
dextrins with reducing ends. The production of these reducing 
sugars can be measured using the DNS assay developed by Miller 
(1960). The method employed for accurate quantitation of 
¿3-glucanase activity using the DNS assay is described in 
section (2.19).
The optimum assay conditions for the commercial Bacillus 
^-glucanase enzyme, recommended by the manufacturers (Novo 
Cereflo) , is at a pH of 5.5 and an incubation temperature of 
55°C. The pH and temperature profiles of /9-glucanase produced 
in S .cerevisiiie (DBY746) were examined. Extracts were prepared 
from pJG317 (0D =1.0) and /3-glucanase activity measured over
a range of pH and temperature values. Assays were carried out 
in duplicate and the pH and temperature profiles below 
represent an average of two values (Figure 3.5). 45°C at pH6.5 
was shown to be optimum for the /3-glucanase enzyme when 
produced in yeast and subsequent liquid assays were carried out 
under these conditions.
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F ig u re  ( 3 . 5 ) .
pH and temperature profiles of ^-glucanase produced in 
S .c e r e v l s l a e .
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(3.4) $-glucanase production in pJG317, pJG205 and pJG314:
comparing intracellular and extracellular levels of activity.
In order to accurately assess and compare the levels of
/0-glucanase produced in pJG317, pJG205 and pJG314,
intracellular and extracellular enzyme activity was monitored
over the complete growth cycles of the three strains using the
DNS assay. 1.0ml of a stationary phase culture was innoculated
into 250mls of minimal medium and shaken (150 rpm) at 30°C. At
3 hourly intervals, 5.0ml of culture was removed and chilled on
ice. An OD reading was recorded at each time point and 
600 b
extracts and supernatants were prepared and assayed for 
/3-glucanase activity as described in sections 2.19 and 2.20. 
The results of the growth curves are shown (Figure 3.6(a), (b) 
and (c)).
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F i g u r e  3 . 6 ( c ) .  GROWTH CURVE pJG31 4 in DBY746
Time (hrs)
F i g u r e  ( 3 . 7 ) .
SECRETED B-GLUCANASE IN pJG314, pJG317 and pJG205
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The g r o w t h  c u r v e s  s h o w  t h a t  e n z y m e  p r o d u c t i o n  a n d  s e c r e t i o n  
c l o s e l y  f o l l o w s  c e l l  g r o w t h .  S e c r e t i o n  o f  t h e  e n z y m e  c o n t i n u e s  
o n  i n t o  s t a t i o n a r y  p h a s e  f o r  up t o  1 0  h o u r s  a f t e r  p r o d u c t i o n  
h a s  c e a s e d .  The  m o s t  s t r i k i n g  a s p e c t  o f  c o m p a r i n g  t h e  t h r e e  
c o n s t r u c t s  i s  t h e  l a r g e  d i f f e r e n c e s  i n  i n t r a c e l l u l a r  l e v e l s  o f  
/ 3 - g l u c a n a s e  a c t i v i t y  o b s e r v e d  i n  pJ G 2 0 5  c o m p a r e d  t o  pJ G 3 1 7  a n d  
p J G 3 1 4 .  p J G 2 0 5 ,  c o n t a i n i n g  t h e  t r u n c a t e d  b a c t e r i a l  s i g n a l
p e p t i d e ,  p r o d u c e s  a l m o s t  n i n e  t i m e s  a s  much e n z y m e  a c t i v i t y  a t  
a n  i n t r a c e l l u l a r  l e v e l  a s  p J G 3 1 7 . C o m p a r i s o n  o f  s e c r e t e d  l e v e l s  
( F i g u r e  3 . 7 ,  ¿ ib o v e)  s h o w s ,  t h a t  w h i l e  p J G 3 1 7  s e c r e t e s  h i g h e r  
l e v e l s  o f  t h e  e n z y m e  t h a n  p J G 2 0 5 , t h i s  d i f f e r e n c e  i n  
e x t r a c e l l u l a r  l e v e l s  c a n n o t  a c c o u n t  f o r  t h e  e x t e n t  o f  t h e  
a c c u m u l a t i o n  o b s e r v e d  i n  p J G 2 0 5 .  T h e  i n c r e a s e  i n  i n t r a c e l l u l a r  
l e v e l s  o f  a c t i v i t y  i n  p J G 2 0 5 , c o u l d  b e  d u e  t o  t r a n s c r i p t i o n a l ,  
t r a n s l a t i o n a l  o r  p o s t - t r a n s l a t i o n a l  e v e n t s ,  a n d  t h e s e  
p o s s i b i l i t i e s  a r e  d i s c u s s e d  a t  a  l a t e r  s t a g e .
S e c r e t i o n  l e v e l s  i n  p J G 3 1 4  a r e  l o w e r  t h a n  b o t h  p J G 3 1 7  a n d  
p J G 2 0 5 ,  p o s s i b l y  r e f l e c t i n g  d i f f e r e n c e s  i n  p r o c e s s i n g  o f  t h e  
t w o  s i g n a l  p e p t i d e s ,  ( a - f a c t o r  b y  t h e  KEX2 c l e a v a g e  e n z y m e  a n d  
t h e  b a c t e r i a l  s i g n a l  b y  s i g n a l  p e p t i d a s e ) .  A l t e r n a t i v e l y ,  
t a k i n g  i n t o  a c c o u n t  t h e  l o w e r  i n t r a c e l l u l a r  l e v e l s  a l s o  
o b s e r v e d  i n  p J G 3 1 4  ( i . e ,  0 . 3  x  1 0 3 U / m l  i n  3 1 4  c o m p a r e d  t o  0 . 5
3x  1 0  i n  3 1 7 )  , t h i s  may b e  a  r e f l e c t i o n  o f  t h e  r e l a t i v e  
s t r e n g t h s  o f  t h e  ADH1 a n d  a - f a c t o r  p r o m o t e r s .
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(3.5) Construction of pVT314 : comparison of the bacterial and 
yeast signal peptides under the same promoter control.
I n  o r d e r  t o  o b t a i n  a  m o r e  d i r e c t  e s t i m a t i o n  o f  t h e  r e l a t i v e  
e f f i c i e n c i e s  o f  t h e  B a c i l l u s  / 3 - g l u c a n a s e  a n d  y e a s t  a - f a c t o r  
s i g n a l  p e p t i d e s ,  a c o n s t r u c t  wa s  made f u s i n g  t h e  / 3 - g l u c a n a s e  
g e n e  t o  t h e  a - f a c t o r  s i g n a l  p e p t i d e  u n d e r  c o n t r o l  o f  t h e  ADH1 
p r o m o t e r .  T h i s  f u s i o n  w o u l d  b e  d i r e c t l y  c o m p a r a b l e  t o  p J G 3 1 7 ,  
d i f f e r i n g  o n l y  i n  t h e  s i g n a l  p e p t i d e s  u s e d  a n d  t o  p J G 3 1 4 ,  w h e r e  
o n l y  t h e  p r o m o t e r s  d i f f e r .  A summary  o f  t h i s  new c o n s t r u c t  i s  
g i v e n  b e l o w  a n d  i n  F i g u r e  3 . 8 ( a )  t o  ( c ) .
P l a s m i d  p G S 4 , c o n t a i n i n g  t h e  a - f a c t o r  s i g n a l  p e p t i d e  o n  a  
H i n d l l l - B a m H I  f r a g m e n t  w a s  o b t a i n e d  f r o m  K . J . S h a w  
( S c h e r i n g - P l o u g h  R e s e a r c h ,  N . J . ) .  The s i g n a l  c o n t a i n s  t h e  
a - f a c t o r  p r e - p r o  r e g i o n  up  t o  a n d  i n c l u d i n g  t h e  KEX2 p r o c e s s i n g  
s i t e ,  L y s - A r g  (S h a w  e t  a.1. 1 9 8 8 ) .  To e a s e  f u r t h e r
m a n i p u l a t i o n s ,  t h i s  f r a g m e n t  w a s  l i g a t e d  i n t o  t h e  t f i n d l l l - B a m H I  
s i t e  o f  pUC19 (pUGS4)  ( F i g u r e  3 . 8 ( a ) ) .  The S t u I  s i t e  m a r k s  t h e  
l o c a t i o n  o f  t h e  L y s - A r g  c l e a v a g e  s i t e .
F i g u r e  3 . 8 ( a ) .  pUGS4 : pUC19 c o n t a i n i n g  t h e  a - f a c t o r  s i g n a l .
AAA-AGG-CCT- 
AAA-GGG- (blunt ena) 
Lys-Arg-
9 3
T he  / 3 - g l u c a n a s e  g e n e ,  i n c l u d i n g  i C s  c o m p l e t e  s i g n a l  p e p t i d e  i s  
p r e s e n t  b e t w e e n  tw o  / / i n d l l l  s i t e s  i n  p J G 1 06  ( F i g u r e  3 . 8 ( b ) ) .  
Th e D d e l  s i t e  i n d i c a t e d  w i t h  a n  a s t e r i x ,  m a r k s  t h e  j u n c t i o n  
b e t w e e n  t h e  e n d  o f  t h e  B a c i l l u s  s i g n a l  p e p t i d e  a n d  t h e  
b e g i n n i n g  o f  t h e  m a t u r e  s e q u e n c e  o f  t h e  g e n e  (M u rp h y  e t  a l .  
1 9 8 4 ) .  The  g e n e ,  m i n u s  i t s  s i g n a l  p e p t i d e  w a s  i s o l a t e d  f r o m  
pJ G 1 0 6  o n  a  D d e l  f r a g m e n t  a n d  t h e  5 '  o v e r h a n g s  w e r e  f i l l e d  i n  
t o  g i v e  a b l u n t  e n d e d  f r a g m e n t .  T h i s  f i l l e d  i n  f r a g m e n t  w a s  
t h e n  c u t  w i t h  H i n d l l l  a n d  t h e  / 3 - g l u c a n a s e  g e n e ,  m i n u s  i t s  
s i g n a l  p e p t i d e  a n d  pUC19 s e q u e n c e s ,  w a s  p u r i f i e d  f r o m  a  g e l .  
T h i s  b l u n t  /  s t i c k y  e n d e d  f r a g m e n t  w a s  l i g a t e d  ( i n  f r a m e )  i n t o  
S t u I / / / i n d I I I -  c u t  pUGS4 t o  g i v e  p J G S 4  ( F i g u r e  3 . 8 ( b ) ) .  The  
/ 3 - g l u c a n a s e  g e n e  a n d  a - f a c t o r  s i g n a l  p e p t i d e  w a s  r e m o v e d  f r o m  
pJGS4 u s i n g  Ba/nHI a n d  l i g a t e d  i n t o  pVT102U ( V e r n e t  e t  a l , 
1 9 8 7 ) ,  p l a c i n g  i t  u n d e r  c o n t r o l  o f  t h e  ADHI p r o m o t e r  ( F i g u r e  
3 . 8 ( c ) ) .  O r i e n t a t i o n  w a s  c o n f i r m e d  b y  r e s t r i c t i o n  d i g e s t  a n d  
t h e  p l a s m i d  na m ed  p V T 3 1 4 .
9 4
F i g u r e  3 . 8 ( b ) .  C o n s t r u c t i o n  o f  pJGS4 : p U G S 4 , w i t h  t h e  
/ 3 - g l u c a n a s e  g e n e  f u s e d  t o  t h e  a - f a c t o r  s i g n a l  p e p t i d e .
D *  H
I I -200 boW 7T/77/Z7/7777Zm
hind I I I
blunt 8 S H
^ 7ZZZZZZZZZZZZ1
blunt fusion
B
F i g u r e  3 . 8 ( c ) .  pV T 3 14 :  / 3 - g L u c a n a s e  g e n e  u n d e r  A d h l  p r o m o t e r  a n d  
a - f a c t o r  s i g n a l  p e p t i d e  c o n t r o l .
a-factor signal - 
/3-glucanase gene Z 2 2
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pVT3 14  w a s  t r a n s f o r m e d  i n t o  DBY746 a n d  e x p r e s s i o n  a n d  s e c r e t i o n  
o f  / 9 - g l u c a n a s e  a c t i v i t y  w a s  m o n i t o r e d  o v e r  a  5 4  h o u r  g r o w t h  
p e r i o d  ( F i g u r e  3 . 9 ) .  S u r p r i s i n g l y ,  t h e  l e v e l s  o f  / S - g l u c a n a s e  
a c t i v i t y  d e t e c t e d  i n t r a c e l l u l a r l y  a n d  e x t r a c e l l u l a r l y  i n  pVT 314  
w e r e  l o w e r  t h a n  i n  p J G 3 1 7 ,  d e s p i t e  t h e  f a c t  t h a t  b o t h  
c o n s t r u c t s  c o n t a i n  t h e  sa m e p r o m o t e r  ( A d h l ) , ( s e e  F i g . 3 . 1 0  f o r  
c o m p a r i s o n  o f  e x t r a c e l l u l a r  e n z y m e  a c t i v i t y ) . I n t r a c e l l u l a r  
l e v e l s  o f  a c t i v i t y  i n  pVT3 14  a r e  m a r g i n a l l y  l o w e r  t h a n  t h o s e  
d e t e c t e d  i n  p J G 3 1 4  a n d  o v e r  t h e  m a j o r i t y  o f  t h e  g r o w t h  c y c l e ,  
e x t r a c e l l u l a r  l e v e l s  a r e  a l s o  l o w e r .  O n l y  i n  s t a t i o n a r y  p h a s e  
( a t  a p p r o x i m a t e l y  3 6 h r s )  d o  t h e  s e c r e t e d  l e v e l s  o f  / 3 - g l u c a n a s e  
i n  pV T 314  a p p r o a c h  t h o s e  o f  p J G 3 1 4 .
F i g u r e  ( 3 . 9 ) .
GROWTH CURVE pVT314 in DBY746
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T a b l e  3 . 1  s u m m a r i z e s  t h e  / 3 - g l u c a n a s e  c o n s t r u c t s  a n d  t h e  l e v e l s  
o f  / 3 - g l u c a n a s e  a c t i v i t y  d e t e c t e d  f o r  e a c h .  To e s t i m a t e  t h e  
o v e r a l l  l e v e l s  o f  a c t i v i t y  i n  e a c h  c a s e ,  i n t r a c e l l u l a r  a n d  
e x t r a c e l l u l a r  a c t i v i t y  w a s  t a k e n  a t  t h e  p o i n t  i n  t h e  g r o w t h  
c u r v e  w h e r e  t h e  h i g h e s t  l e v e l s  o f  e n z y m e  a r e  p r e s e n t  
e x t r a c e l l u l a r l y , i e .  4 2 h r s  f o r  p J G 3 1 4  a n d  p V T 3 1 4  a n d  4 5 h r s  f o r  
p J G 3 1 7  a n d  p J G 2 0 5 . I n t r a c e l l u l a r  a n d  e x t r a c e l l u l a r  / 3 - g l u c a n a s e  
w e r e  a l s o  e x p r e s s e d  a s  p e r c e n t a g e s  o f  t h e  t o t a l  a c t i v i t y  a t  
t h a t  p o i n t .
On o n e  l e v e l ,  l o o k i n g  a t  t h e  e x t r a c e l l u l a r  l e v e l s  d e t e c t e d  i n  
t h e  t w o  b a c t e r i a l  s i g n a l  c o n s t r u c t s  a n d  t h e  tw o  a - f a c t o r  s i g n a l  
c o n s t r u c t s ,  t h i s  t a b l e  s h o w s  t h a t  t h e  b a c t e r i a l  s i g n a l  p e p t i d e  
i s  c a p a b l e  o f  s e c r e t i n g  up  t o  4 5 0  u n i t s  o f  / 3 - g l u c a n a s e  / i n i  
w h i l e  t h e  a - f a c t o r  s i g n a l  s e c r e t e s  l e s s  ( 2 3 0 - 2 5 0  u n i t s / m l )  . 
L o o k i n g  a t  t h e  p e r c e n t a g e s , t h e  f i g u r e s  a l s o  s h o w  t h a t  t h e  tw o  
s i g n a l s  ( e x c l u d i n g  p J G 2 0 5 )  a r e  c o m p a r a b l e  i n  t h e i r  e f f i c i e n c i e s  
t o  s e c r e t e  / 3 - g l u c a n a s e  w i t h  5 0 -6 0 %  o f  t h e  t o t a l  a c t i v i t y  
d e t e c t e d  e x t r a c e l l u l a r l y  i n  e a c h  c a s e .
Time (h rs )
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T a b l e  ( 3 . 1 ) .  Summary o f  / 3 - g l u c a n a s e  c o n s t r u c t s  a n d  l e v e l s  o f  
e n z y m e  p r o d u c t i o n  a t  o n e  p o i n t  i n  t h e  g r o w t h  c y c l e .
CONSTRUCT PROMOTER SIGNAL PEPTIDE
pJ G 2 0 5 ADH1 T r u n c a t e d  / 3 - g l u c a n a s e
p J G 317 ADH1 C o m p l e t e  / 3 - g l u c a n a s e
p J G 3 1 4 a - f a c t o r a - f a c t o r
pVT314 ADH1 a - f a c t o r
C o n s t r u c t
T o t a l  U n i t s  
A c t i v i t y / m l
%
I n t r a c e l l u l a r
%
E x t r a c e l l u l a r
p J G 2 0 5 3 4 4 0 86% 14%
pJ G 3 17 8 2 0 46% 54%
pJ G 3 1 4 3 9 0 41% 59%
pVT314 3 7 0 38% 62%
N o t e  t h a t  t h i s  t a b l e  r e p r e s e n t s  / 3 - g l u c a n a s e  a c t i v i t y  a t  o n e  
p o i n t  i n  t h e  g r o w t h  c y c l e  o n l y ,  i n  o r d e r  t o  g i v e  s o m e  i d e a  o f  
t h e  p e r c e n t a g e s  o f  i n t r a c e l l u l a r  a n d  e x t r a c e l l u l a r  p r o d u c t i o n  
l e v e l s . Th e  g r o w t h  c u r v e s  g i v e  a  m o re  g e n e r a l  i d e a  o f  t h e  
o v e r a l l  l e v e l s  a n d  c h a r a c t e r i s t i c s  o f  t h e  s t r a i n s ,  a n d  a s  w i l l  
b e c o m e  a p p a r e n t ,  t h e  s i t u a t i o n  i s  m o re  c o m p l i c a t e d  t h a n  t h i s  
t a b l e  s u g g e s t s .
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(3.6) Removal of the /9-glucanase signal peptide.
The e x t r a c e l l u l a r  l e v e l s  o f  / 3 - g l u c a n a s e  a c t i v i t y  o b s e r v e d  i n  
p J G 3 1 7  a n d  p J G 2 0 5  w o u l d  s u g g e s t  t h a t  i n  y e a s t ,  t h i s  
h e t e r o l o g o u s  s i g n a l  p e p t i d e  i s  c a p a b l e  o f  d i r e c t i n g  / 3 - g l u c a n a s e  
o u t  i n t o  t h e  m e d iu m .  I f  t h i s  b a c t e r i a l  s i g n a l  p e p t i d e  i s  t o  b e  
u s e f u l  a s  a  g e n e r a l  s e c r e t i o n  s i g n a l  f o r  h e t e r o l o g o u s  p r o t e i n  
p r o d u c t i o n  i n  y e a s t ,  i t  i s  n e c e s s a r y  t o  e n s u r e  t h a t  t h e  
e x t r a c e l l u l a r  / 3 - g l u c a n a s e  l e v e l s  o b s e r v e d  i n  pJ G 3 1 7  a n d  p J G 2 05  
a r e  d u e  t o  t r a n s p o r t  o f  t h e  e n z y m e  t h r o u g h  t h e  c o n v e n t i o n a l  
s e c r e t o r y  p a t h w a y  a n d  n o t  d u e  t o  c e l l  l e a k a g e  o r  l y s i s .  I n  
o r d e r  t o  i n v e s t i g a t e  t h i s  a n d  t o  e x a m i n e  t h e  o v e r a l l  p r o d u c t i o n  
l e v e l s  o f  t h e  e n z y m e  i n  t h e s e  v e c t o r  s y s t e m s ,  i t  w a s  d e c i d e d  t o  
r e m o v e  t h e  / 3 - g l u c a n a s e  s i g n a l  p e p t i d e  a n d  e x p r e s s  t h e  g e n e  
d i r e c t l y  u n d e r  ADH1 p r o m o t e r  c o n t r o l .  I n  t h i s  c o n s t r u c t ,  t h e  
/ 3 - g l u c a n a s e  a c t i v i t y  w a s  e x p e c t e d  t o  b e  l i m i t e d  t o  t h e  y e a s t  
c y t o p l a s m .
I n  r e m o v i n g  t h e  / 3 - g l u c a n a s e  s i g n a l  p e p t i d e ,  t h e  ATG 
t r a n s l a t i o n a l  s t a r t  s i t e  i s  a l s o  d e l e t e d .  Th e  pAH s e r i e s  o f  
v e c t o r s  ( p A H 9 , pAHIO a n d  pAH21) p r o v i d e  t h e  ADH1 p r o m o t e r  o n  
t h r e e  d i f f e r e n t  p l a s m i d s  e a c h  w i t h  a n  ATG s t a r t  s i t e  i n  o n e  o f  
t h e  t h r e e  r e a d i n g  f r a m e s  a n d  a  f f i n d l l l  c l o n i n g  s i t e  (A m m er er ,  
1 9 8 3 ) .  Th e  / 3 - g l u c a n a s e  g e n e ,  m i n u s  i t s  s i g n a l  p e p t i d e  ( s t a r t i n g  
f r o m  t h e  Dde  I  s i t e )  w a s  c l o n e d  i n t o  t h e  BamHI s i t e  o f  pUC8 
a f t e r  t h e  a d d i t i o n  o f  BamHI l i n k e r s  t o  t h e  f i l l e d  i n  e n d s  t o  
g i v e  p J G 1 0 4 ,  a p p . ( 4 )  (T .  R y a n ,  D . C . U . ) .  A H i n d l l l  l i n k e r
( 8 ' m e r )  w a s  i n t r o d u c e d  i n t o  t h e  S m a l  s i t e  o f  p J G 1 0 4  ( p J G l 0 4 a ) , 
( F i g u r e  3 . 1 1 ) .  The  t f i n d l l l  f r a g m e n t  f r o m  p J G 1 0 4 a  w a s  
t r a n s f e r r e d  i n t o  t h e  c l o n i n g  s i t e  o f  pAH9 t o  g e n e r a t e  a n  
i n - f r a m e  f u s i o n  b e t w e e n  t h e  ATG s t a r t  a n d  t h e  / 3 - g l u c a n a s e  g e n e .  
T h i s  c o n s t r u c t  w a s  n a m ed  pJB/?4 .  O r i e n t a t i o n  o f  t h e  / 3 - g l u c a n a s e  
g e n e  w a s  c o n f i r m e d  b y  S a i l  d i g e s t s  ( F i g u r e  3 . 1 2 )  a n d  t h e  
p l a s m i d  (p JB/34)  t r a n s f o r m e d  i n t o  DBY 746 .  H o w e v e r ,  no  
/ 3 - g l u c a n a s e  a c t i v i t y  w a s  d e t e c t a b l e  i n t r a c e l l u l a r l y  o r  
e x t r a c e l l u l a r l y  u s i n g  t h e  p l a t e  o r  DNS a s s a y .
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s i g n a l
Figure
H
SOCbp | JUODp | |
V //////////777 ,130Cbc
H
Sequence around ATG start of pJB04:
i t a r t  o f  / 9 - g l u c « n a s a  g a n a
&TG-TCT-CAA-/-AGC-TTG-GGG-GAT-CCG-TCA.......................
pAH9 pJG104a
( 3 . 1 1 ) .  C o n s t r u c t i o n  o f  pJB/34 : / 5 - g l u c a n a s e  g e n e  m i n u s  
, u n d e r  A d h l  p r o m o t e r  c o n t r o l .
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F i g u r e  ( 3 . 1 2 ) .  R e s t r i c t i o n  a n a l y s i s  o f  pJB/34.
The  a p p r o x i m a t e  s i z e s  o f  t h e  r e s t r i c t i o n  f r a g m e n t s  i n  e a c h  
d i g e s t  a r e  sh o w n  i n  b r a c k e t s  b e l o w .  pAH9 w i t h  o n e  c o p y  o f  t h e  
/ 3 - g l u c a n a s e  g e n e  ( i e .  pJB/34)  i n  t h e  c o r r e c t  o r i e n t a t i o n  i s  
s h o w n  i n  l a n e  6 .
1 2  3 4 5 - 6
bp
3675  
2323  1929  
1371 
1264 
702
L a n e  1 : p J G 1 0 6  /  H i n d l l l  ( 2 . 6 K b ;  0 . 9 K b ) .
La n e  2 : pAH9 /  S a i l  /  f f i n d l l l  ( 6 . 6 K b ;  3 . 4 K b ;  1 . 8 K b ) .
L a n e  3 : A /  B s t E I I  ( r e l e v a n t  s i z e s  m a r k e d  o n  g e l ) .
L a n e  4  : p J B £ l  /  S a i l  ( 6 . 6 K b ;  3 . 8 K b ;  1 . 8 K b ;  0 . 3 . K b ) .
L a n e  5 : p J B £ 2  /  S a i l  ( 6 . 6 K b ;  3 . 4 K b ;  2 . 3 K b ;  0 . 5 K b ;  0-3Kb :
c o n t a i n s  t w o  c o p i e s  o f  t h e  / 9 - g l u c a n a s e  g e n e ) .
L a n e  6 : pJB/34 /  S a i l  ( 6 . 6 K b ;  3 . 4 K b ,  2 . 3 K b ;  0.3Kb)
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The pAH s e r i e s !  o f  p l a s m i d s  u s e d  i n  c o n s t r u c t i n g  pJB/34 ,  d i f f e r  
f r o m  pAAH5 i n  t h a t  t h e y  l a c k  t h e  ADH1 t e r m i n a t o r  s e q u e n c e .  
A l t h o u g h  t h e  / 3 - g l u c a n a s e  g e n e  h a s  i t s  own t e r m i n a t o r  s e q u e n c e  
p r e s e n t  i n  a l l  t h e  p l a s m i d  c o n s t r u c t s ,  i t  i s  p o s s i b l e  t h a t  t h e  
b a c t e r i a l  t e r m i n a t o r  a l o n e  i s  n o t  s u f f i c i e n t  f o r  e f f e c t i v e  
t e r m i n a t i o n .  I n  t h e  a b s e n c e  o f  a  y e a s t  t e r m i n a t o r ,  
t r a n s c r i p t i o n a l  r e a d  t h r o u g h  may h a v e  a  d e s t a b i l i s i n g  e f f e c t  o n  
t h e  / 3 - g l u c a n a s e  t r a n s c r i p t  i t s e l f  o r  o n  t h e  p l a s m i d  a s  a  w h o l e .  
I t  w a s  t h e r e f o r e  d e c i d e d  t o  c o n s t r u c t  a n  a l t e r n a t i v e  p l a s m i d  
u t i l i z i n g  pAAH5 a s  a  m o r e  d i r e c t  c o m p a r i s o n  t o  p J G 3 1 7  a n d  
p J G 2 0 5 .  H o w e v e r ,  u n d e r  c e r t a i n  c o n d i t i o n s  d e s c r i b e d  a t  a  l a t e r  
s t a g e  ( s e c t i o n  3 . 9 ) ,  pJB/34 c a n  p r o d u c e  a c t i v e  /3 - g l u c a n a s e .
( 3 . 7 )  C o n s t r u c t i o n  o f  pJB C55A.
An ATG s t a r t  s i t e  w a s  i n t r o d u c e d  i n  f r o n t  o f  t h e  / 3 - g l u c a n a s e  
g e n e  i n  p J G 1 0 4  v i a  t w o  i n t e r m e d i a t e s :  To c r e a t e  a  s u i t a b l e
r e s t r i c t i o n  s i t e s  f o r  i n s e r t i n g  t h e  g e n e  u l t i m a t e l y  i n t o  pAAH5, 
a  f f i n d l l l  l i n k e r  ( 8 ' m e r ) ,  w a s  f u s e d  t o  t h e  f i l l e d  i n  £ c o R I  s i t e  
o f  p J G 1 0 4  ( p J G 1 0 4 b )  . T h i s  a l l o w s  t h e  / 3 - g l u c a n a s e  g e n e  t o  b e  
i s o l a t e d  o n  a H i n d l l l  f r a g m e n t .  p J G l 0 4 c  w a s  c o n s t r u c t e d  f r o m  
p J G 1 0 4 b  b y  i n s e r t i n g  a  C l a l  l i n k e r  d(pCATCGATG), i n t o  t h e  SmaI  
s i t e  ( F i g u r e  3 . 1 3 ) .  T h e  p r o p o s e d  s e q u e n c e  a r o u n d  t h e  5 '  e n d  o f  
t h e  g e n e  i s  a s  f o l l o w s :
s ta r t  o f  /3-glucanase gene
f f i n d l l l ------- CCGCATCGATG - GGG - GAT - CCT - TCA-GCT - ............................- f f i n d l l l
C l a l  BamHI
l i n k e r  l i n k e r
As  a  p r e c a u t i o n ,  t o  e n s u r e  t h a t  t h e  o r i g i n a l  p J G 1 0 4  p l a s m i d  
c o n t a i n e d  o n l y  o n e  BamHI l i n k e r  a s  i n d i c a t e d ,  p J G 1 0 4 c  w a s  
r e s t r i c t e d  e x h a u s t i v e l y  w i t h  BamHI ,  t h e  v e c t o r  a n d  i n s e r t  
f r a g m e n t s  g e l  p u r i f i e d  a n d  l i g a t e d  t o  r e f o r m  p J G 1 0 4 c .  The  
r e s u l t a n t  p l a s m i d  w a s  t h e n  c u t  w i t h  C l a l ,  g e l  p u r i f i e d  a n d  
r e l i g a t e d  t o  e n s u r e  t h a t  o n l y  o n e  C l a l  l i n k e r  w a s  a l s o  p r e s e n t .  
Th e / 3 - g l u c a n a s e  g e n e  w a s  i s o l a t e d  u s i n g  f f i n d l l l  a n d  l i g a t e d  
i n t o  t h e  t f i n d l l l  s i t e  o f  pAAH5 ( p J B C 5 5 A ) , ( F i g u r e  3 . 1 3 ) .  I n
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DB Y7 46 ,  l i k e  pJB/34,  pJBC55A p r o d u c e d  no  d e t e c t a b l e  ^ f l - g l u c a n a s e  
a c t i v i t y .
F i g u r e  ( 3 . 1 3 ) .  C o n s t r u c t i o n  o f  pJB C55A.
-> A T G  H
J-G L U C A N A S EVzzzizt7ZZZZZZL
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(3.8) Northern analysis of pJB/94 and pJBC55A transcripts.
To i n v e s t i g a t e  i f  s p e c i f i c  / 3 - g l u c a n a s e  t r a n s c r i p t s  c o u l d  b e  
d e t e c t e d  i n  pJB/34 a n d  pJB C55A a n d  t o  g a i n  s o m e  i n s i g h t  i n t o  t h e  
r e l a t i v e  s t a b i l i t i e s  o f  t h e s e  t r a n s c r i p t s  c o m p a r e d  t o  pJ G 205
a n d  p J G 3 1 7 ,  N o r t h e r n  a n a l y s i s  w a s  c a r r i e d  o u t .  T o t a l  RNA w a s
p r e p a r e d  f r o m  a l l  o f  t h e  s t r a i n s  c o n t a i n i n g  t h e  ADH1
c o n s t r u c t s :  pAAH5, p J G 3 1 7 ,  p J G 2 0 5 , pJ B C 55 A ,  pJB/34 ,  pAH10/3 a n d  
pAH21/3.  pAH10/3 a n d  pAH21/3 c o n t a i n  t h e  / 3 - g l u c a n a s e  g e n e  c l o n e d  
i n t o  t h e  T i i n D I I I  s i t e  o f  pAHIO a n d  pAH21 ( c o n s t r u c t e d  b y  
M . D u f f y ,  D . C . U . ) .  U n t r a n s f o r m e d  DBY746 w a s  a l s o  i n c l u d e d  a s  a  
n e g a t i v e  c o n t r o l .
The  RNA wa s
f r a c t i o n a t e d  b y  f o r m a l d e h y d e  g e l  e l e c t r o p h o r e s i s  ( 2 . 2 6 ) ,  a n d  
b l o t t e d  b i - d i r e c t i o n a l l y  o n t o  n i t r o c e l l u l o s e .  One f i l t e r  w a s
h y b r i d i s e d  t o  a  / 3 - g l u c a n a s e  p r o b e  ( t h e  t f i n d l l l  f r a g m e n t  f r o m  
p J G 1 0 6 )  a n d  t h e  s e c o n d  t o  t h e  y e a s t  / 9 - a c t i n  g e n e  ( f r o m  p R B 1 5 5 , 
S h o r t l e  e t  a l , 1 9 8 2 ) .  The  a c t i n  p r o b e  w a s  i n c l u d e d  a s  a n
i n t e r n a l  c o n t r o l  t o  e q u a t e  h y b r i d i s a t i o n  i n t e n s i t i e s .  F i g u r e s  
3 . 1 4 ( a )  a n d  ( b )  s h o w  t h e  RNA g e l  a n d  c o r r e s p o n d i n g  
/ 3 - g l u c a n a s e - p r o b e d  a u t o r a d i o g r a p h .  T h r e e  t r a n s c r i p t s  w e r e  
d e t e c t e d  u s i n g  t h e  / 3 - g l u c a n a s e  p r o b e  c o r r e s p o n d i n g  t o  pJBC5!5A 
( a p p r o x i m a t e l y  1 4 8 0 b p ) , p J G 2 0 5  ( a p p r o x i m a t e l y  1 5 2 0 b p )  a n d  
p J G 3 1 7  ( a p p r o x i m a t e l y  1 6 2 0 b p ) . No t r a n s c r i p t  w a s  d e t e c t e d  i n  
pJB/34 o r  i n  t h e  pAH c o n t r o l  p l a s m i d s .
R e s u l t s  f r o m  d e n s i o m e t r i c  s c a n n i n g  o f  t h e  / 3 - a c t i n  a n d  
/ 3 - g l u c a n a s e  t r a n s c r i p t s  a r e  s h o w n  i n  T a b l e  ( 3 . 2 ) .  Th e  r e l a t i v e  
i n t e n s i t i e s  o f  t h e  / 3 - a c t i n  a n d  / 3 - g l u c a n a s e  t r a n s c r i p t s  a r e  
g i v e n .  C o r r e c t i n g  t h e  / 3 - g l u c a n a s e  v a l u e s  f o r  t h e  a m o u n t  o f  RNA 
l o a d e d  i n  e a c h  c a s e  ( g u a g e d  f r o m  t h e  / 3 - a c t i n  r e a d i n g )  , s h o w s  
t h a t  t h e  r e l a t i v e  i n t e n s i t i e s  o f  t h e  / 9 - g l u c a n a s e  s p e c i f i c  
t r a n s c r i p t s  i n  pJ B C 55 A ,  p J G 2 0 5  a n d  p J G 3 1 7  a r e  2 . 5  : 0 . 7  : 0 . 8  
r e s p e c t i v e l y .  T h i s  i n d i c a t e s  t h a t  t h e r e  i s  up  t o  t h r e e  t i m e s  
t h e  a m o u n t  o f  / 9 - g l u c a n a s e  s p e c i f i c  t r a n s c r i p t  i n  t h e  
s i g n a l - l e s s  c o n s t r u c t  c o m p a r e d  t o  t h e  o t h e r  t w o .  Th e  r e l a t i v e  
i n t e n s i t i e s  o f  p J G 2 0 5  a n d  p J G 3 1 7  a r e  a p p r o x i m a t e l y  t h e  s a m e .
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F i g u r e  3 . 1 4 ( a ) .  N o r t h e r n  g e l  s h o w i n g  RNA p r e p a r a t i o n s  f r o m  
S . c e r e v i s i a e  s t r a i n s .
1 2 3 4  5 6  7 8 9  10
L a n e 1: E . c o l i  r i b o s o m a l  RNA ( 2 3 S a n d  1 6 S )
L a n e 2: DBY746 ,  n e g a t i v e  c o n t r o l .
L a n e 3: p J B C 5 5 A .
L a n e 4 : pJB/34
L a n e 5: p J G 2 0 5 .
L a n e 6: p J G 3 1 7 .
La n e 7 : pAAH5, n e g a t i v e  c o n t r o l .
L a n e 8: E . c o l i  r i b o s o m a l  RNA ( 2 3 S a n d  1 6 S )
L a n e 9: pAH10/3.
L a n e 10 : pAH21/3.
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Figure 3.14(b). Autoradiograph of /3-glucanase transcripts.
L a n e  2 :  pJB C55A;  L a n e  3 :  pJB/94;  L a n e  4 :  p J G 2 0 5 ;  L a n e  5 :  p J G 3 1 7 .
T a b l e  ( 3 . 2 ) .
R e l a t i v e  i n t e n s i t i e s  o f  t r a n s c r i p t s  c a l c u l a t e d  b y  d e n s i o m t r i c  
s c a n n i n g .
pJ BC 55A p J G 2 0 5 p J G 3 1 7
0 -A CT IN 2 . 5 1 . 5 1 . 0
/3-GLUCANASE 6 . 2 5 1 . 0 1 . 2 5
CORRECTED
/3-GLUCANASE
2 . 5 0 . 7 0 . 8
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(3.9) Assay of pJB/34 and pJBC55A in a pep4-3 (protease 
deficient) mutant of S . c e r e v i s i a e .
W i t h  t h e  p r e s e n c e  o f  a  s t a b l e  t r a n s c r i p t  i n  p J B 5 5 A ,  t h e  
p o s s i b i l i t y  r e m a i n e d  o p e n  t h a t  t h e  l a c k  o f  d e t e c t a b l e  en zy ine  
a c t i v i t y  a s s o c i a t e d  w i t h  t h i s  c o n s t r u c t ,  may  b e  a  r e s u l t  o f  
i n s t a b i l i t y  o f  t h e  h e t e r o l o g o u s  p r o t e i n  i n  t h e  y e a s t  c y t o p l a s m .  
I n  t h e  c y t o p l a s m ,  / 3 - g l u c a n a s e  c o u l d  b e  a  t a r g e t  o f  c e l l u l a r  
p r o t e a s e s  i n  v i v o ,  p o s s i b l y  e v e n  a  s u b s t r a t e  o f  t h e  u b i q u i t i n  
d i r e c t e d  d e g r a d a t i o n  s y s t e m  ( s e c t i o n  1 . 1 . 2 ) .  F o l d i n g  
d i f f e r e n c e s ,  d u e  t o  t h e  a b s e n c e  o f  t h e  s i g n a l  p e p t i d e  s e q u e n c e  
may a l s o  c o n t r i b u t e  t o  a n y  i n s t a b i l i t y  o f  t h e  / 3 - g l u c a n a s e  
e n z y m e  i n  t h e  c y t o p l a s m .  I n  a d d i t i o n ,  t h e  p r o t e i n  may b e  
s u s c e p t i b l e  t o  t h e  a c t i o n  o f  v a c u o l a r  a n d  o t h e r  p r o t e a s e s ,  
w h i c h  c a n  b e  r e l e a s e d  d u r i n g  a s s a y i n g  p r o c e d u r e s  ( s e e  s e c t i o n  
1 . 1 . 2 ) .  To i n v e s t i g a t e  t h i s ,  t h e  s i g n a l  p e p t i d e - m i n u s  
c o n s t r u c t s  w e r e  t r a n s f o r m e d  i n t o  t h e  p r o t e a s e  d e f i c i e n t  m u t a n t  
MD50. T h i s  m u t a n t  i s  d e f i c i e n t  i n  t h e  f o u r  m a j o r  v a c u o l a r  
p r o t e i n a s e s  P r A l , P r B l , P r C l  a n d  C p S l  a n d  c o n t a i n s  t h e  p e p 4 - 3  
m u t a t i o n  (Ammerer  e t  a l  1 9 8 6 ) .
pJBC55A a n d  pJB/34 w e r e  t r a n s f o r m e d  i n t o  MD50 a n d  p l a t e d  o n  
m i n i m a l  m ed iu m .  Th e  c e l l s  w e r e  i n c u b a t e d  a t  25°C f o r  4 8 h r s , 
l y s e d  u s i n g  a  h o t  a g a r  o v e r l a y  ( s e c t i o n  2 . 1 8 )  a n d  i n c u b a t e d  a t  
25°C f o r  a  f u r t h e r  4 8 h r s  b e f o r e  s t a i n i n g  w i t h  c o n g o
r e d  d y e . Th e  l o w e r  t e m p e r a t u r e  w a s  c h o s e n  t o  m i n i m i z e  
p r o t e o l y s i s ,  e n z y m e  i n s t a b i l i t y  a n d  t e m p e r a t u r e  a c t i v a t i o n  o f  
p r o t e a s e s  a f t e r  l y s i s .  S t a i n i n g  w i t h  c o n g o  r e d  r e v e a l e d  h a l o s  
a r o u n d  pJB/34 ( p l a t e d  i n  d u p l i c a t e )  , i n d i c a t i n g  i n t r a c e l l u l a r  
/ 3 - g l u c a n a s e  a c t i v i t y  ( F i g u r e  3 . 1 5 ) .  T h e  h a l o  o b s e r v e d  f o r  pJB/34 
w a s  c o n s i d e r a b l y  s m a l l e r  t h a n  t h o s e  g e n e r a t e d  a r o u n d  pJG317 a n d  
p J G 2 0 5  ( a l s o  t r a n s f o r m e d  i n t o  t h e  MD50 m u t a n t ) , p r e s u m a b l y  
r e f l e c t i n g  d i f f e r i n g  l e v e l s  o f  a c t i v e  e n z y m e .  Th e  a p p a r e n t  
i n s t a b i l i t y  o f  t h e  pJB/34 RNA t r a n s c r i p t  ( s e c t i o n  3 . 8 ) ,  m u s t  
c o m p o u n d  t h i s  p r o t e a s e  p r o b l e m  a n d  t h e  c o m b i n a t i o n  o f  t h e s e  two  
f a c t o r s  a r e  l i k e l y  t o  b e  t h e  r e a s o n  f o r  t h e  l a c k  o f  d e t e c t a b l e  
a c t i v i t y  f o r  pJB/34 i n  DBY746 .
I n  c o n t r a s t  t o  pJB/34,  n o  , 5 - g l u c a n a s e  a c t i v i t y  w a s  d e t e c t e d  i n  
pJBC 55A t r a n s f o r m e d  i n t o  MD50, d e s p i t e  t h e  o b v i o u s  s t a b i l i t y  o f
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t h e  RNA t r a n s c r i p t .  P o s s i b l e  r e a s o n s  f o r  t h i s ,  i n c l u d i n g  
p o t e n t i a l  p r o b l e m s  a t  a  t r a n s l a t i o n a l  l e v e l  a r e  d i s c u s s e d  i n  
s e c t i o n  ( 4 . 2 ) .
F i g u r e  ( 3 . 1 5 ) .
/ 3 - g l u c a n a s e  p r o d u c t i o n  i n  MD50 t r a n s f o r m e d  w i t h  pJ B C5 5 A,  pJB/34  
a n d  t h e  n e g a t i v e  c o n t r o l  pJB/31 (pAH9 c o n t a i n i n g  t h e  / 3 - g l u c a n a s e  
g e n e  i n  t h e  o p p o s i t e  o r i e n t a t i o n  t o  pJB/34)  . pJ B C 50  a n d  pJBC5!5B 
a r e  i d e n t i c a l  i n d e p e n d a n t  i s o l a t e s  o f  p J B C 5 5 A .
109
( 3 . 1 0 )  A n a l y s i s  o f  / 3 - g l u c a n a s e  s e c r e t i o n  i n  s e c r e t i o n  d e f e c t i v e  
m u t a n t s .
A t  t h e  n o n - p e r m i s s i v e  t e m p e r a t u r e  ( 3 7 ° C ) , s e c r e t i o n  d e f e c t i v e  
( s e c )  m u t a n t s  o f  S . c e r e v i s i a e  b l o c k  s e c r e t i o n  a t  v a r i o u s  s t a g e s  
a l o n g  t h e  s e c r e t o r y  p a t h w a y .  Th e  a b i l i t y  o f  t h e  b a c t e r i a l  
s i g n a l  p e p t i d e  t o  t r a n s p o r t  t h e  / 3 - g l u c a n a s e  e n z y m e  t h r o u g h  t h e  
c o n v e n t i o n a l  y e a s t  s e c r e t o r y  p a t h w a y  w a s  e x a m i n e d  i n  a  s e r i e s  
o f  t h e s e  m u t a n t s .  T a b l e  ( 3 . 3 )  s u m m a r i z e s  t h e  s e c  s t r a i n s  u s e d  
a n d  t h e  c h a r a c t e r i s t i c s  o f  e a c h  m u t a n t .
T a b l e  ( 3 . 3 ) .  Summary o f  s e c  m u t a n t s .
S t r a i n  M u t a t i o n  B l o c k  I n  P a t h w a y
RSY11 s e c l 8  ER t o  G o l g i , ( l a c k s  p r o t e i n  i n v o l v e d  i n
v e s i c l e  f u s i o n ) .
RSY12 s e c 5 3  ER, ( g l y c o s y l a t i o n  m u t a n t ,  s e c t i o n  1 . 6 )
RSY45 s e e l S e c r e t o r y  v e s i c l e s  b e t w e e n  G o l g i  a n d  
c e l l  s u r f a c e .
pJ G 3 1 7  w a s  t r a n s f o r m e d  i n t o  e a c h  o f  t h e  m u t a n t  s t r a i n s  a n d  
/ 3 - g l u c a n a s e  s e c r e t i o n  e x a m i n e d  a t  p e r m i s s i v e  a n d  n o n - p e r m i s s i v e  
t e m p e r a t u r e s ,  u s i n g  t h e  f o l l o w i n g  p r o c e d u r e :
M u t a n t s ,  t r a n s f o r m e d  w i t h  p J G 3 1 7 , w e r e  g r o w n  t o  0 0 ^ = 1 . 0 ,  a t  
25°C.  Th e  c e l l s  w e r e  w a s h e d  t w i c e  i n  1M s o r b i t o l  t o  r e m o v e  
/ 3 - g l u c a n a s e  p r e s e n t  i n  t h e  m ed iu m a n d  d i v i d e d  i n t o  t w o  e q u a l  
s a m p l e s .  The  s a m p l e s  w e r e  r e s u s p e n d e d  i n  f r e s h  m ed iu m  p r e w a r m e d  
t o  ( a )  25°C a n d  ( b )  37°C.  G r o w t h  w a s  a l l o w e d  t o  c o n t i n u e  a t
t h e s e  r e s p e c t i v e  t e m p e r a t u r e s  f o r  3 - 6  h o u r s .  The  c e l l s  w e r e  
t h e n  h a r v e s t e d  a n d  t h e  e x t r a c t s  a n d  s u p e r n a t a n t s  a s s a y e d  f o r  
/ 3 - g l u c a n a s e  a c t i v i t y  u s i n g  t h e  p l a t e  a s s a y .  6mm w e l l s  w e r e  c u t  
i n t o  b u f f e r e d  a g a r  c o n t a i n i n g  0 . 0 5 %  l i c h e n a n .  S u p e r n a t a n t s  w e r e  
a d d e d  t o  t h e  w e l l s  a n d  t h e  p l a t e s  i n c u b a t e d  a t  37°C o v e r n i g h t .  
H a l o s  i n d i c a t i n g  / 3 - g l u c a n a s e  a c t i v i t y  w e r e  v i s u a l i s e d  b y  
s t a i n i n g  w i t h  c o n g o  r e d  d y e  ( s e c t i o n  2 . 1 8 )  a n d  F i g u r e  ( 3 . 1 6 ) .  
As a c o n t r o l ,  t h i s  p r o c e d u r e  w a s  a l s o  c a r r i e d  o u t  w i t h  DBY746  
t r a n s f o r m e d  w i t h  p J G 3 1 7 .
A b l o c k  i n  s e c r e t i o n  o f  / 3 - g l u c a n a s e  w a s  o b s e r v e d  i n  b o t h  RSY11
110
a n d  RSY45 a t  t h e  r e s t r i c t i v e  t e m p e r a t u r e  ( F i g . 3 . 1 7 ) .  T h i s  
i n d i c a t e s  t h a t  t h e  b a c t e r i a l  s i g n a l  p e p t i d e  i s  a c t i n g  a s  a  
s e c r e t i o n  s i g n a l  i n  i t s  h e t e r o l o g o u s  h o s t .
I n  RSY12 ( s e c 5 3 ) ,  a n  u n e x p e c t e d  r e s u l t  w a s  o b s e r v e d .  I n  t h i s  
m u t a n t ,  no  b l o c k  i n  s e c r e t i o n  o f  / 3 - g l u c a n a s e  w a s  s e e n  a t  t h e  
n o n - p e r m i s s i v e  t e m p e r a t u r e .  I n s t e a d ,  a  s i g n i f i c a n t  i n c r e a s e  i n  
t h e  l e v e l  o f  e n z y m e  a c t i v i t y  w a s  d e t e c t e d  a t  37°C c o m p a r e d  t o  
25°C ( F i g . 3 . 1 8 ) .  More a c c u r a t e  q u a n t i t a t o n  o f  t h i s  i n c r e a s e ,  
u s i n g  t h e  DNS a s s a y ,  i n d i c a t e s  t h a t  a t  t h e  r e s t r i c t i v e  
t e m p e r a t u r e ,  up t o  3 t i m e s  a s  much a c t i v i t y  i s  p r o d u c e d  b o t h  
i n t r a c e l l u l a r l y  a n d  e x t r a c e l l u l a r l y .
p J G 2 0 5  w a s  a l s o  t e s t e d  f o r  / 3 - g l u c a n a s e  a c t i v i t y  i n  t h e s e  s e c  
m u t a n t  s t r a i n s .  A b l o c k  i n  s e c r e t i o n  o f  t h e  e n z y m e  w a s  o b s e r v e d  
i n  RSY11 a n d  RSY45 a t  t h e  n o n - p e r m i s s i v e  t e m p e r a t u r e .  S i m i l a r  
t o  p J G 3 1 7 ,  a n  i n c r e a s e  i n  / 3 - g l u c a n a s e  a c t i v i t y  w a s  d e t e c t e d  
b o t h  i n t r a c e l l u l a r l y  a n d  e x t r a c e l l u l a r l y , a t  t h e  r e s t r i c t i v e  
t e m p e r a t u r e  i n  R S Y 1 2 .
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F ig u re  ( 3 . 1 6 )
Calibration curve of j3 -g lu ca n a se  plate assay
H alo s ize  (m m )
Calibration curve for the ^-glucanase plate assay showing that 
an increase in halo size can be related to increased levels of 
activity and is therefore useful for qualitative assessment of 
assay results.
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Figure (3.17)
( a )  B l o c k  i n  s e c r e t i o n  o f  / 3 - g l u c a n a s e  i n  RSY11 ( p J G 3 1 7 )  a t  
37°C.  A s i m i l a r  b l o c k  i s  s e e n  w i t h  RSY45 ( n o t  s h o w n ) .
( b )  DBY746 c o n t r o l  a s s a y  ( n o  b l o c k  i n  s e c r e t i o n  i n  w i l d  t y p e ) .
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Figure (3 .18).
Increase in ^-glucanase activity seen at 37°C in RSY12 (pJG317) 
at intracellular and extracellular levels.
RSY12 / p J G 3 1 7
Supernatant Extract
DNS assay showing the extent of the increase in RSY12 (pJG317).
1 1 4
To e n s u r e  t h a t  t h e  m u t a n t  p h e n o t y p e  w a s  b e i n g  i n d u c e d  i n  RSY12  
i n  t h e  p r e s e n c e  o f  t h e  / 9 - g l u c a n a s e  p l a s m i d s ,  a n  a s s a y  was  
a d a p t e d  t o  a s s e s s  t h e  s e c r e t i o n  p a t t e r n s  o f  t h e  h o m o l o g o u s  
a - f a c t o r  p r o t e i n  i n  t h i s  m u t a n t  s t r a i n :
a - f a c t o r  p h e r o m o n e  i n h i b i t s  t h e  g r o w t h  o f  s t r a i n s  o f  t h e  
o p p o s i t e  m a t i n g  t y p e  ( M a t - a ) . RC631  i s  a  M a t - a  s t r a i n
c o n t a i n i n g  t h e  s s t 2 - l  m u t a t i o n ,  r e n d e r i n g  i t  e x t r a s e n s i t i v e  t o  
t h e  i n h i b i t o r y  e f f e c t s  o f  a - f a c t o r  ( J u l i u s  e t  a.1. 1 9 8 3 ) .  RC631  
w a s  i n c o r p o r a t e d  i n t o  MYGP a g a r  a s  d e s c r i b e d  i n  s e c t i o n  2 . 3 2 .  
6mm w e l l s  w e r e  c u t  i n  t h e  a g a r  a n d  s u p e r n a t a n t s  f r o m  M a t - a  
s t r a i n s  a d d e d  t o  t h e  w e l l s  ( R S Y 1 1 , 1 2  a n d  4 5  a n d  DBY746  a r e  a l l  
M a t - a )  . Th e  p l a t e s  w e r e  i n c u b a t e d  a t  30°C f o r  4 8 h r s  t o  a l l o w  
g r o w t h  ( F i g . 3 . 1 9 ) .  C l e a r  h a l o s  a r o u n d  t h e  w e l l s  s h o w  t h e  g r o w t h  
i n h i b i t i o n  o f  RC631  d u e  t o  t h e  p r e s e n c e  o f  a - f a c t o r  i n  t h e  
s u p e r n a t a n t s  o f  t h e  M a t - a  c e l l s .  Th e  l a r g e  h a l o s  i n  w e l l s  2 a n d  
4  a r e  d u e  t o  o v e r e x p r e s s i o n  o f  a - f a c t o r  - i n  c e l l s  c a r r y i n g  t h e  
p l a s m i d  p 6 9 A .
F i g u r e  ( 3 .
W e l l 1: R C 6 3 1 ( M a t  a ) W e l l 4 :  D B Y 7 4 6 / p 6 9 A
W e l l 2: R S Y 4 5 / p 6 9 A W e l l 5 :  DBY746
W e l l 3: RSY45 W e l l 6 :  RSY12
1 9 ) .  T h e  a - f a c t o r  p l a t e  a s s a y
1 1 5
p 6 9 A  ( a p p . 2 ) ,  i s  a  m u l t i c o p y  p l a s m i d  c o n t a i n i n g  t h e  a - f a c t o r  
s t r u c t u r a l  g e n e s  u n d e r  c o n t r o l  o f  t h e  a - f a c t o r  p r o m o t e r  a n d  
s i g n a l  p e p t i d e  ( K u r j a n  a n d  H e r s k o w i t z  1 9 8 2 ) .  When t h e  m u t a n t  
p h e n o t y p e  i s  i n d u c e d  i n  m u t a n t s  R S Y 1 1 . 1 2  a n d  4 5 ,  c a r r y i n g  t h i s  
p l a s m i d ,  a  b l o c k  i n  s e c r e t i o n  o f  a - f a c t o r  i s  o b s e r v e d  a t  37°C  
( F i g .  3 . 2 0 ) .  T h i s  b l o c k  i s  r e f l e c t e d  i n  a  d e c r e a s e  i n  t h e  z o n e  
o f  i n h i b i t i o n  o f  R C6 31 .
F i g u r e  ( 3 . 2 0 ) .
B l o c k  i n  a - f a c t o r  s e c r e t i o n  a t  37°C i n  RSY45 t r a n s f o r m e d  w i t h  
p 6 9 A .  W i l d  t y p e  DBY746 s h o w s  n o  b l o c k  a t  t h a t  t e m p e r a t u r e .
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T h e s e c  m u t a n t  s t r a i n s ,  t r a n s f o r m e d  w i t h  t h e  / 3 - g l u c a n a s e  
p l a s m i d s ,  a l s o  e x h i b i t  a  b l o c k  i n  s e c r e t i o n  o f  e n d o g e n o u s  
l e v e l s  o f  a - f a c t o r  a t  37°C ( F i g . 3 . 2 1 ) .  T h i s  c o n f i r m s  t h a t  t h e  
i n c r e a s e  i n  / 5 - g l u c a n a s e  a c t i v i t y  d e t e c t e d  i n  RSY12 a t  t h e  
n o n - p e r m i s s i v e  t e m p e r a t u r e ,  d o e s  n o t  i n t e r f e r e  w i t h  t h e  n o r m a l  
s e c r e t i o n  p a t t e r n s  o f  t h e  c e l l  a n d  t h a t  t h e  a b n o r m a l  b e h a v i o r  
i s  a s s o c i a t e d  o n l y  w i t h  t h e  h e t e r o l o g o u s  g e n e  p r o d u c t .
F i g u r e  ( 3 . 2 1 )
B l o c k  i n  a - f a c t o r  s e c r e t i o n  a t  37°C i n  s u p e r n a t a n t s  o f  RSY12  
c o n t a i n i n g  pJ G 3 1 7  a n d  p J G 3 1 4 .
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To i n v e s t i g a t e :  i f  t h e  i n c r e a s e  o b s e r v e d  i n  p J G 3 1 7  a n d  pJ G 2 05  
w a s  a s s o c i a t e d  w i t h  t h e  B a c i l l u s  s i g n a l  p e p t i d e ,  p J G 3 1 4 ,  w h i c h  
c o n t a i n s  t h e  / 3 - g l u c a n a s e  g e n e  u n d e r  c o n t r o l  o f  t h e  a - f a c t o r  
s i g n a l  p e p t i d e ,  w a s  a l s o  t e s t e d  f o r  s e c r e t i o n  o f  / 3 - g l u c a n a s e  a t  
t h e  r e s t r i c t i v e  t e m p e r a t u r e  i n  RSY1 2.  An i n c r e a s e  w a s  o b s e r v e d  
b o t h  i n t r a c e l  l u l a r l y  a n d  e x t r a c e l l u l a r  l y  i n  t h i s  c a s e  a l s o .  
B e c a u s e  pJ G 3 1 4  c o n t a i n s  t h e  y e a s t  a - f a c t o r  s i g n a l  p e p t i d e ,  t h e  
i n c r e a s e  i n  a c t i v i t y  c a n n o t  b e  s i g n a l  s p e c i f i c  b u t  m u s t  b e  
a s s o c i a t e d  w i t h  t h e  / 3 - g l u c a n a s e  e n z y m e  i t s e l f .  To  i n v e s t i g a t e  
w h e t h e r  t h i s  e f f e c t  i s  p e c u l i a r  t o  / 3 - g l u c a n a s e , a n o t h e r  
h e t e r o l o g o u s  p r o t e i n ,  a  B a c i l l u s  a - a m y l a s e ,  w a s  a l s o  t e s t e d  i n  
RSY12 f o r  s e r e t i o n  a t  t h e  n o n - p e r m i s s i v e  t e m p e r a t u r e .  S e c r e t i o n  
o f  t h i s  h e t e r o l o g o u s  e n z y m e  w a s  b l o c k e d  a t  37°C ( d a t a  n o t  
s h o w n ) .
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( 3 . 1 1 )  The e f f e c t  o f  t u n i c a r a y c i n  o n  / 3 - g l u c a n a s e  p r o d u c t i o n .
RSY12 ( s e c 5 3 )  i s  d e f i c i e n t  t h e  p h o s p h o m a n n o m u t a s e  a c t i v i t y
r e s p o n s i b l e  f o r  t h e  c o n v e r s i o n  o f  i n a n n o s e - 6 - p h o s p h a t e  t o
m a n n o s e - l - p h o s p h a t e  ( s e c t i o n  1 . 5 . 1 ) .  The  g e n e r a t i o n  o f  t h e s e
m a n n o s e  r e s i d u e s  i s  r e q u i r e d  f o r  t h e  a s s e m b l y  o f  c o r e
o l i g o s a c c h a r i d e  u n i t s  i n  t h e  N - g l y c o s y l a t i o n  g r o u p s  o f
s e c r e t o r y  p r o t e i n s .  A t  37 °C ,  s e c 5 3  m u t a n t s  a c c u m u l a t e  s e c r e t o r y
p r o t e i n s  w i t h  i n c o m p l e t e  c o r e  o l i g o s a c c h a r i d e  u n i t s  i n  t h e  ER
( s e c t i o n  1 . 5 . 1 ) .  T u n i c a m y c i n  a l s o  i n h i b i t s  t h e  a s s e m b l y  o f
t h e s e  c o r e  u n i t s ,  a l t h o u g h  a t  a n  e a r l i e r  s t a g e  i n  t h e i r
s y n t h e s i s  i e . t h e  a d d i t i o n  o f  t h e  f i r s t  G l c N A c  r e s i d u e .
S e q u e n c e  a n a l y s i s  o f  t h e  / 3 - g l u c a n a s e  g e n e  s h o w s  t h a t  t h e  e n z y m e
h a s  f o u r  p o t e n t i a l  g l y c o s y l a t i o n  s i t e s ,  a t  p o s i t i o n s  3 1 , 3 8 , 6 4
a n d  1 8 5  ( a p p . l ) .  Th e  r e s u l t  o b t a i n e d  w i t h  RSY12 s u g g e s t  t h a t
t h e  i n c r e a s e  i n  a c t i v i t y  m i g h t  b e  r e l a t e d  t o  t h e  g l y c o s y l a t i o n
p a t t e r n  o f  t h e  h e t e r o l o g o u s  p r o t e i n  i n  y e a s t .  I f  t h i s  i s  s o ,
t u n i c a m y c i n  t r e a t m e n t  o f  w i l d  t y p e  c e l l s  c a r r y i n g  t h e
/ 3 - g l u c a n a s e  p l a s m i d s  s h o u l d  y i e l d  s i m i l a r  r e s u l t s .  T h i s
p o s s i b i l i t y  w a s  t e s t e d  f o r  p J G 3 1 7 ,  p J G 2 0 5  a n d  p J G 3 1 4  i n  DBY746:
C e l l s  w e r e  g r o w n  t o  OD = 1 . 0  a t  30°C,  h a r v e s t e d ,  w a s h e d  t w i c e  
°  6 00
i n  1M s o r b i t o L  a n d  d i v i d e d  i n t o  tw o  e q u a l  s a m p l e s .  T u n i c a m y c i n  
( 1 0 / ^ g / m l )  w a s  a d d e d  t o  o n e  s a m p l e  i n  e a c h  c a s e  a n d  b o t h  s a m p l e s  
r e t u r n e d  t o  30°C f o r  6 h r s . S u p e r n a t a n t s  w e r e  a s s a y e d  f o r  
/ 3 - g l u c a n a s e  a c t i v i t y  u s i n g  b o t h  t h e  w e l l  p l a t e  a n d  DNS a s s a y s .  
T r e a t m e n t  w i t h  t u n i c a m y c i n  r e s u l t e d  i n  a n  i n c r e a s e  i n  
/ 3 - g l u c a n a s e  a c t i v i t y  i n  t h e  s u p e r n a t a n t s  o f  a l l  t h r e e  s t r a i n s  
( F i g . 3 . 2 2 ,  f o r  r e s u l t s  o f  t h e  DNS a s s a y ) .  I n  p J G 3 1 7 , t h e  e f f e c t  
w a s  m o re  s t r i k i n g  t h a n  o b s e r v e d  i n  t h e  s e c 5 3  m u t a n t ,  w i t h  
a l m o s t  9 t i m e s  t h e  a c t i v i t y  b e i n g  r e l e a s e d  i n  t h i s  i n s t a n c e  
w i t h  t h e  a d d i t i o n  o f  t u n i c a m y c i n .  I n  p J G 2 0 5  a n d  p J G 3 1 4  a n  
i n c r e a s e  o f  3 - 4  f o l d  w a s  o b s e r v e d .
I n t r a c e l l u l a r L y , p J G 3 1 7  a l s o  e x h i b i t s  a n  i n c r e a s e  i n  a c t i v i t y  
a f t e r  t r e a t m e n t  w i t h  t u n i c a m y c i n .  T h i s  i s  i n  c o n t r a s t  t o  pJ G 2 0 5  
a n d  p J G 3 1 4  w h e r e  l o w e r  l e v e l  o f  a c t i v i t y  a r e  d e t e c t e d  i n s i d e  
t h e  c e l l .
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F i g u r e  ( 3 . 2 2 )  E x t r a c e l l u l a r  a n d  i n t r a c e l l u l a r  ^ - g l u c a n a s e  
a c t i v i t y  i n  p J G 3 1 7 ,  p J G 3 1 4  a n d  p J G 2 0 5 ,  a f t e r  t r e a t m e n t  w i t h  
t u n i c a r a y c i n .
The results obtained with tunicamycin treatment correlate well 
with the observations in sec53, in that inhibiting 
glycosylation causes an increase in /9-glucanase activity in 
both cases. Each of these treatments causes disruptions to core 
oligosaccharides addition, an event that occurs in the E R .
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( 3 . 1 2 )  W e s t e r n  b l o t  a n a l y s i s  o f  t h e  B a c i l l u s  / 3 - g l u c a n a s e  e n z y ia e  
To e x a m i n e  t h e  g l y c o s y l a t i o n  p a t t e r n  o f  t h e  B a c i l l u s  e n z y m e  i n  
D B Y 7 4 6 , W e s t e r n  b l o c  a n a l y s i s  w a s  c a r r i e d  o u t .  T h e  / 3 - g l u c a n a s e  
a n t i b o d y  u s e d  i n  C h i s  a n a l y s i s  w a s  o b t a i n e d  f r o m  E . G o r m l e y ,  
T . C . D .  T h i s  p o l y c l o n a l  a n t i b o d y  w a s  r a i s e d  a g a i n s t  a  c o m m e r c i a l  
p r e p a r a t i o n  o f  t h e  m a t u r e  B . s u b t i l i s  / 3 - g l u c a n a s e  e n z y m e  
( E . G o r m l e y ,  P h . D .  t h e s i s ,  T . C . D . ) .
E x t r a c t s  a n d  s u p e r n a t a n t s  w e r e  p r e p a r e d  ( s e c t i o n  3 . 1 1 )  f r o m  
p J G 3 1 7 ,  pJ G 2 0 5  a n d  pJ G 3 1 4  a f t e r  g r o w t h  i n  t h e  p r e s e n c e  a nd  
a b s e n c e  o f  t u n i c a m y c i n .  T h e  s a m p l e s  w e r e  p r e p a r e d  f o r  SDS PAGE 
a s  d e s c r i b e d  s e c t i o n  ( 2 . 2 2 ) .  The  g e l s  (10%) w e r e  b l o t t e d  o n t o  
n i t r o c e l l u l o s e  a n d  h y b r i d i s e d  t o  t h e  / 3 - g l u c a n a s e  a n t i b o d y  a n d  
e n z y m e - c o n j u g a t e d  s e c o n d a r y  a n t i b o d y  ( s e c t i o n  2 . 2 3 ) .  F i g u r e s
( 3 . 2 3 )  a n d  ( 3 . 2 4 )  s h o w  t h e  W e s t e r n  b l o t s  o f  e x t r a c t s  a n d  
s u p e r n a t a n t s  f r o m  p J G 3 1 7  p J G 3 1 4  a n d  p J G 2 0 5 .
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F i g u r e  ( 3 . 2 3 )  a n d  ( 3 . 2 4 ) .  W e s t e r n  b l o t s  s h o w i n g  e x t r a c t s  a nd  
s u p e r n a t a n t s  p r e p a r e d  f r o m  p J G 3 1 7 , p J G 3 1 4  a n d  p J G 2 0 5 ,  
h y b r i d i s e d  t o  t h e  / 3 - g l u c a n a s e  a n t i b o d y . .
F i g u r e  ( 3 . 2 3 ) .
KDa
1 2 3  5 4  6 7 , 8  9 11
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L a n e  1 :  B . s u b t i l i s ,  c o n t r o l  
L a n e  2 :  p J G 3 1 4  ( E x t )  + T u n i c .  
L a n e  3 :  " ( S u p )  +  T u n i c .
L a n e  4 :  " ( E x t )  - T u n i c .
L a n e  5 :  " ( S u p )  - T u n i c .
L a n e  6 :  p J G 3 1 7  ( S u p )  +  T u n i c .
La n e  7:  " ( E x t )  +  T u n i c .
L a n e  8:  " ( S u p )  - T u n i c .
L a n e  9 :  " ( E x t )  - T u n i c .
L a n e  1 0 :  S i g m a  p r e s t a i n e d  m a r k e r s
L a n e  1 1 :  DBY746  ( E x t ) .
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Figure (3.24)
1 2 3 4 5 6 7 8 IO
"I
ri-A 43KDa
Lane 1: marker.
Lane 2 
Lane 3 
Lane 4 
Lane 5
B .subcilis, control. 
pAAHS (E x t )(control). 
pJG205 (Sup) - Tunic.
" (Ext) - Tunic.
Lane 6: pJG205 (Sup) + Tunic.
Lane 7: " (Ext) + Tunic.
Lane 8: p69B (Ext) control.
Lane 9: pAAH5 (Ext) control.
Lane 10: DBY746 (Ext) control.
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T h e s e  W e s t e r n  b l o t s  r e v e a l  no  h i g h  m o l e c u l a r  w e i g h t  f o r m s  t h a t  
a r e  s p e c i f i c  f o r  / 3 - g l u c a n a s e , w h i c h  w o u l d  i n d i c a t e  t h a t  
g l y c o s y l a t e d  « n z y m e  i s  p r e s e n t .  F i g u r e  ( 3 . 2 3 ) ,  l a n e  9 ,  s h o w s  
t h e  e x t r a c t  f r o m  pJ G 3 17  c e l l s .  Two b a n d s  o f  m o l e c u l a r  w e i g h t s  
22KDa a n d  24KDa a r e  p r e s e n t .  Th e  m o b i l i t y  o f  t h e  l o w e r  b a n d  
c o r r e s p o n d s  e x a c t l y  t o  t h e  22KDa B a c i l l u s  c o m m e r c i a l  e n z y m e  
p r e p a r a t i o n  ( l a n e  1 )  a n d  r e p r e s e n t s  f u l l y  p r o c e s s e d ,  
u n g l y c o s y l a t e d  / 3 - g l u c a n a s e .  Th e  h i g h e r  m o l e c u l a r  w e i g h t  b a n d  
(2 4 K Da )  c o r r e s p o n d s  i n  s i z e  t o  t h a t  e x p e c t e d  f o r  t h e  
u n p r o c e s s e d  u n g l y c o s y l a t e d  f o r m  o f  t h e  e n z y m e  w i t h  t h e  s i g n a l  
p e p t i d e  s t i l l  i n t a c t .  I n  p J G 2 0 5  ( F i g . 3 . 2 4 ,  l a n e  5 ) ,  t w o  b a n d s  
a r e  a l s o  v i s i b l e ,  r u n n i n g  v e r y  c l o s e  t o g e t h e r  a n d  c o r r e s p o n d i n g  
t o  p r o c e s s e d  a n d  u n p r o c e s s e d  f o r m s  o f  u n g l y c o s y l a t e d  
/ 3 - g l u c a n a s e .  In  t h i s  c a s e ,  t h e  u n p r o c e s s e d  b a n d  c o n t a i n s  t h e  
t r u n c a t e d  f o r m  o f  t h e  / 3 - g l u c a n a s e  s i g n a l  a n d  t h i s  c a n  a c c o u n t  
f o r  i t  r u n n i n g  v e r y  c l o s e  t o  t h e  p r o c e s s e d  b a n d  i n  t h i s  s a m p l e .  
I n  p J G 3 1 4  ( F i g .  3 . 2 3 ,  l a n e  4). t h e  / 3 - g l u c a n a s e  b a n d  o b s e r v e d  i n  
t h e  e x t r a c t ,  i s  l a r g e r  t h a n  t h e  c o m m e r c i a l  c o n t r o l .  T h i s  
s l i g h t l y  s l o w e r  m o b i l i t y  c a n  b e  e x p l a i n e d  b y  r e t e n t i o n  o f  t h e  
G l u - A l a  r e p e a t  s e q u e n c e s  o n  t h e  /3- g l u c a n a s e  N - t e r m i n u s .  T h e s e  
s e q u e n c e s  a r e  p r e s e n t  a f t e r  t h e  L y s - A r g  c l e a v a g e  s i t e  i n  t h e
a - f a c t o r  s i g n a l  p e p t i d e  t h a t  w a s  u s e d  i n  t h i s  c o n s t r u c t i o n  a n d
a r e  n o r m a l l y  r e m o v e d  b y  t h e  a c t i o n  o f  t h e  STE13 g e n e  p r o d u c t  
( s e c t i o n  1 . 5 . 4 )  ( s e e  s e c t i o n  4 . 6  f o r  d e t a i l s ) .
A 43KDa b a n d  i s  p r e s e n t  i n  e x t r a c t s  f r o m  p J G 3 1 7 ,  p J G 3 1 4  a n d
p J G 2 0 5 . T h i s  b a n d  a l s o  a p p e a r s  i n  e x t r a c t s  p r e p a r e d  f r o m  DBY746  
c a r r y i n g  t h e  v e c t o r s  u s e d  t o  c o n s t r u c t  t h e s e  p l a s m i d s , pAAH5 
a n d  p 6 9 B  ( l a n e s  9 a n d  1 0 ,  F i g .  3 . 2 4 ) ,  a n d  i s  t h e r e f o r e  n o t
a s s o c i a t e d  w i t h  / 3 - g l u c a n a s e  a c t i v i t y  i n  t h e s e  s t r a i n s .  Th e  
o t h e r  h i g h  m o l e c u l a r  w e i g h t  b a n d s ,  i n d i c a t e d  w i t h  t h e  s q u a r e  
b r a c k e t ,  a r e  a l s o  p r e s e n t  i n  t h e s e  l a n e s  a n d  a r e  a s s u m e d  t o  b e  
d u e  t o  n o n  s p e c i f i c  h y b r i d i s a t i o n  o f  t h e  a n t i b o d y  p r e p a r a t i o n .  
I n  t h e  a b s e n c e  o f  t u n i c a m y c i n ,  n o  b a n d s  a r e  v i s i b l e  i n  t h e  
s u p e r n a t a n t  f r a c t i o n s  c o r r e s p o n d i n g  t o  e a c h  o f  t h e  a b o v e  
e x t r a c t s .  A l t h o u g h  t h e s e  s a m p l e s  c o n t a i n  a c t i v e  / 3 - g l u c a n a s e ,  
e v e n  i n c r e a s e d  c o n c e n t r a t i o n s  o f  s u p e r n a t a n t  a d d e d  t o  e a c h  l a n e  
r e v e a l s  no  e v i d e n c e  o f  g l y c o s y l a t e d  o r  u n g l y c o s y l a t e d  b a n d s
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( d a t a  n o t  s h o w n ) .
The  i n c r e a s e  i n  / 3 - g l u c a n a s e  a c t i v i t y ,  s e e n  p r e v i o u s l y  a f t e r  
t u n i c a m y c i n  t r e a t m e n t  ( s e c t i o n  3 . 1 1 ) ,  i s  r e f l e c t e d  i n  t h e
W e s t e r n  b l o t  w i t h  t h e  a p p e a r a n c e  o f  a  s t r o n g  b a n d  a t  22KDa i n  
t h e  s u p e r n a t a n t  f r a c t i o n  o f  p J G 3 1 7  ( F i g . 3 . 2 3 ,  l a n e  6 ) .  Th e  b a n d  
c o r r e s p o n d s  t o  f u l l y  p r o c e s s e d ,  u n g l y c o s y l a t e d  / 3 - g l u c a n a s e . 
T h i s  f i n d i n g  s u p p o r t s  t h e  i d e a  t h a t  s o m e  f o r m  o f  g l y c o s y l a t i o n  
o f  t h e  e n z y m e  m u s t  b e  t a k i n g  p l a c e .  I t  i s  p o s s i b l e  t h a t  t h e
g l y c o s y l a t e d  f o r m  i s  s e c r e t e d  b u t  i s  o n l y  r e c o g n i s e d  b y  t h e
a n t i b o d y  whe n t h e  a d d i t i o n  o f  t h e  s u g a r  m o i e t i e s  i s  i n h i b i t e d  
b y  t h e  a c t i o n  o f  t u n i c a m y c i n .  G l y c o s y l a t e d  f o r m s  o f  / 3 - g l u c a n a s e  
a r e  n o t  d e t e c t e d  i n  c e l l  e x t r a c t s  f r o m  p J G 3 1 7  u s i n g  t h e
/ 3 - g l u c a n a s e  a n t i b o d y .  H o w e v e r ,  t h e  i n c r e a s e  i n  i n t e n s i t y  o f  t h e  
tw o  / 3 - g l u c a n a s e  s p e c i f i c  b a n d s ,  a f t e r  t u n i c a m y c i n  t r e a t m e n t ,  
s u g g e s t s  t h a t  g l y c o s y l a t e d  f o r m s  a r e  a l s o  p r e s e n t  
i n t r a c e l l u l a r l y  a t  t h i s  s t a g e .  I n  . p J G 3 1 4  a n d  p J G 2 0 5  
e x t r a c e l l u l a r  f r a c t i o n s ,  n o  b a n d s  a p p e a r  i n  t h e  s u p e r n a t a n t s  o f  
e i t h e r  s t r a i n  e v e n  a f t e r  t u n i c a m y c i n  t r e a t m e n t .
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( 3 . 1 3 )  A c t i v i t y  g e l  a n a l y s i s  o f  t h e  / 3 - g l u c a n a s e  e n z y m e .
Th e  W e s t e r n  b l o t  d a t a  s u g g e s t s  t h a t  much o f  t h e  i n t r a c e l l u l a r  
p o o l  o f  / 3 - g l u c a n a s e  i s  f u l l y  p r o c e s s e d  w i t h  r e s p e c t  t o  s i g n a l  
p e p t i d e  c l e a v a g e .  E x t r a c e l l u l a r  f r a c t i o n s ,  a l t h o u g h  c o n t a i n i n g  
/ 3 - g l u c a n a s e  a c t i v i t y  ( i n d i c a t e d  b y  DNS a n d  p l a t e  a s s a y s ) ,  
r e v e a l  n o  b a n d s  c o r r e s p o n d i n g  t o  t h e  e n z y m e .  The  a p p e a r a n c e  o f  
a  p r o c e s s e d ,  u n g l y c o s y l a t e d  b a n d  a f t e r  t r e a t m e n t  w i t h  
t u n i c a m y c i n ,  s u g g e s t s  t h a t  s o m e  l e v e l  o f  g l y c o s y l a t i o n  m u s t  b e  
o c c u r r i n g ,  a t  l e a s t  i n  t h e  s e c r e t e d  e n z y m e  f r a c t i o n  a n d  i t  i s  
p o s s i b l e  t h a t  t h e  p r o b l e m  l i e s  w i t h  t h e  a n t i b o d y .  T h i s  
a n t i b o d y ,  r a i s e d  a g a i n s t  t h e  b a c t e r i a l  f o r m  o f  t h e  e n z y m e ,  may  
b e  u n a b l e  t o  r e c o g n i s e  m o d i f i e d  f o r m s  o f  t h e  e n z y m e  p r o d u c e d  i n  
y e a s t .
To a d d r e s s  t h i s  p r o b l e m  i n  a  m o r e  d i r e c t  m a n n e r ,  a c t i v i t y  g e l  
a n a l y s i s  w a s  c a r r i e d  o u t .  I t  w a s  h o p e d  t h a t  b y  t a k i n g  t h i s  
a p p r o a c h  t h a t  a n y  h i g h e r  m o l e c u l a r  w e i g h t  f o r m s  o f  t h e  e n z y m e ,  
i f  a c t i v e ,  w o u l d  b e  d e t e c t e d .  T h e  p r o c e d u r e  f o r  t h i s  
z y m o g r a m - t y p e  g e l  a n a l y s i s  i s  o u t l i n e d  i n  d e t a i l  i n  s e c t i o n
( 2 . 2 4 ) .  B a n d s  r e p r e s e n t i n g  a c t i v e  / 3 - g l u c a n a s e  a p p e a r  a s  
c l e a r i n g s  o n  a c o n g o  r e d  s t a i n e d  b a c k g r o u n d .  F i g u r e  ( 3 . 2 5 )  
s h o w s  a  10% p o l y a c r y l a m i d e  a c t i v i t y  g e l  w i t h  e x t r a c t  s a m p l e s  o f  
p J G 3 1 7 ,  p J G 3 1 4  a n d  p J G 2 05  p r e p a r e d  a t  m i d - l o g  a n d  
s t a t i o n a r y  p h a s e s  o f  t h e  g r o w t h  c y c l e .  I n  c o n t r a s t  t o  t h e  
W e s t e r n  a n a l y s i s ,  h i g h e r  m o l e c u l a r  w e i g h t  f o r m s ,  t h a t  d i d  n o t  
r e a c t  w i t h  t h e  / 3 - g l u c a n a s e  a n t i b o d y ,  c a n  b e  c l e a r l y  s e e n .  T h i s  
i n d i c a t e s  t h a t  t h e  e n z y m e  i s  i n d e e d  g l y c o s y l a t e d  a n d  t h a t  t h e s e  
f o r m s  o f  t h e  e n z y m e  h a v e  a c t i v i t y .
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F i g u r e  ( 3 . 2 5 ) .  A c t i v i t y  g e l  s h o w i n g  i n t r a c e l l u l a r  / 3 - g l u c a n a s e  
a c t i v i t y  i n  p J G 3 1 4 ,  pJ G 3 1 7  a n d  p J G 2 0 5 .
L a n e 1 p J G 3 1 4 e a r l y
L a n e 2 II l a t e
Lan e 3 p J G 3 17 e a r l y
L a n e 4 II l a t e
La ne 5 p J G 2 05 e a r l y
L a n e 6 II l a t e
L a n e 7 c o n t r o l (B . s u b t i l i s
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p J G 3 1 4  s h o w s  a  r a n g e  o f  b a n d s  c o r r e s p o n d i n g  t o  / 3 - g l u c a n a s e  
a c t i v i t y  ( l a n e s  1 a n d  2 )  . Th e  s e c o n d  s m a l l e s t  b a n d  ( a r r o w e d ) , 
c o r r e s p o n d s  t o  t h e  b a n d  t h a t  w a s  v i s i b l e  o n  t h e  W e s t e r n  b l o t .  
Th e l o w e r  b a n d ,  a t  22KDa, r e p r e s e n t s  f u l l y  p r o c e s s e d  
/ 3 - g l u c a n a s e ,  w i t h  t h e  G l u - A l a  r e p e a t s  r e m o v e d  b y  t h e  a c t i o n  o f  
t h e  STE13 g e n e  p r o d u c t .  The  tw o  h i g h e r  b a n d s  ( a p p r o x i m a t e l y  
28KDa a n d  3 4 K D a ) , a r e  p o t e n t i a l l y  g l y c o s y l a t e d  f o r m s  o f  
/ 3 - g l u c a n a s e .  T h e s e  m o l e c u l a r  w e i g h t s  c o r r e s p o n d  t o  t h e  a d d i t i o n  
o f  2 a n d  4  c o r e  o l i g o s a c c h a r i d e  u n i t s  r e s p e c t i v e l y  ( o n e  c o r e  
u n i t  i s  e s t i m a t e d  t o  i n c r e a s e  t h e  m o l e c u l a r  w e i g h t  o f  a  p r o t e i n  
b y  a p p r o x i m a t l y  3KDa ( M e l n i c k  a t  al 1 9 9 0 ) ) .  I n  l a n e  2 ,  a f i f t h  
b a n d  a p p e a r s ,  j u s t  a b o v e  34KDa. T h i s  c o u l d  r e p r e s e n t  f u r t h e r  
g l y c o s y l a t i o n  o f  t h e  e n z y m e  o r  p o s s i b l y  / 3 - g l u c a n a s e  w i t h  t h e  
a - f a c t o r  p r o  r e g i o n  s t i l l  i n t a c t .
E x t r a c t s  f r o m  t h e  b a c t e r i a l  s i g n a l  p e p t i d e  c o n s t r u c t s ,  pJ G 3 1 7  
a n d  p J G 2 0 5 ,  a r e  a l s o  s h o w n  ( l a n e s  3 t o  6 ) .  T h e s e  l a n e s  w e r e  
o v e r l o a d e d  i n  o r d e r  t o  h i g h l i g h t  t h e  h i g h e r  m o l e c u l a r  w e i g h t  
b a n d s .  I n  p J G 3 1 7 ,  a  v e r y  s t r o n g  b a n d  c o r r e s p o n d i n g  t o  
u n m o d i f i e d  / 3 - g l u c a n a s e  i s  v i s i b l e .  Two f u r t h e r  b a n d s ,  a t  27KDa  
a n d  33KDA a p p r o x i m a t e l y ,  a r e  a l s o  a p p a r e n t .  T h e s e  w e r e  n o t  
d e t e c t e d  o n  W e s t e r n  b l o t s .  S i m i l a r  t o  p J G 3 1 4 ,  t h e s e  b a n d s  
c o r r e s p o n d  t o  t h e  a d d i t i o n  o f  2 a n d  4  c o r e  g l y c o s y l a t i o n  u n i t s .  
Th e d i s a p p e a r a n c e  o f  t h e  l a r g e r  b a n d  l a t e  i n  t h e  c e l l  c y c l e  
( l a n e  4 ) ,  c o u l d  p o s s i b l y  b e  d u e  t o  i t s  s e c r e t i o n .
I n  p J G 2 0 5 ,  n o  h i g h e r  m o l e c u l a r  w e i g h t  b a n d s  a r e  v i s i b l e  a t  a n y  
c o n c e n t r a t i o n  o f  e x t r a c t ,  e a r l y  o r  l a t e  i n  t h e  g r o w t h  c y c l e .  
T h i s  e v i d e n c e  s u g g e s t s  t h a t  p J G 2 0 5  p r o d u c e s  n o  a c t i v e  
g l y c o s y l a t e d  / 3 - g l u c a n a s e  i n t r a c e l l u l a r l y . I n  p J G 3 1 7 , a l t h o u g h  
t h e r e  i s  s o m e e v i d e n c e  o f  g l y c o s y l a t i o n ,  a  l a r g e  p r o p o r t i o n  o f  
t h e  i n t r a c e l l u l a r  / 3 - g l u c a n a s e  e n z y m e  r e m a i n s  u n m o d i f i e d .  T h i s  
i s  i n  c o n t r a s t  t o  p J G 3 1 4  w h e r e  a  m o re  e v e n  s p r e a d  o f  a c t i v i t y
t h r o u g h o u t  t h e  d i f f e r e n t  f o r m s  i s  o b s e r v e d  ( F i g . 3 . 2 5 ) ,  l a n e s  1
a n d  2 ) .
To i n v e s t i g a t e  w h i c h  f o r m s  o f  t h e  / 3 - g l u c a n a s e  e n z y m e  i n  e a c h
t h e s e  s t r a i n s  a r e  s e c r e t e d ,  s u p e r n a t a n t  s a m p l e s  w e r e  a l s o
e x a m i n e d .  F i g u r e  ( 3 . 2 6 )  s h o w s  t h e  e x t r a c t s  w i t h  t h e  
c o r r e s p o n d i n g  s u p e r n a t a n t s  r u n  a l o n g s i d e .  L a n e s  2 a n d  5 ,  s h o w
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t h a t  g l y c o s y l a t e d  a n d  u n g l y c o s y l a t e d  / 3 - g l u c a n a s e  i s  s e c r e t e d  i n  
p J G 3 1 7  a n d  p J G 3 1 4  ( u n g l y c o s y l a t e d  b a n d s  a r e  i n d i c a t e d  w i t h  
a r r o w s )  . I n  t h i s  g e l  (15%) ( a n d  i n  t h e  g e l  o f  s u p e r n a t a n t s  i n  
F i g . 3 . 2 7 ) ,  t h e  s l i g h t l y  s l o w e r  m o b i l i t y  o f  t h e  e n z y m e  i n  p J G 3 1 4  
i s  m o r e  a p p a r e n t . Th e  a n a l y s i s  a l s o  r e v e a l s  t h a t  i n  e a c h  c a s e ,  
t h e  s a m e  f o r m s  o f  / 3 - g l u c a n a s e  a r e  s e c r e t e d  a s  w e r e  s e e n  
i n t r a c e l l u l a r l y . i e . a n  u n g l y c o s y l a t e d  f o r m  a n d  t h e  t w o  c o r e  
g l y c o s y l a t e d  f o r m s .  I n  p J G 2 0 5 ,  t h e  s e c r e t e d  e n z y m e  i s  s i m i l a r  
t o  t h e  i n t e r n a l  f o r m  a n d  t h e r e  i s  n o  s i g n  o f  a n y  m o d i f i c a t i o n  
b y  o l i g o s a c c h a r i d e  a d d i t i o n  u n d e r  n o r m a l  g r o w t h  c o n d i t i o n s .  
T h i s  i s  s e e n  i n  t h e  s u p e r n a t a n t  f r a c t i o n  o f  p J G 2 0 5  s h o w n  i n  
F i g .  3 . 2 7 ,  ( l a n e  8 ,  m i n u s  t u n i c a m y c i n )  , w h e r e  o n l y  o n e  b a n d  i s  
v i s i b l e .
F i g u r e  ( 3 . 2 6 )  A c t i v i t y  g e l  a n a l y s i s  o f  i n t r a c e l l u l a r  a n d  
s e c r e t e d  f o r m s  o f  / 3 - g l u c a n a s e  i n  p J G 3 1 7 ,  p J G 3 1 4 .
*
1 2 3 4  5
L a n e  1 :  c o n t r o l  ( B . s u b t i l i s  c o m m e r c i a l  p r e p . )
L a n e  2 :  pJ G 317  i n t r a c e l l u l a r .  L a n e  4 :  p J G 3 1 4  i n t r a c e l l u l a r .  
L a n e  3 :  pJ G 317  e x t r a c e l l u l a r .  L a n e  5 :  p J G 3 1 4  e x t r a c e l l u l a r .
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E x a m i n a t i o n  o f  t h e  / 3 - g l u c a n a s e  p r o d u c t s  o n  a c t i v i t y  g e l s  a f t e r  
t r e a t m e n t  w i t h  t u n i c a m y c i n  ( F i g . 3 . 2 7 ) ,  c o n f i r m s  t h a t  t h e  h i g h  
m o l e c u l a r  w e i g h t  f o r m s  s e e n  i n  t h e  s u p e r n a t a n t s  o f  pJ G 3 1 7  an d  
p J G 3 1 4  do  r e p r e s e n t  g l y c o s y l a t e d  / 3 - g l u c a n a s e . I n  t h e  a b s e n c e  o f  
t u n i c a m y c i n ,  t h e  m a j o r i t y  o f  t h e  s e c r e t e d  e n z y m e  i n  p J G 3 1 7  a n d  
p J G 3 1 4 ,  c o n s i s t s  o f  t h e  h i g h e r  m o l e c u l a r  w e i g h t  s p e c i e s  a n d  i n  
b o t h  c a s e s ,  t h e  h i g h e r  m o l e c u l a r  w e i g h t  b a n d s  a r e  m o re  i n t e n s e  
t h a n  t h e  u n m o d i f i e d  b a n d s  ( l a n e s  3 a n d  5 ,  F i g . 3 . 2 7 ) .  T r e a t m e n t  
w i t h  t u n i c a m y c i n  c a u s e s  t h e s e  b a n d s  t o  d e c r e a s e  i n  i n t e n s i t y .  
T h i s  i s  a c c o m p a n i e d  b y  a n  i n c r e a s e  i n  c o n c e n t r a t i o n  o f  t h e  l o w  
m o l e c u l a r  w e i g h t ,  u n m o d i f i e d  / 3 - g l u c a n a s e  b a n d .  T h i s  i s  a p p a r e n t  
i n  b o t h  p J G 3 17  a n d  p J G 3 1 4  ( l a n e s  2 a n d  4 ) .
T he  a d d i t i o n  o f  m a n n o s e  s i d e  c h a i n s  l e a d i n g  t o  e x t e n s i v e l y  
g l y c o s y l a t e d  / 9 - g l u c a n a s e  i s  n o t  e v i d e n t  i n  e i t h e r  p J G 3 1 7  o r  
p J G 3 1 4 .  H y p e r g l y c o s y l a t i o n  w o u l d  c a u s e  a  d r a m a t i c  i n c r e a s e  i n  
m o l e c u l a r  w e i g h t  o f  t h e  e n z y m e .  H o w e v e r ,  f a i n t  s m e a r s  o f  
a c t i v i t y  a t  m o l e c u l a r  w e i g h t s  >  58KDa a r e  s e e n  i n  p J G 3 1 7  a n d  
p J G 3 1 4  ( l a n e s  3 a n d  5 ;  F i g . 3 . 2 7 ) .  T h e s e  s m e a r s  may r e p r e s e n t  
e x t e n s i v e l y  g l y c o s y l a t e d  e n z y m e  a n d  t h e  h i g h  l e v e l  o f  
g l y c o s y l a t i o n  i n  t h e s e  b a n d s  c o u l d  p o s s i b l y  h a v e  a n  i n h i b i t o r y  
e f f e c t  o n  / 3 - g l u c a n a s e  a c t i v i t y .  The  i n c r e a s e s  i n  a c t i v i t y ,  
o b s e r v e d  u n d e r  c o n d i t i o n s  w h e r e  g l y c o s y l a t i o n  i s  d i s r u p t e d  
( s e c t i o n s  ( 3 . 1 0 )  a n d  ( 3 . 1 1 ) ) ,  may b e  a  c o n s e q u e n c e  o f  t h e  
r e l e a s e  o f  t h i s  f r a c t i o n  o f  / 3 - g l u c a n a s e  f r o m  t h e  i n h i b i t o r y  
e f f e c t s  o f  e x t e n s i v e  g l y c o s y l a t i o n .
I n  p J G 2 0 5 ,  t u n i c a m y c i n  t r e a t m e n t  r e s u l t s  i n  t h e  a p p e a r a n c e  o f  a  
b a n d  o f  m o l e c u l a r  w e i g h t  2 6 - 2 7 K D a  ( F i g . 3 . 2 7 ,  l a n e  7 ) ,  s l i g h t l y  
s m a l l e r  t h a n  a n y  o f  t h e  b a n d s  d e t e c t e d  w i t h  t h e  o t h e r  
/ 3 - g l u c a n a s e  c o n s t r u c t s .  F u r t h e r m o r e ,  t h i s  b a n d  i s  n o t  f o u n d  f o r  
p J G 2 0 5  s a m p l e s  i n  t h e  a b s e n c e  o f  t u n i c a m y c i n  a n d  i t s  a p p e a r a n c e  
c o i n c i d e s  w i t h  t h e  i n c r e a s e  i n  a c t i v i t y  d e t e c t e d  a f t e r  
t u n i c a m y c i n  t r e a t m e n t  ( s e c t i o n  3 . 1 1 ) .  A l t h o u g h  no  g l y c o s y l a t e d  
f o r m s  o f  / 3 - g l u c a n a s e  f o r  p J G 2 0 5  w e r e  d e t e c t e d  u s i n g  W e s t e r n  
a n a l y s i s  o r  a c t i v i t y  g e l s  i n  t h e  a b s e n c e  o f  t u n i c a m y c i n ,  t h e  
s e c 5 3  d a t a ,  c o m b i n e d  w i t h  t h e  t u n i c a m y c i n  a s s a y  d a t a  f o r  t h i s  
s t r a i n  ( s e c t i o n s  3 . 1 0  a n d  3 . 1 1  r e s p e c t i v e l y ) ,  s t r o n g l y  s u g g e s t  
t h a t  g l y c o s y l a t i o n  o f  t h e  e n z y m e  i s  o c c u r r i n g .  T h i s  2 6 - 2 7  KDa
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b a n d  m u s t  t h e r e f o r e  r e p r e s e n t  a n  e a r l y  i n t e r m e d i a t e  i n  
g l y c o s y l a t i o n  o f  / 3 - g l u c a n a s e  i n  p J G 2 0 5 .
F i g . ( 3 . 2 7 ) .  A c t i v i t y  g e l  o f  s u p e r n a t a n t s  f r o m  p J G 3 1 7 , p J G 3 1 4  
a n d  p J G 2 0 5  w i t h  a n d  w i t h o u t  t u n i c a m y c i n  t r e a t m e n t .
L a n e 1: c o n t r o l ( B . s u b t i l i s  c o m m e r c i a l
L a n e 2: p J G 3 1 4 , + t u n i c a m y c i n .
L a n e 3: p J G 3 1 4 , - t u n i c a m y c i n .
L a n e 4 : p J G 3 1 7, + t u n i c a m y c i n .
L a n e 5: p J G 3 1 7, - t u n i c a m y c i n .
L a n e 6: p J G 3 1 7 , - t u n i c a m y c i n  ( r e p e a t )
L a n e 7: p J G 2 0 5 , + t u n i c a m y c i n .
L a n e 8: p J G 2 0 5 , - t u n i c a m y c i n .
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S a m p l e s  i s o l a t e d  f r o m  pVT3 14  ( c o n t a i n i n g  t h e  a - f a c t o r  s i g n a l  
a n d  ADH1 p r o m o t e r )  w e r e  a l s o  e x a m i n e d  o n  a c t i v i t y  g e l s  t o  
i n v e s t i g a t e  t h e  n a t u r e  o f  t h e  / 3 - g l u c a n a s e  e n z y m e  p r o d u c e d  b y  
t h i s  s t r a i n .  F i g u r e  ( 3 . 2 8 )  ( l a n e s  1 a n d  3 ) ,  s h o w  t h a t  t h r e e  
a c t i v e  b a n d s  a r e  p r e s e n t  i n  t h e  s u p e r n a t a n t  o f  p V T 3 1 4 ,  s i m i l a r  
t o  t h o s e  o b s e r v e d  f o r  p J G 3 1 7  a n d  p J G 3 1 4 .  I n t r a c e l l u l a r l y , tw o  
o f  t h e s e  b a n d s  a r e  v i s i b l e  i n  pVT3 14  ( l a n e  4 )  .
Th e  a - f a c t o r  s i g n a l  p e p t i d e  i n c l u d e d  i n  t h i s  c o n s t r u c t ,  d i f f e r s  
f r o m  t h e  p J G 3 1 4  s i g n a l  i n  t h a t  a  f u s i o n  w a s  g e n e r a t e d  p l a c i n g  
t h e  / 3 - g l u c a n a s e  g e n e  d i r e c t l y  i n  f r o n t  o f  t h e  a - f a c t o r  L y s - A r g  
c l e a v a g e  s i t e  ( s e c t i o n  3 . 5 ) .  The  i n t e r v e n i n g  G l u - A l a  r e p e a t s  
a r e  n o t  p r e s e n t  i n  t h e  a - f a c t o r  p r o  r e g i o n  i n  pV T 3 14  a n d  t h i s  
i s  r e f l e c t e d  i n  t h e  s i z e s  o f  t h e  / 3 - g l u c a n a s e  b a n d s  o b s e r v e d .  
F i g u r e  ( 3 . 2 8 )  s h o w s  t h a t  t h e  s m a l l e s t  u n g l y c o s y l a t e d  
/ 3 - g l u c a n a s e  i n  pV T 3 1 4  i s  d i r e c t l y  c o m p a r a b l e  i n  s i z e  t o  t h e  
/ 3 - g l u c a n a s e  c o n t r o l  ( l a n e s  4  a n d  5 )  a n d  t h e  t h r e e  s e c r e t e d  
f o r m s  o f  t h e  e n z y m e  a r e  c o m p a r a b l e  t o  t h e  t h r e e  s e c r e t e d  f o r m s  
i n  pJG3 17  ( l a n e  1 ) .
F i g u r e  ( 3 . 2 8 ) .  A c t i v i t y  g e l  s h o w i n g  p V T 3 1 4  i n t r a c e l l u l a r  a n d  
e x t r a c e l l u l a r  f r a c t i o n s .
L a n e  1:  pJ G 3 17  ( S u p ) .  L a n e  3:  p V T 3 1 4  ( S u p ) .
L a n e  2:  pJ G 3 1 7  ( E x t ) .  L a n e  4 :  p V T 3 1 4  ( E x t ) .
La n e  5: c o n t r o l  ( B . s u b t i l i s  c o m m e r c i a l  p r e p . ) .
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Section (3.2)
P r e l i m i n a r y  s t u d i e s  o n  t h e  s u i t a b i l i t y  o f  a n  
¡3 - g l u c u r o n i d a s e  a s  a  r e p o r t e r  g e n e  f o r  S  . c e r e v i s  l a e .
E . c o l i
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( 3 . 1 4 )  / 3 - g l u c u r o n i d a s e  a s  a r e p o r t e r  e n z y m e  f o r  S . c e r e v i s i a e .
The E . c o l i  a c i d  h y d r o l a s e ,  / 3 - D - g l u c u r o n i d a s e  (EC 3 . 2 . 1 . 3 1 )  h a s  
b e e n  c l o n e d  a n d  a d a p t e d  f o r  u s e  a s  a  r e p o r t e r  e n z y m e  t o  e x a m i n e  
f o r e i g n  g e n e  e x p r e s s i o n  i n  p l a n t s  ( J e f f e r s o n  e t  a l . 1 9 8 6  a n d
1 9 8 7 )  . The  a d a p t a b i l i t y  o f  t h e  e n z y m e  t o  t h i s  r o l e  a n d  t h e  
v e r s a t i l i t y  o f  t h e  a s s a y s  a v a i l a b l e  f o r  q u i c k  a n d  a c c u r a t e  
q u a n t i t a t i o n  o f  a c t i v i t y ,  p r o m p t e d  t h e  i n v e s t i g a t i o n  o f  i t s  
p o t e n t i a l  a s  a  r e p o r t e r  g e n e  f o r  y e a s t .
Two p l a t e  a s s a y s  a r e  a v a i l a b l e  f o r  t h e  i d e n t i f i c a t i o n  o f  E . c o l i  
c e l l s  p r o d u c i n g  /3 - g l u c u r o n i d a s e . Th e  c h r o m o g e n i c  s u b s t r a t e ,  
X - g l u c  ( 5 - b r o m o - 4 - c h l o r o - 3 - i n d o l y l  g l u c u r o n i d e ) , c a n  b e  
i n c o r p o r a t e d  i n t o  p l a t e s  a n d  p o s i t i v e  c o l o n i e s  a p p e a r  b l u e  
( s e c t i o n  2 . 3 0 ) .  C e l l s  s p r a y e d  w i t h  t h e  f l o u r i m e t r i c  s u b s t r a t e  
MUG ( 4 - m e t h y l  u m b e l l i f e r y l  g l u c u r o n i d e ) , f l o u r e s c e  w h e n  v i e w e d  
u n d e r  UV. T h i s  f l o u r i m e t r i c  a s s a y  c a n  a l s o  b e  u s e d  t o  q u a n t i f y  
e n z y m e  p r o d u c t i o n .  I n  a d d i t i o n  t o  t h e s e  p l a t e  a s s a y s ,  a  s i m p l e  
s p e c t r o p h o t o m e t r i c  a s s a y  i s  a v a i l a b l e  w h e r e b y  t h e  p r o d u c t i o n  o f  
p - n i t r o p h e n y l  f r o m  t h e  s u b s t r a t e  p - n i t r o p h e n y l  g l u c u r o n i d e  
( P N P G ) , c a n  b e  q u i c k l y  a n d  a c c u r a t e l y  a s s e s s e d  ( s e c t i o n 2 . 3 0 ) .  
T h i s  s i m p l e  a s s a y  w o u l d  b e  i d e a l  f o r  a p p l i c a t i o n  t o  t h e  
/ 3 - g l u c a n a s e  s e c r e t i o n  s y s t e m s  d e s c r i b e d .  I n v e s t i g a t i o n s  w e r e  
made t o  a s s e s s  t h e  p o t e n t i a l  o f  i n t r o d u c i n g  / 3 - g l u c u r o n i d a s e  a s  
a  r e p o r t e r  e n z y m e  i n t o  S . c e r e v i s i a e .
( 3 . 1 5 )  E x p r e s s i n g  / 3 - g l u c u r o n i d a s e  i n  S . c e r e v i s i a e  .
The E . c o l i  /3 - g l u c u r o n i d a s e  ( /3-GUS) g e n e  w a s  o b t a i n e d  i n  pR AJ 26 0  
a s  a  l , 8 0 0 b p  P s t I  f r a g m e n t  i n  pEMBL9 ( J e f f e r s o n  e t  a l . 1 9 8 6 ) .  A 
H i n d l l l  l i n k e r  w a s  i n s e r t e d  i n t o  t h e  S m a l  s i t e  o f  pR A J 2 6 0  t o
g i v e  p R A J 2 6 0 a .  Th e  /3-GUS g e n e  w a s  i s o l a t e d  f r o m  p R A J 2 6 0 a  o n  a
t f i n d l l l  f r a g m e n t  a n d  l i g a t e d  i n t o  t h e  c l o n i n g  s i t e  o f  pAAH5 
u n d e r  c o n t r o l  o f  t h e  ADHI p r o m o t e r  ( F i g .  3 . 2 9 ) .  O r i e n t a t i o n  w a s  
c o n f i r m e d  b y  Bamt t l  d i g e s t  a n d  pJBU7 t r a n s f o r m e d  i n t o  DBY 746 .
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Figure (3.29). Construction of pJBU7.
r-vllS
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(9 -g l u c u r o n i d a s e  p r o d u c t i o n  i n  pJBU7 w a s  m o n i t o r e d  o v e r  a  4 8 h r  
g r o w t h  p e r i o d  ( F i g .  3 . 3 0 ) .  Th e  s p e c t r o p h o t o m e t r i c  a s s a y  
( s e c t i o n  2 . 3 0 ) ,  w a s  u s e d  t o  m e a s u r e  e n z y m e  a c t i v i t y .  T h e  0 -GUS  
g e n e  a p p e a r s  t o  b e  e x p r e s s e d  w e l l  i n  y e a s t  a n d  i n t r a c e l l u l a r  
p r o d u c t i o n  l e v e l s  r e a c h  4 0 u n i t s / m l  ( 1  u n i t  i s  e q u i v a l e n t  t o  
5 n g ) . A l o w  l e v e l  o f  e x t r a c e l l u l a r  a c t i v i t y  wa s  d e t e c t e d  d u r i n g  
s t a t i o n a r y  p h a s e ,  p r e s u m a b l y  d u e  t o  a  c e r t a i n  a m o u n t  o f  c e l l  
d e a t h  a n d  l y s i s  l a t e  i n  t h e  g r o w t h  c y c l e .
F i g u r e  ( 3 . 3 0 ) .  g l u c u r o n i d a s e  p r o d u c t i o n  i n  pJB U7.
1 3 6
A d a p t a t i o n  o f  t h e  p l a t e  a s s a y s  t o  ¡3- g l u c u r o n i d a s e  p r o d u c t i o n  i n  
DBY746 h o w e v e r ,  p r o v e d  l e s s  s u c c e s s f u l .  pJ B U 7,  w h e n  g r o w n  i n  
t h e  p r e s e n c e  o f  X - G l u c ,  d o e s  n o t  a p p e a r  b l u e  i n  c o l o u r .  A l s o ,  
s p r a y i n g  c o l o n i e s  w i t h  t h e  f l o u r i m e t r i c  s u b s t r a t e  MUG, d o e s  n o t  
p r o d u c e  f l o u r e s c e n c e  u n d e r  UV i l l u m i n a t i o n .  I t  i s  l i k e l y  t h a t  
t h e  y e a s t  c e l l  w a l l  i s  n o t  p e r m e a b l e  t o  t h e  s u b s t r a t e s  X - G l u c  
a n d  MUG. H o w e v e r ,  pJBU7 i n  l i q u i d  c u l t u r e  d o e s  f l o u r e s c e  u n d e r  
UV a f t e r  i n c u b a t i o n  i n  ImM MUG. T h i s  i s  d u e  p r e s u m a b l y  t o  d i e  
t h e  l o w  l e v e l  o f  e x t r a c e l l u l a r  a c t i v i t y  t h a t  c a n  b e  d e t e c t e d  i n  
t h e  m e d iu m ,  l a t e  i n  t h e  g r o w t h  c y c l e .  T h i s  s u g g e s t s  t h a t  t h e  
p l a t e  a s s a y s  c o u l d  b e  u s e f u l ,  i f  t h e  /3- g l u c u r o n i d a s e  e n z y m e  w a s  
b e i n g  s e c r e t e d  f r o m  t h e  c e l l s .  I n  o r d e r  t o  a s s e s s  t h e  p o t e n t i a l  
o f  / 3 - g l u c u r o n i d a s e  t o  m o n i t o r  s e c r e t i o n  i n  S . c e r e v i s i a e , t h e  
/3-GUS g e n e  w a s  p l a c e d  u n d e r  c o n t r o l  o f  t h e  a - f a c t o r  s i g n a l  
p e p t i d e  i n  p 6 9 B .
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(3.16) Fusion of fi-GVS to the a-factor signal peptide.
p G U S l ,  pGUS2 a n d  pGUS3 c o n t a i n  t h e  /3-GUS g e n e  i n s e r t e d  i n t o  t h e  
t h e  m u l t i p l e  c l o n i n g  s i t e  o f  pUC19 ( F i g . 3 . 3 1 ) .  I n  e a c h  c a s e  t h e  
g e n e  i s  p r e s e n t  i n  a  d i f f e r e n t  r e a d i n g  f r a m e  w i t h  r e s p e c t  t o  
t h e  / i i n d l l l  s i t e .  T h i s  wa s  a c h i e v e d  b y  i n t r o d u c i n g  e x t r a  
n u c l e o t i d e s  i n t o  t h e  Sm a l  s i t e  a s  i n d i c a t e d  ( T . K a v a n n a g h , 
T . C . D ) . T o  a i d  f u r t h e r  m a n i p u l a t i o n s  a n d  t o  s u i t  t h e  v e c t o r s  
b e i n g  u s e d  i n  t h i s  s t u d y ,  a H i n d l l  l i n k e r  w a s  a d d e d  t o  t h e  
f i l l e d  i n  e n d s  o f  t h e  F c o R I  s i t e  o f  e a c h  p l a s m i d  t o  g e n e r a t e  
p G U S l a , pGUS2a a n d  pGUS3a.
F i g u r e  ( 3 . 3 1 )  The  pGUS s e r i e s  o f  p l a s m i d s .
GUS-
H
pGUSl
pGUS2
pGUSB
\
i H
pUC19
Sma Sst E
GGATCCCC G - G G T - G G T - C A G - T C C - C T T - A T G --------- GUS --------------
GGATCCCC G G - G T A - G G T - C A G - T C C - C T T - A T G --------- GUS---------------
GGATCCCC G G G -T A C “ G G T - C A G - T C C - C T T - A T G --------- GUS -------------
tt
BsMH I Smal (extra bases in bold)
1 3 8
To c o n s t r u c t  t h e  f u s i o n  b e t w e e n  t h e  a - f a c t o r  s i g n a l  p e p t i d e  a n d  
t h e  /3-GUS g e n e ,  a t f i n d l l l  l i n k e r  w a s  f i r s t  i n s e r t e d  i n t o  t h e  
S m a l  s i t e  o f  p G U S l a  t o  f o r m  p G U S l b .  The  /3-GUS g e n e  w a s  t h e n  
i s o l a t e d  o n  t h i s  s m a l l e r  f f i n d l l l  f r a g m e n t  a n d  l i g a t e d  i n t o  p 6 9 B  
t o  g i v e  pGUSa6 ( F i g . 3 . 3 2 ) .
F i g u r e  ( 3 . 3 2 )  C o n s t r u c t i o n  o f  pGUSa6.
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A n a l y s i s  o f  g l u c u r o n i d a s e  p r o d u c t i o n  i n  pGUSa6 w a s  m o n i t o r e d  
o v e r  a  4 8 h r  g r o w t h  p e r i o d  ( F i g . 3 . 3 3 ) .  L e v e l s  o f  i n t r a c e l l u l a r  
a c t i v i t y  a r e  l o w e r  o v e r a l l  t h a n  pJBU7 a n d  n o  e x t r a c e l l u l a r  
a c t i v i t y ,  a p a r t  f r o m  t h e  v e r y  l o w  l e v e l s  c o m p a r a b l e  t o  t h o s e  
d e t e c t e d  i n  t h e  s i g n a l - l e s s  c o n s t r u c t  pJ B U 7,  w a s  o b s e r v e d .  
F i g u r e  ( 3 . 3 3 ) .
Growth curve pGUS°(6 in DBY746
Time (hrs)
To ensure that glycosylation was not having a similar effect on 
/3-glucuronidase as had been seen with /?-glucanase (the 
glucuronidase enzyme has two potential glycosylation sites), 
pGUSa6 was treated with tunicamycin (10/ig/ml) as described 
section (3.11). Tunicamycin had no effect on /3-glucuronidase 
activity produced from pGUSa6 intracellularly or 
extracellularly. It appears that the /9-glucuronidase enzyme 
cannot be secreted in S.cerevisiae using the a-factor signal 
peptide. However, these results do give some idea about the 
relative strengths of the ADH1 and a-factor promoters. If the 
a-factor signal peptide does not interfere with ^-glucuronidase 
activity in pGUSa6, then the ADH1 promoter is the stronger of 
the two.
140
(3.17) Adapting /3-glucuronidase as a useful reporter in yeast.
/ 3 - g l u c u r o n i d a s e  d o e s  n o t  a p p e a r  t o  b e  a m e n a b l e  t o  m o n i t o r i n g  
s e c r e t i o n  i n  S . cerevisiae . I n  t h e  y e a s t  c y t o p l a s m  h o w e v e r ,  t h e  
e n z y m e  s h o w s  n o  s i g n s  o f  i n s t a b i l i t y  a n d  c a n  b e  u s e d  t o  m o n i t o r  
e x p r e s s i o n  l e v e l s .  /3- g l u c u r o n i d a s e  may a l s o  b e  u s e f u l  i n  o t h e r  
r e s p e c t s  f o r  h e t e r o l o g o u s  p r o t e i n  p r o d u c t i o n  i n  S .cerevisiae. 
F o r  e x a m p l e ,  t h e  e n z y m e  c o u l d  p o s s i b l y  b e  u s e d  a s  a  f u s i o n
p r o t e i n  t o  a c t  a s  a c a r r i e r  f o r  o t h e r  f o r e i g n  p r o t e i n s  i n  
y e a s t .  I t  may a l s o  b e  p o s s i b l e  t o  s t a b i l i z e  p r o t e i n s ,  
e g . / 3 - g l u c a n a s e  , b y  f u s i o n  t o  t h e  / 3 - g l u c u r o n i d a s e  e n z y m e .
/ 3 - g l u c u r o n i d a s e  i s  a  73KDa p r o t e i n ,  a n d  a  s m a l l e r  p r o t e i n  w o u l d  
b e  p o t e n t i a l l y  m o r e  u s e f u l  f o r  f u s i o n  s t u d i e s .  I f  a  t r u n c a t e d ,  
b u t  s t i l l  a c t i v e  f o r m  o f  t h e  e n z y m e  c o u l d  b e  g e n e r a t e d ,  t h i s  
w o u l d  b e  u s e f u l  b o t h  a s  a  f u s i o n  t o  s t a b i l i z e  o t h e r  p r o t e i n s  i n  
t h e  y e a s t  c y t o p l a s m  a n d  t o  i n v e s t i g a t e  t h e  y e a s t  s e c e t o r y
p a t h w a y  f u r t h e r .  I f  t h e  l i m i t i n g  f a c t o r  f o r  s e c r e t i n g  
/ 9 - g l u c u r o n i d a s e  i n  y e a s t  i s  i t s  s i z e ,  t r u n c a t e d  f o r m s  o f  t h e  
e n z y m e  w o u l d  b e  p a r t i c u l a r l y  u s e f u l .  A l t e r n a t i v e l y ,  i f  t h e r e  
a r e  s e q u e n c e s  i n  t h e  e n z y m e  t h a t  d i r e c t  t h e  p r o t e i n  e l s e w h e r e
i n  t h e  y e a s t  c e l l ,  t r u n c a t e d  f o r m s  w o u l d  a l s o  a i d  t h e
i n v e s t i g a t i o n  o f  t h i s  p o s s i b i l i t y .
An e a r l i e r  o b s e r v a t i o n  i n v o l v i n g  / 9 - g l u c u r o n i d a s e  s u g g e s t e d  t h a t  
i t  s h o u l d  b e  p o s s i b l e  t o  p r o d u c e  a  s h o r t e n e d  f o r m  o f  t h e  e n z y m e  
t h a t  w a s  s t i l l  a c t i v e  ( T . K a v a n a g h ,  T . C . D . ) .  On a c t i v i t y  g e l s ,  
a c t i v e  e n z y m e  b a n d s  w e r e  o b s e r v e d  b e l o w  t h e  m a i n  a c t i v e  b a n d  
(7 2 K D a )  i n  p a r t l y  d e g r a d e d  p r e p a r a t i o n s  o f  t h e  e n z y m e .  T h i s  
i n d i c a t e d  t h a t  t h e  a c t i v e  d o m a i n  o f  t h e  e n z y m e  w a s  c o n f i n e d  t o  
a  s h o r t e r  d e f i n e d  r e g i o n  o f  t h e  m o l e c u l e .  I n i t i a l  s t e p s  w e r e  
t a k e n  t o  l o c a t e  t h e  a c t i v e  s i t e  o f  /9 - g l u c u r o n i d a s e  u s i n g  B a l 31  
d e l e t i o n  a n a l y s i s  f r o m  b o t h  t h e  N - t e r m i n a l  a n d  c a r b o x y  t e r m i n a l  
o f  t h e  e n z y m e .  A n t i b o d y  t o  t h e  E . c o l i  e n z y m e  w a s  a l s o  r a i s e d  t o  
a i d  f u t u r e  i n v e s t i g a t i o n s  i n  t h i s  a r e a  a n d  a  f u s i o n  p r o t e i n  
i n v o l v i n g  t h e  / 9 - g l u c a n a s e  a n d  ^ - g l u c u r o n i d a s e  g e n e s  wa s  
c o n s t r u c t e d .
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( 3 . 1 8 )  T r u n c a t i n g  /9-GUS f r o m  t h e  3 '  e n d .
pGUSl  w a s  l i n e a r i s e d  w i t h  E c o R I  a n d  d e l e t i o n s  w e r e  made  i n t o  
t h e  3 '  e n d  o f  t h e  g e n e  u s i n g  B a l 3 1  e x o n u c l e a s e  a s  d e s c r i b e d  i n  
s e c t i o n  ( 2 . 1 5 )  a n d  F i g u r e  ( 3 . 3 4 ) .  D i g e s t i o n  w a s  s t o p p e d  a t  
t i m e s  T= 2  t o  T= 2 0  m i n s  ( F i g .  3 . 3 4 )  a n d  t h e  s a m p l e s  c l e a n e d  b y  
s p i n n i n g  t h r o u g h  s e p h a r o s e  c o l u m n s .  The  l i n e a r  p l a s m i d s  f r o m  
T=io w e r e  r e l c i r c u l a r i s e d  i n  t h e  p r e s e n c e  o f  a  t f i n d l l l  l i n k e r  
a n d  t r a n s f o r m e d  i n t o  J A 2 2 1 .  T r a n s f o r m a n t s  w e r e  t e s t e d  f o r  
/ 3 - g l u c u r o n i d a s e  a c t i v i t y  u s i n g  t h e  f l o u r e s c e n t  MUG a s s a y  
( s e c t i o n  2 . 3 0 ) .  D e l e t i o n s  f r o m  t h e  3 '  e n d  d i s r u p t e d  a c t i v i t y  o f  
t h e  e n z y m e  a l m o s t  i m m e d i a t l y .  E v e n  t h e  s m a l l e s t  d e l e t i o n  o f  
1 5 0 b p  w a s  i n a c t i v e  i n  E . c o l i .  Two o f  t h e s e  t r u n c a t e d  g e n e s  w e r e  
i s o l a t e d  o n  f f i n d l l l  f r a g m e n t s  a n d  l i g a t e d  i n t o  t h e  t f i n d l l l  s i t e  
o f  pAAH5 b e t w e e n  t h e  ADH1 p r o m o t e r  a n d  t e r m i n a t o r  s e q u e n c e s .  
T h e s e  d e l e t i o n s  pJBUAb a n d  p J B U A i ,  m i s s i n g  1 5 0 b p  a n d  5 0 0 b p  o f
t h e  /3-GUS g e n e  r e s p e c t i v e l y ,  n o t  s u r p r i s i n g l y ,  e x h i b i t e d  no
a c t i v i t y  i n  DBY746 ( n o t  s h o w n ) .
T h e  c a r b o x y l  e n d  o f  t h e  / 3 - g l u c u r o n i d a s e  a p p e a r s  t o  b e  e s s e n t i a l  
f o r  a c t i v i t y . T h i s  s u g g e s t s  t h a t  t h e  a c t i v e  s i t e  o f  t h e  e n z y m e  
i s  l o c a t e d  i n  t h i s  r e g i o n .  T h e  /9-GUS g e n e  h a s  tw o  p o t e n t i a l  
g l y c o s y l a t i o n  s i t e s  a l s o  l o c a t e d  i n  t h i s  a r e a ,  a t  p o s i t i o n s  
1 , 2 0 0  a n d  1 , 4 0 0  b p  a p p r o x i m a t l y  ( J e f f e r s o n  e t  a l . 1 9 8 6 ) .
G l y c o s y l a t i o n  o f  / 3 - g l u c u r o n i d a s e  a t  t h e s e  t w o  s i t e s  i n  t h e  ER 
o f  p l a n t  c e l l s  h a s  b e e n  s h o w n  t o  h a v e  a n  a d v e r s e  e f f e c t  o n
a c t i v i t y  a n d  i s  c o n s i s t e n t  w i t h  t h i s  o b s e r v a t i o n  ( I t t a g u r i a  e t
a l ,  1 9 9 0 ) .  T h e s e  s t u d i e s  c a r r i e d  o u t  i n  p l a n t s ,  a l s o  s h o w  t h a t  
t h e  e n z y m e  i s  n o t  a d v e r s e  t o  t r a n s l o c a t i o n ,  a t  l e a s t  i n  t h i s  
h i g h e r  e u k a r y o t e . l t  may b e  p o s s i b l e  t h e r e f o r e ,  t o  s e c r e t e  
g l u c u r o n i d a s e  i n  y e a s t ,  p e r h a p s  u s i n g  a  d i f f e r e n t  s i g n a l  
p e p t i d e .
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Figure (3.34) 3' Bal31 deletions of /3-GUS gene.
H
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Lane 1 : pGUSl / tfindlll.
Lanes 2-7 : BaI31 deletions, T- 2, 4, 6, 8, 10, 12 mins. 
Lane 8: X / HindiII
Lanes 9-13 : Bal31 deletions, T- 14, 16, 18, 20 rains.
1 4 3
(3.19) Truncating /3-GUS from the 5' end.
To g e n e r a t e  5'  d e l e t i o n s  i n  t h e  ^-GUS g e n e ,  pGUS2,  c u t  w i t h  
/ / i n d l l l ,  wa s  t r e a t e d  w i t h  B a l  31 e x o n u c l e a s e  ( s e c t i o n  2 .115)  
( F i g . 3 . 3 5 ) .  D i g e s t i o n  w a s  s t o p p e d  a t  t i m e s  T= 2-20  m i n s . a n d  
t h e  s a m p l e s  c l e a n e d  b y  s p i n n i n g  t h r o u g h  s e p h a r o s e  c o l u m n s .  
B e c a u s e  t h e  t r a n s l a t i o n a l  s t a r t  s i t e  i s  a u t o m a t i c a l l y  r e m o v e d  
i n  t h i s  p r o c e d u r e ,  t h e  d e l e t e d  p l a s m i d  ( f r o m  T = 1 0 ) w as  
r e c i r c u l a r i s e d  i n  t h e  p r e s e n c e  o f  a  C l a l  l i n k e r  t o  g e n e r a t e  an  
ATG s t a r t  s i t e  a n d  t r a n s f o r m e d  i n t o  JA221.
Figure (3.35). Generation of 5' Bal31 deletions,
C la l  linker
Bq I31
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F i g u r e  ( 3 . 3 5 )  c o n t d . : G e l  s h o w i n g  Balll  d e l e t i o n s  T= 2  t o  T=20 
m i n s . ,  a f t e r  d i g e s t i o n  w i t h  E c o R I  t o  s e p a r a t e  v e c t o r  a n d  /3-GUS 
g e n e .  T=10 w a s  t a k e n  f o r  r e l i g a t i o n  i n  t h e  p r e s e n c e  o f  C l a l  
l i n k e r .
L a n e  1 :  pGUSl  /  H i n d l l l  ( l i n e a r i z e d ) .
L a n e  2 :  pGUSl  /  t f i n d l l l  /  E c o R I .
L a n e s  3 - 9 :  B a l 3 1  d e l e t i o n s ,  T= 2 ,  4 ,  6 ,  8 ,  1 0 ,  2 0 ,  15  m i n s .  
L a n e  1 0 :  pGUSl  /  f f i n d l l l  /  E c o R I .
L a n e  1 1 :  X /  H i n d l l l .
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A n a l y s i s  o f  t h e  r e l i g a t e d  T=io t r a n s f o r m a n t s  s h o w  t h a t  b e t w e e n  
2 0 0  a n d  6 0 0 b p  o f  t h e  g e n e  h a s  b e e n  r e m o v e d  b y  t h e  a c t i o n  o f  t h e  
B a l 3 1  e n z y m e .  F i g u r e  ( 3 . 3 6 )  s h o w s  8 o f  t h e s e  t r a n s f o r m a n t s  c u t  
w i t h  C l a l  a n d  £ c o R I .
F i g u r e  ( 3 . 3 6 )
L a n e  1 :  pG USl  C l a l  /  F c o R I .
L a n e  2 :  p A l 6 . 1 3  
L a n e  3 : p A l 6 . 1 5  
L a n e  4 :  A /  f f i n d l l l  /  £ c o R I .
L a n e  5 : p A l 6 . 1  
L a n e  6 :  p A 1 6 .2  
L a n e  7 :  p A l 6  6 
L a n e  8 p A l 6 .9  
L a n e  9 : p A l 6 . 1 0
A l l  t h e  a b o v e  d e l e t i o n  f r a g m e n t s  w e r e  g e l  p u r i f i e d  a n d  c l o n e d  
i n t o  t h e  pGUS2c v e c t o r  a s  d e s c r i b e d  b e l o w .
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These t r u n c a t e d  genes ( f r o m  Fig.3.36) were i s o l a t e d  o n  
Clal/EcoRl fragments and ligated into the vector portion of 
pGUS2c. pGUS2c was constructed to mediate transfer of the 
truncated /3-GUS genes into pUC19 under control of a fully 
intact lacZ promoter (Fig.3.37): A Clal linker was inserted
into the Smal site of pGUS2 and the vector portion of the 
resultant plasmid (pGUS2c), was gel purified after digestion 
with Clal and £coRI. The truncated /3-GUS genes were ligated to 
this vector and transformed into JA221 (JA221 has no endogenous 
glucuronidase activity).
Figure (3.37). Construction of pGUS2c.
E
C Bal31 OELETIONS
When t e s t e d  f o r  / 3 - g l u c u r o n i d a s e  a c i t v i t y  u s i n g  t h e  f l o u r e s c e n t  
MUG a s s a y  ( F i g .  3 . 3 8 ) ,  tw o  o f  t h e  d e l e t i o n s  w e r e  s h o w n  t o  h a v e  
r e t a i n e d  a c t i v i t y  i e .  p A l 6 . 1  a n d  p A l 6 . 9  , m i s s i n g  a p p r o x i m a t e l y  
5 0 0 b p  a n d  3 0 0 b p  o f  t h e  /3-GUS g e n e  r e s p e c t i v e l y  ( s e e  F i g . 3 . 3 6 ) .  
T h i s  i n d i c a t e s  t h a t  a t  l e a s t  5 0 0 b p  o f  t h e  /3-GUS g e n e  c a n  b e  
r e m o v e d  w i t h o u t  t h e  e n z y m e  l o s i n g  i t s  a c t i v i t y  a n d  i t  w o u l d  
o b v i o u s l y  b e  w o r t h w h i l e  t o  c o n t i n u e  t h e  d e l e t i o n  a n a l y s i s  
f u r t h e r  i n t o  t h e  5 '  e n d  o f  t h e  g e n e ,  Th e  l a c k  o f  a c t i v i t y  i n  
t h e  o t h e r  d e l e t i o n s ,  w h e r e  l e s s  t h a n  5 0 0 b p  h a s  b e e n  r e m o v e d ,  i s  
l i k e l y  t o  b e  a  r e s u l t  o f  o u t  o f  f r a m e  f u s i o n s  b e t w e e n  t h e  
d e l e t e d  g e n e  a n d  t h e  t r a n s l a t i o n a l  s t a r t  s i t e  o f  t h e  C l n  I  
l i n k e r .
F i g u r e  ( 3 . 3 8 ) .  MUG a s s a y  o f  B a I 3 1  d e l e t i o n s .
To t e s t  f o r  / 3 - g l u c a n a s e  a c t i v i t y ,  t h e  c u l t u r e s  w e r e  m i x e d  w i t h  
ImM MUG i n  m i c r o t i t r e  w e l l s ,  i n c u b a t e d  a t  37°C f o r  2 0  m i n s  a n d  
v i e w e d  u n d e r  UV.
( 3 . 2 0 ) .  / 3 - g l u c u r o n i d a s e  a s  a  f u s i o n  p r o t e i n .
To i n v e s t i g a t e  i f  / 3 - g l u c u r o n i d a s e  c a n  t o l e r a t e  a  5 '  f u s i o n ,  t h e  
/ 3 - g l u c a n a s e  g e n e  w a s  l i g a t e d  i n - f r a m e  t o  t h e  5 '  e n d  o f  t h e  
/3-GUS g e n e  i n  t h e  p l a s m i d  p G U S l . I n  g e n e r a t i n g  t h i s  f u s i o n ,  i t  
w a s  n e c e s s a r y  t o  l i g a t e  t h e  tw o  g e n e s  i n - f r a m e ,  e l i m i n a t i n g  a l l  
t r a n s c r i p t i o n a l  a n d  t r a n s l a t i o n a l  t e r m i n a t i o n  s e q u e n c e s  b e t w e e n  
t h e  t w o .  T h i s  w a s  a c h i v e d  b y  i s o l a t i n g  t h e  / 3 - g l u c a n a s e  g e n e  o n  
a  f f i n d l l l - S a l l  f r a g m e n t  f r o m  b o t h  p J G 1 0 4  a n d  p J G 1 0 6 ,  a s  
o u t l i n e d  i n  F i g u r e  ( 3 . 3 9 ) .  B o t h  p l a s m i d s  w e r e  u s e d  i n  o r d e r  t o  
g e n e r a t e  f u s i o n s  b e t w e e n  / 3 - g l u c u r o n i d a s e  a n d  t h e  / 3 - g l u c a n a s e  
g e n e ,  w i t h  a n d  w i t h o u t  i t s  s i g n a l  p e p t i d e .  T r u n c a t i n g  t h e  
/ 3 - g l u c a n a s e  g e n e  a t  t h e  S a l  I  s i t e  ( p o s i t i o n  1 1 1 5 ,  a p p . 1 f o r  
d e t a i l s )  r e s u l t s  i n  t h e  r e m o v a l  o f  5 4  a m i n o  a c i d s  o f  t h e  
/ 3 - g l u c a n a s e  c a r b o x y l  t e r m i n u s .  W h e t h e r  o r  n o t  t h i s  d e s t r o y e d  
t h e  a c t i v e  s i t e  o f  t h e  / 3 - g l u c a n a s e  e n z y m e  r e m a i n e d  t o  b e
d e t e r m i n e d .  H o w e v e r ,  t h e  c o m p l e t e  / 3 - g l u c u r o n i d a s e  g e n e  w o u l d  b e  
p r e s e n t  i n  t h e s e  f u s i o n s  a n d  i t  w a s  h o p e d  t h a t  t h i s  e n z y m e
w o u l d  r e m a i n  a c t i v e . T h e  t r u n c a t e d  / 3 - g l u c a n a s e  g e n e s  w e r e  e a c h  
l i g a t e d  i n t o  t f i n d l l l - S a l l  c u t  p G U S l ,  5 '  t o  t h e  /3-GUS g e n e ,
g e n e r a t i n g  a n  i n - f r a m e  f u s i o n  b e t w e e n  t h e  t w o  e n z y m e s  i n  e a c h  
c a s e  ( F i g . 3 . 3 9 ) .  Th e  r e s u l t a n t  p l a s m i d s  p J G U S 4 . 1  ( c o n t a i n i n g  
t h e  s i g n a l - l e s s  / 3 - g l u c a n a s e )  a n d  p J G U S 6 , l  ( w i t h  t h e  / 3 - g l u c a n a s e  
s i g n a l  i n c l u d e d ) ,  w e r e  t r a n s f o r m e d  i n t o  J A 2 2 1 ,  r e p l i c a  p l a t e d  
a n d  t e s t e d  f o r  / 3 - g l u c a n a s e  a c t i v i t y  u s i n g  t h e  p l a t e  a s s a y
( s e c t i o n  2 . 1 8 )  a n d  f o r  / 3 - g l u c u r o n i d a s e  u s i n g  t h e  f l o u r e s c e n t  
MUG a s s a y  ( s e c t i o n  2 . 3 0 ) .  I n  b o t h  c a s e s ,  t h e  f u s i o n s  w e r e  
p o s i t i v e  f o r  / 3 - g l u c u r o n i d a s e  a n d  n e g a t i v e  f o r  / 3 - g l u c a n a s e  
a c t i v i t y .  T h i s  i n d i c a t e s  t h a t  / 3 - g l u c u r o n i d a s e  c a n  b e  made  a s  a n  
a c t i v e  f u s i o n  t o  o t h e r  p e p t i d e s .  T h e s e  f u s i o n s  h a v e  y e t  t o  b e  
t e s t e d  i n  y e a s t .
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F i g u r e  ( 3 . 3 9 ) .  C o n s t r u c t i o n  o f  / 3 - g l u c a n a s e  /  - g l u c u r o n i d a i s e
f u s i o n  p l a s m i d s .
H D  S
^  EZZZZZZZZZZZZZZ3 106 fragment
tZ Z Z Z Z Z Z Z Z Z Z Z Z a i04 fragment
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(3.21) Raising a polyclonal antibody to the E . c o l i  
¡3-glucuronidase enzyme.
An a c t i v i t y  g e l  t e c h n i q u e  i s  a v a i l a b l e  f o r  a n a l y s i s  o f  t h e  
/3- g l u c u r o n i d a s e  p r o t e i n  u s i n g  SDS PAGE ( s e c t i o n  2 . 3 1 ) .  T h i s  
t e c h n i q u e  i s  b a s e d  o n  t h e  f l o u r e s c e n t  MUG a s s a y  w h e r e  
f l o u r e s c i n g  b a n d s  o f  r e n a t u r e d  ¿3-g l u c u r o n i d a s e  a r e  v i e w e d  b y  UV 
i l l u m i n a t i o n .  T h i s  t e c h n i q u e  h o w e v e r ,  i s  u n r e l i a b l e  a n d  t h e  
s p e e d  a t  w h i c h  t h e  f l o u r e s c e n c e  f a d e s  u n d e r  UV h i n d e r s  i t  e v e n  
f u r t h e r .  I n  o r d e r  t o  f a c i l i t a t e  t h e  f u t u r e  a n a l y s i s  o f  t h e  
f u l l ,  t r u n c a t e d  a n d  f u s i o n  f o r m s  o f  /3-g l u c u r o n i d a s e , i t  w a s  
d e c i d e d  t o  make a  p o l y c l o n a l  a n t i b o d y  t o  t h e  e n z y m e  f o r  
a n a l y s i s  i n  E . c o l i  a n d  y e a s t .
A c o m m e r c i a l  p r e p a r a t i o n  ( S i g m a )  o f  t h e  E . c o l i  / 3 - g l u c u r o n i d a s e  
e n z y m e  w a s  a n a l y s e d  b y  SDS PAGE. C o o m a s s i e  b l u e  s t a i n i n g  s h o w e d  
t h i s  p r e p a r a t i o n  t o  b e  l a r g e l y  f r e e  o f  c o n t a m i n a t i n g  p r o t e i i i s  
( d a t a  n o t  s h o w n ) .  A 72  d a y  o l d  r a t  w a s  i n j e c t e d  s u b - c u t a n e o u s l y  
w i t h  5 0 0  u n i t s  ( i n  0 . 5 m l  H^O) o f  t h i s  e n z y m e  p r e p a r a t i o n ,  
s o n i c a t e d  i n  0 . 5 m l  c o m p l e t e  F r e u n d s  a d j u v u n c t .  A b o o s t e r  
i n j e c t i o n  o f  t h e  sa me a m o u n t ,  t h i s  t i m e  s o n i c a t e d  i n  0 .  5rnl 
F r e u n d s  i n c o m p l e t e  a d j u v u n c t ,  w a s  s u b s e q u e n t l y  a d m i n i s t e r e d  a t  
3 w e e k l y  i n t e r v a l s ,  5 t i m e s  i n  t o t a l .  One w e e k  a f t e r  t h e  l a s t  
i n j e c t i o n ,  1 . 0 m l  o f  s e r u m  w a s  r e m o v e d ,  a l l o w e d  t o  c l o t  
o v e r n i g h t  a t  4°C a n d  c l e a r e d  b y  c e n t r i f u g a t i o n .  T h e  c l e a r e d  
a n t i s e r u m  w a s  t e s t e d  f o r  r e a c t i v i t y  a g a i n s t  t h e  c o m m e r c i a l  
/3 - g l u c u r o n i d a s e  e n z y m e  u s i n g  W e s t e r n  b l o t  a n a l y s i s .  On 
e s t a b l i s h i n g  r e a c t i v i t y  o f  t h e  a n t i s e r u m  w i t h  t h e  
/ 3 - g l u c u r o n i d a s e  p r o t e i n ,  1 5 m l  o f  b l o o d  w a s  e x t r a c t e d  f r o m  t h e  
r a t .  T h i s  w a s  a l l o w e d  t o  c l o t  a n d  t h e  c l e a r e d  s e r u m  c o l l e c t e d  
a f t e r  c e n t r i f u g a t i o n  a s  b e f o r e .  A t o t a l  o f  8 . 0 m l  o f  a n t i s e r u m  
w a s  r e c o v e r e d .
T h e  a n t i b o d y  p r e p a r a t i o n  w a s  t i t r e d  a g a i n s t  varioAis 
c o n c e n t r a t i o n s  o f  c o m m e r c i a l  / 3 - g l u c u r o n i d a s e  b y  W e s t e r n  b l o t  
a n a l y s i s .  3 0 ,  6 0  a n d  1 8 0  u n i t s  o f  t h e  e n z y m e  p r e p a r a t i o n  w e r e
s e p a r a t e d  o n  a  15% SDS p o l y a c r y l a m i d e  g e l ,  b l o t t e d  o n t o  
n i t r o c e l l u l o s e  a n d  d e v e l o p e d  u s i n g  a 1 : 2 0 0 ,  1 : 5 0 0  a n d  1 : 1 , 0 0 0
d i l u t i o n  o f  / 3 - g l u c u r o n i d a s e  a n t i s e r u m .  As  a  c o n t r o l ,  n o n - i m m u n e  
r a t  s e r u m  w a s  a l s o  u s e d  t o  r u l e  o u t  n o n - s p e c i f i c  b i n d i n g  o f  t h e
1 5 1
a n t i b o d y .  F i g u r e  ( 3 . 4 0 )  s h o w s  t h e  b l o t  o f  t h e  1 : 1 , 0 0 0  d i l u t i o n  
w h i c h  g a v e  t h e  b e s t  r e s u l t s  w i t h  r e s p e c t  t o  i n t e n s i t y  o f  b a n d s  
a n d  c l e a r n e s s  o f  b a c k g r o u n d .  H y b r i d i z a t i o n  t o  t h e  n o n - i m m u n e  
r a t  s e r u m  c o n t r o l  s h o w e d  t h a t  n o n - s p e c i f i c  b i n d i n g  w a s  a t  a 
m i n i m u m .
F i g u r e  ( 3 . 4 0 ) .  T i t r i n g  t h e  ¡3- g l u c u r o n i d a s e  a n t i b o d y  ( 1 : 1 0 0 0 ) ,
2 3 4
A = n e g a t i v e  c o n t r o l ,  n o n - i m m u n e  r a t  s e r u m .
B =  1 : 1 0 0 0  d i l u t i o n  o f  ¡3- g l u c u r o n i d a s e  a n t i s e r u m .  
C = 1 : 5 0 0  d i l u t i o n  o f  / 3 - g l u c u r o n i d a s e  a n t i s e r u m .
L a n e  1 
L a n e  2 
L a n e  3 
L a n e  4
m a r k e r s
3 0  u n i t s  E . c o l i  c o m m e r c i a l  0 - g l u c u r o n i d a s e  
6 0  u n i t s  " " 11
1 8 0  u n i t s  "
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To ensure that the antibody also recognises ¡3-glucuronidase 
produced in the yeast cytoplasm and to compare the sizes of the 
E.coli and S.cerevisiae enzyme, the antibody was tested against 
a protein extract prepared from pJBU7. The Western blot, sho^m 
in Figure (3.41) reveals a band at the same mobility in E.coli 
and pJBU7 (72KDa). pAAH5 was also run to ensure against 
non-specific binding and the same blot was tested against 
non-immune rat serum. The faintness of the band in pJBU7 is 
likely to be a result of the low amount of extract run on the 
gel (approximately equivalent to 200^1 of a stationary phase 
culture). This shows however, that the antibody does recognize 
the enzyme when produced in yeast, even at low concentrations 
and should prove useful in future investigations of 
/3-glucuronidase production S .cerevisiae. Contaminating bands 
that appear in the commercial preparation of the enzyme, 
running at a faster mobility than /3 - glucuronidase, also appear 
in the yeast extract samples. These bands are most likely to be 
a result of non-specific binding of the antibody preparation 
and are not associated with /3-glucuronidase activity.
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Figure (3.41). Reactivity of the /?-glucuronidase antibody with 
enzyme produced in yeast (1:1,000 dilution of antibody).
KDa
-116
_  84 
-  58
Lane 1: markers
Lane 2: E .coli commercial
Lane 3: pJBU7 extract.
Lane 4: DBY746 extract.
Lane 5: pAAH5 extract.
Close up of lanes 1, 2 and 3 showing the /3-glucuronidase band 
in pJBU7 more distinctly.
1 2 3
5 4 3 2 1
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CHAPTER 4 
Discussion
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(4.1) The ¿3-glucanase signal peptide.
The B.subtlis signal peptide has been shown to act as a natural 
signal sequence in S .cerevisiae, directing secretion of 
/3-glucanase through the conventional secretory pathway. This 
was verified with pJG317, in secl8 and seel mutants, where 
secretion of the /?-glucanase enzyme was blocked at the initial 
and final stages of the transport system. The bacterial signal 
peptide is typical of prokaryotic and eukaryotic secretory 
proteins and a physical dissection of the sequence into its 
structural domains is shown in Figure (4.1).
Figure (4.1). Physical dissection of the /3-glucanase signal 
peptide.
pJG317 pJG205
| + + | - 3 - 1 + 1
1 _  6 7_____________________________ _22 23_______ 28
I I I
N-domain Hydrophobic core C-domain
□ = hydrophobic residue; ■ = polar residue, O = basic residue
The N-terminal hydrophillic domain consists of 6 amino acids, 
ending with two positively charged residues, Lys and Arg. This 
is followed by a hydrophobic core sequence of 16 amino acids. 
The C-terminal domain of 6 amino acids contains the signal 
peptidase cleavage site. Cleavage by signal peptidase is likely 
to occur after the Ala residue at position 28. Von Heijne 
(1984b), suggests that the cleavage window begins at 4-5 
residues from the end of the hydrophobic core and takes place 
at the strongest site allowed. According to these rules, there 
is a strong preference for Ala at positions -1 and -3 and a 
charged or polar amino acid is preferred at position +1, serine 
however, is seldom seen at this position. Small uncharged
residues predominate at position -2. The sequence
Ala-Ser-Ala-Lys at position -3 to +1 fits in exactly with these
predictions. Western blot analysis indicated that the bacterial
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signal peptide is processed by signal peptidase during 
translocation of /3-glucanase across the ER membrane This is 
demonstrated in the appearance of a single, processed band in 
the supernatant of pJG317 after tunicamycin treatment (Fig. 
3.24). Although protein sequence analysis would be required to 
establish the exact cleavage site, according to the general 
rules, cleavage is most likely to occur at this site.
(4.2) Deletion of the /3-glucanase signal peptide.
Complete removal of the /3-glucanase signal peptide in JB/34 and 
pJBC55A, resulted in a loss of detectable enzyme activity when 
expressed on a multicopy plasmid in the yeast cytoplasm. In the 
protease deficient mutant MD50 however, partial recovery of low 
levels of activity was achieved with pJB/34.
Recovery of low levels of /3-glucanase activity in the cytoplasm 
in the absence of these proteases demonstrates that without its 
signal peptide, the /3-glucanase enzyme is unstable and is a 
substrate for proteolysis. In vivo, this form of the enzyme may 
also be a substrate for cellular proteases in the yeast 
cytoplasm.
Degradation in the cytoplasm is a common problem encountered 
with the production of foreign proteins in yeast and in higher 
eukaryotic cells (Townsend et al 1986). This has been shown for 
the yeast secretory protein acid phospatase, where up to 80% of 
the protein is subject to degradation with the signal peptide 
removed (Silve et al 1987). Removal of the signal peptide in 
/3-glucanase is likely to result in conformational changes in 
the /3-glucanase enzyme, possibly rendering it more sensitive to 
the action of cellular proteases. The identity of the 
N-terminal amino acid residue has also been shown to affect 
protein stability in yeast (section 1.1.2). In pJB/34 and 
PJBC55A however, the respective N-terminal Met-Ser-Lys and 
Met-Gly-Asp sequences, fall into the stabilizing category. Even 
if the N-terminal Met was removed in vivo, the second residue 
in each case is also stabilizing.
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In pJB/34, a contributory factor to the lack of detectable 
activity in DBY746 and the low levels of activity produced in 
MD50, is likely to be the instability of the /3-glucanase 
transcript. This instability is reflected in Northern blots 
where no /3-glucanase specific transcript is detected for pJBjS4. 
Efficient termination has been shown to be important for RITA 
stability in yeast and expression levels can increase 
dramatically when this is achieved (Ammerer, 1983; Zaret and 
Sherman, 1982). In pJB/34, the bacterial terminator alone may 
not terminate transcription efficiently.
pJBC55A on the other hand, produces a remarkably strong 
/3-glucanase transcript, but reveals no sign of any enzyme 
activity when expressed in DBY746, or in MD50. Examination of 
the 5' untranslated leader regions of the signal-less gene in 
pJB55A, suggests that the absence of active enzyme may be 
associated with translation efficiency. Highly expressed yeast 
genes tend to contain untranslated 5' leader regions that are 
short (approximatly 52 nucleotides) and void of secondary 
structure (Cigan and Donaghue, 1987). A lack of secondary
structure is promoted by a bias toward A and a strict avoidance 
of G nucleotides in this region. These features promote 
conditions ideal for attachment and movement of the ribosome 
towards the initiator codon. In addition, a consensus sequence 
has been identified around the AUG start that has been shown to 
promote efficient translation, presumably optimizing conditions 
for recognition of the initiator. This sequence, compiled by 
examining nucleotide bias around the AUG of highly expressed 
genes, is also rich in A and void of G nucleotides and takes 
the form A/Y-A-A/U-A-AUG, where Y is a pyrimidine (U or C) . 
Optimization of the 5' leaders of foreign genes in accordance 
with these guidelines, has been shown to have dramatic effects, 
resulting in increased expression levels in yeast (Bitter and 
Egan, 1988; Fieschko et al 1987).
Comparison of the 5' leaders of pJB/34 and pJBC55A, reveals 
differences both in their lengths and composition. Assuming 
that transcription is initiated at the same site as that 
defined for the ADH1 promoter (between positions -37 and -27,
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(Ammerer, 1983)), the 5' untranslated regions of the 
/?-glucanase transcripts in pJB/34 and pJBC55A are as shown in 
Fig.(4.2). The sequences from position -12 are shown to 
highlight these differences. pJB/34, is completely void of Gs 
and exhibits an almost ideal consensus around the AUG start. 
pJBC55A on the other hand, is longer (by 9 nucleotides), 
contains 3 G nucleotides and has no consensus at the initiator 
AUG. These features of pJBC55A may contribute to inefficient 
translational initiation in pJBC55A compared to pJB/34. A 
combination of inefficient translation with a certain amount of 
protein instability and degradation are possible reasons for 
the lack of enzyme activity in pJBC55A.
Figure (4.2) 5' untranslated regions of pJB/34 and pJBC55A. 
pJB/34
CAAUCAACUAUCUCAUAUACA-AUG-UCU-CAA-AGC-UUG-GGG-GAU-CCG-UCA
from pAH9 Met-Ser-Lys-.................... -Ser
pJBC55A
CAAUCAACUCCAAGCUUGAAUUCCCCAUCG-AUG -GGG-GAU-CCU-UCA- - 
pAAH5 Met-Gly-Asp.....Ser
Sequence around AUG initiator in pJB/34 and pJBC55A:
pJB/34 U-A-C-A-AUG
Consensus A/Y-A-A/U-A-AUG 
pJBC55A A-U-C-G-AUG
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(4.3) Truncating the /3-glucanase signal peptide.
pJG205 contains a truncated version of the /3-glucanase signal 
peptide, starting with the Met residue at position 17 (see Fig. 
4.1). This signal peptide, although missing the complete 
hydrophillic and the bulk of the hydrophobic domains, directs 
secretion of /3-glucanase into the yeast cell medium. Sec mutant 
analysis confirms that the extracellular /3-glucanase activity 
detected in pJG205, is due to transport through the 
conventional secretory pathway. This suggests that the severely 
truncated bacterial signal sequence can direct translocation 
and secretion of heterologous proteins in yeast.
Kaiser et al (1987), has proposed that translocation of 
proteins into the ER only requires the presence of a short 
stretch of hydrophobic amino acids (section 1.3.2). pJG205 
fulfills this obligation with a hydrophobic core of 4 residues. 
However, Kaisers experiments also showed that the levels of 
translocation achieved with limited hydrophobicity are 
extremely low. Initial observations with pJG205, comparing the 
levels of secreted enzyme to pJG317, suggested that the 
truncated version of the signal peptide secretes /3-glucanase in 
amounts comparable to the complete sequence, with extracellular 
levels of enzyme activity being almost the same in each case. 
This comparison however, is complicated by the very high levels 
of /3-glucanase activity detected intracellularly in pJG205. 
Taking into account the total amount of /3-glucanase activity 
produced by the cells, the secretion efficiency in pJG205 is 
only 14%, whereas in pJG317, approximately 50% of the overall 
levels are secreted. The total amount of activity produced in 
pJG317 however, is significantly lower than in pJG205 
(80-90% lower) (section 3.4).
Examination of the steady state levels of the /3-glucanase RNA 
transcripts by Northern analysis, revealed no significant 
differences between pJG317 and pJG205. This indicates that the 
lower levels of activity observed in pJG317 are not due to RNA 
instability. Also, differences in translation efficiencies are 
not likely to be the cause of the discrepancies in overall 
levels of enzyme produced. The two plasmid constructions are
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identical except for a region of 10 and 11 base pairs, derived 
from the /3-glucanase gene sequence preceding the initiator 
methionines. These 5' untranslated regions, while they do not 
constitute ideal 5' leader sequences according to the accepted 
guidelines outlined in section (4.2) above, are similar in 
length and contain equal numbers of G nucleotides. Of the two, 
the pJG317 sequence is more conducive to efficient initiation 
of translation than pJG205. (The pJG205 sequences 5' to the 
initiator Met are: TGGATTGTTTATG ; the pJG317 sequences 5' to 
the initiator Met are: GGAATGCCAATATG).
Glycosylation of the /3-gluucanase enzyme, in the secretory 
pathway of DBY746, appears to inhibit activity of the enzyme 
(see section 4.5). Activity gel analysis suggests that 
glycosylation of the enzyme produced in pJG205 does not occur 
to the extent seen in pJG317 or pJG314. Reduced glycosylation 
may therefore contribute to the high levels of activity 
observed intracellularly in pJG205.
This lack of glycosylation in pJG205 could reflect inefficient 
translocation of the /3-glucanase enzyme into the secretory 
pathway, caused by the presence of the truncated signal 
peptide. Western analysis of pJG205 extracts suggests that 
there is a substantial amount of unprocessed enzyme, with the 
signal peptide still intact, present intracellularly in this 
strain. The wide smear of activity observed on activity gels is 
also consistent with the presence of processed and unprocessed 
bands (Fig. 3.25). The fraction that is secreted in pJG205 
however, is processed with respect to signal cleavage. This is 
evident by comparing the size of the extracellular fraction to 
the B.subtilis control enzyme (Fig. 3.26).
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(4.4) Comparison of the /3-glucanase and a-factor signal 
peptides in pJG317, pJG314 and pVT314.
Comparison of the full bacterial signal peptide with the yeast 
a-factor signal, in relation to their abilities to secrete 
/3-glucanase, is also complicated by the problem of 
glycosylation. The growth curves presented in section (3.4), 
suggest that the Bacillus signal is at least as efficient as 
the a-factor signal. In pJG317 and pJG314, approximately half 
of the overall levels produced in each case is secreted. In 
pJG314, the total amount of /3-glucanase produced is 
approximately 50% of that produced in pJG317. These lower 
overall levels were assumed to reflect the differences in the 
relative strengths of the Adhl and a-factor promoters. However, 
pJG317 demonstrates that DBY746 is capable of secreting almost 
450 units of /3-glucanase activity per ml of culture under the 
conditions used. The lower levels secreted in pJG314 may 
simply reflect reduced efficiency of the a-factor signal 
peptide to secrete and process the enzyme.
In an attempt to clarify this and to obtain a more direct 
comparison of the secretion efficiencies of the bacterial and 
yeast signal peptides, pVT314 was made. This construct places 
the /3-glucanase gene, fused to the a-factor signal sequence, 
under control of the Adhl promoter and was intended to act as a 
direct control for comparison to pJG317. It was expected that 
the same promoter in pVT314 and pJG317 would result in similar 
overall levels of /3-glucanase production with the levels 
secreted reflecting the relative strengths of the two signal 
peptides. The levels detected in pVT314 however, 
intracellularly and extracellularly, are significantly reduced. 
Surprisingly, these overall levels are also lower than those 
observed in pJG314. Over much of the growth curve the secreted 
enzyme levels of pVT314 are also lower than those observed in 
pJG314 despite the fact that in both constructs the /3-glucanase 
gene is fused to the a-factor signal peptide.
Other studies have shown that overexpression of heterologous 
genes, in comoination with certain signal peptides, can result 
in reduced secretion efficiencies (Smith eC al, 1985). This is
162
not the case with pVT314, as interference in secretion 
efficiencies alone would presumably be accompanied by 
accumulation inside the cell. Instead, as with the other 
constructs, approximately 50-60% of what is produced in pVT314 
is secreted, although lower levels are reached overall.
The vector used in constructing pVT314 is similar to pAAH5 and 
p69D, except for the auxotrophic marker used for selection 
(uracil in pVT314 and leucine in the pJG series). According to 
the growth curves shown, higher cell densities are reached in 
both pJG317 and pJG314 compared to pVT314, and this feature of 
pVT314 may contribute to the overall lower levels. However, 
other factors such as glycosylation must also be considered. 
Glycosylation appears to interfere with activity of the 
/3-glucanase enzyme and would therefore interfere with the true 
approximation of /3-glucanase production in each strain. This 
effect would also mask the relative efficiencies of the two 
signal peptides, since the extent of glycosylation must also be 
taken into fccount. If the enzyme is more likely to be 
glycosylated when attached to the a-factor signal, then the 
lower level observed in these constructs would be expected. 
This is also the case if the a-factor signal is more efficient 
than the bacterial signal at translocating the enzyme. These 
a-factor signal constructs however, also pose additional 
problems for /3-glucanase when one considers that the signal 
itself is also glycosylated in vivo in yeast. Furthermore, in 
contrast to the bacterial signal which is cleaved as the enzyme 
is translocated through the ER membrane, the a-factor signal is 
retained until the it reaches Golgi.
The sharp increase in extracellular activity seen in the growth 
curves of pJG314 and pVT314 at approximately 36 hours 
interesting feature which may reflect processing 
characteristics of the a-factor signal peptide. This increase 
is accompanied by a corresponding decrease in activity levels 
intracellularly and is not apparent in the bacterial signal 
constructs, a-factor is not processed until the Golgi stage of 
the pathway and ongoing processing of the intracellular pool of 
/3-glucanase may manifest in this slight delay in secretion of
163
the enzyme.
(4.5) The effect of glycosylation on the Bacillus /3-glucana:>e 
enzyme.
It is not entirely unexpected that glycosylation could 
interfere with the activity of a bacterial protein when 
produced in yeast. Glycosylation of secretory proteins is not a 
feature of the bacterial secretory process and modifications to 
areas of a protein that may constitute active sites, can easily 
be envisaged as interfering with enzyme activty. The evidence 
from the sec mutants, combined with the tunicamycin effect, 
shows that this is the case for the B.subtilis /3-glucanase 
enzyme. The enzyme appears to be less active when modified by 
glycosylation than in its natural state.
Tunicamycin has a more profound effect on recovery of enzyme 
activity than production of the enzyme at the restrictive 
temperature in the glycosylation mutant, sec53. As described 
earlier, tunicamycin inhibits all glycosylation by interfering 
at the earliest stage in core assembly. The sec53 phenotype 
reduces glycosylation by limiting the number of mannose 
residues available for incorporation into glycoproteins. This 
difference could explain the larger increase seen with the 
inhibition of all sugar additions in the presence of 
tunicamycin.
Glycosylation has also been shown to interfere with the 
activity of ^-glucanase produced in another Bacillus species 
(B.macerans). A reduced specific activity was observed for the 
glycosylated form when compared to the native form (Oleson and 
Thomsen, 1991).The glycosylated form of the B.macerans enzyme 
was shown to be more stable than the unglycosylated form. 
Preliminary analysis of the thermostability of the B.subtilis 
enzyme (not shown) however, suggests the opposite. In this case 
the unglycosylated form (prepared by treatment with 
tunicamycin) exhibits a greater tolerance for incubation at 
high temperatures.
Glycosylation of the E.coli /5-glucuronidase enzyme in the ER of 
the tobacco plant has also been shown to interfere with the
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activity of this bacterial enzyme (Ittaguria et al 1989). 
Tunicamycin treatment of tobacco cell suspension cultures, 
carrying the /3-GUS gene fused to various lengths of the plant 
patatin signal sequence, resulted in up to a 100 fold increase 
in /?-glucuronidase activity. Western analysis showed that the 
enzyme was present at a higher molecular weight than expected 
in the plant cultures and treatment with tunicamycin or EndoH, 
reduced it to its normal mature size. In this case, the 
glycosylation sites occur at amino acid positions 358 and 423. 
The disruption of activity by glycosylation at these sites, 
suggests that the active site of the enzyme is toward the 
carboxy terminus. This is futher substantiated by the Bal 31 
deletion analysis carried out in this study.
Fusion of the /3-GUS gene to the a-factor signal peptide in 
pGUSa6, did not allow secretion of the enzyme out into the 
yeast culture medium. Also, tunicamycin had no effect on the 
activity of the enzyme in this strain. Taken in conjunction 
with Ittaguria's observations, this suggests that the enzyme is 
not translocated in pGUSa6 . Why translocation is prevented may 
be associated with the large size of the enzyme, in combination 
with the relatively large signal peptide, presenting steric 
problems for translocation.
The potential glycosylation sites in the /3-glucanase enzyme are 
more widely spread, occurring at positions 31,38,64 and 184. 
Activity gel analysis shows that in both pJG317 and pJG314, all 
of these sites can become modified with core oligosaccharides. 
However, complete modification does not always occur and a 
proportion of the enzyme in the secretory pathway is only 
partly modified at two sites, while a further fraction contains 
no glycosylation additions. Although most of the secreted 
fraction in both pJG317 and pJG314 is partially glycosylated to 
some extent, unglycosylated enzyme is also secreted. This shows 
that glycosylation is not a prerequisite for secretion of this 
enzyme in yeast. The extent of the modifications to the higher 
molecular weight forms of the enzyme, present as a smear in the 
extracellular samples in pJG317 and pJG314, cannot be examined 
in this type of zymogram analysis.
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Different levels of glycosylation appears to have different 
effects on the activity of the enzyme. It is obvious that core 
glycosylation does not completely inhibit /3-glucanase activity 
and it is impossible to tell if the bands visible on activity 
gels, have reduced enzymatic activity compared to the 
unmodified bands. It is likely that the core additions do 
affect activity of the enzyme, but that the inhibition observed 
is also contributed to by extensive chain additions which have 
a more severe effect.
Examination of tunicamycin treated /3-glucanase in pJG317 and 
pJG314 confirms that these higher molecular weight bands 
represent glycosylated forms of the enzyme. In the gel shown in 
figure (3.27), the higher molecular weight forms are reduced to 
the size of the unglycosylated band, which can be clearly seen 
to have increased in intensity. In these supernatant samples, 
the loadings represent equal levels of /3-glucanase activity as 
determined by DNS assay (ie. a 1/10 dilution of the 
+tunicamycin sample in pJG317 and a 1/3 dilution of the 
+tunicamycin sample in pJG314). This dilution was necessary as 
the large increases in activity caused by tunicamycin treatment 
resulted in indistinguishable smears of activity running the 
length of the +tunicamycin lane when equal volumes were added. 
This underlines the extent of the increase seen and suggests 
that it is contributed to by previously unseen material, 
possibly representing highly modified /3-glucanase. When 
cyclohexamide is added to RSY12 cells at the same time as the 
mutant phenotype is induced, the increases in /3-glucanase 
activity seen at intracellular and extracellular levels are no 
longer observed (data not shown). Extracellular levels of 
/3-glucanase activity are equal at both 25°C and 37 C. Although 
cyclohexamide will have halted protein synthesis, the enzyme 
activity detected extracellularly is presumably derived from 
the intracellular levels of /3-glucanase that was synthesized 
before induction of the mutant phenotype. This further 
substantiates the idea that the increases seen at the 
non-permissive temperature, in the absence of cyclohexamide, is 
due to the inhibition of oligosaccharide additions to newly
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formed /3-glucanase.
The smallest glycosylated band representing core 
oligosaccharide additions at 2 sites, is still visible in the 
the supernatants after tunicamycin treatment. Because of the 
nature of this analysis a certain amount of glycosylated 
enzyme, modified before the addition of tunicamycin and 
subsequently secreted, is likely to be present and this band 
may reflect this fraction. In retrospect, this could be 
eliminated by a short preincubation period in the presence of 
the drug. A similar band appears in the supernatant of pJG205 
cells after tunicamycin treatment. Its slightly faster mobility 
suggests that it could represent /3-glucanase with one core 
oligosaccharide addition or possibly the enzyme with its signal 
peptide still intact. Whatever its identity, the band is only 
evident after glycosylation is inhibited and therefore is 
derived from /3-glucanase material not seen in pJG205 under 
normal growth conditions.
Why the /3-glucanase enzyme produced in yeast is present in a 
range of different glycosylated forms may be due to the folding 
properties of the protein as it passes through the ER. Rapid 
folding may preclude glycosylation, while modification at one 
site may promote further additions. In pJG317 and pJG205 the 
proportion of glycosylated material seems to be affected by the 
amount that is translocated and subsequently secreted. How the 
majority of the enzyme in pJG205 avoids glycosylation is not 
clear. Also, the proportion that appears to be glycosylated in 
this strain seems to have undergone extensive modifications and 
is only assayable after glycosylation is disrupted. These 
differences may be associated with the nature of the 
translocation event and the orientation of the protein passing 
through the ER membrane when fused to the truncated signal. 
This limited amount of glycosylation observed in pJG205 can 
explain the lower increases in activity observed in tunicamycin 
treated pJG203 compared to tunicamycin treated pJG317 (section 
3.11). Where less glycosylation has taken place the inhibitory 
effect on ¿3-glucanase activity would be expected to be less 
pronounced.
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When compared to pJG317, the effect of tunicamycin in pJG314 is 
also less dramatic. Inhibition of glycosylation of the a-factor 
pro-region results in a reduction of a-factor secretion. This 
is thought to be a result of interference with the folding 
patterns of the region causing a certain amount of accumulation 
in the ER (Julius et al, 1984b). Reduced secretion of 
/3-glucanase, when fused to the a-factor signal peptide in 
pJG314, would dilute the extent of the increase expected after 
tunicamycin treatment in the supernatant of this strain. The 
resultant accumulation of unprocessed and malfolded enzyme in 
the lumen of the ER, may also account for the lack of an 
increase seen at intracellular levels.
(4.6) Processing of the a-factor signal peptide in pJG314 and 
pJG317.
As outlined in section (1.6.4), processing of the a-factor 
pheromone protein involves a series of enzymatic cleavage 
events. The main section of the pro-region is removed after the 
Lys Arg dibasic cleavage site by the action of the KEX2 
protease. The mature portion of the a-factor protein is further 
processed by the action of STE13 which removes the remaining 
N-terminal Glu-Ala sequences (Bussey, 1988).
In pJG314, the sequence around the cleavage site of the 
a-factor pro-region includes these Glu-Ala repeats. A short 
segment of pUC8 DNA is also included, derived from the BamHl 
site used to isolate the signal-less /3-glucanase gene from 
pJG104 (Fig. 4.3). Cleavage at Lys-Arg results in the 
/9-glucanase enzyme retaining 10 extra amino acids at its 
N-terminus. This is reflected in the slower mobility of the 
unglycosylated, processed band in the extract of pJG314, seen 
on the Western blots. The action of the STE13 gene product in 
a-factor maturation is thought to be the rate limiting factor 
in secretion of the pheromone (Bussey, 1988). In conjunction 
with heterologous sequences, cleavage at this site is often 
inefficient (section 1.7.0) and this seems to be the case in 
pJG314. The activity gel in Figure (3.25), shows that a small 
amount of processing by STE13 has occurred with the appearance
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of a smaller molecular weight band. In the higher % gel showing 
the supernatants of pJG314 (Figs. 3.26 and 3.27), the slower 
mobility of the enzyme is more evident. Also, both of the 
glycosylated bands are also slightly larger than those seen in 
pJG317, indicating that the majority of secreted /3-glucanase in 
pJG314 has retained these extra sequences.
Figure (4.3). Sequence around the signal cleavage site in 
pJG314 and pVT314.
p69D pJG104
pJG314 AAA-AGA-GAG-GCT-GAA-GCT-CCG-GAT-CCG -TCA-GCT------
Lys Arg Glu Ala Glu Ala Pro Asp Pro Ser Ala Lys 
t t
KEX2 STE13
4-
pVT314 AAA-AGA-TCA-GCT --------
Lys Arg Ser Ala Lys
In pVT314, the fusion between the a-factor signal and the 
/3-glucanase gene eliminated these extra sequences, including
the STE13 cleavage site (Fig.4.3). By virtue of the Stul site,
the Lys Arg cleavage site was fused directly to the the
/3-glucanase ,signal-less gene after filling in the Dde 1 
overhang. Activity gels suggest that cleavage does occur,
producing an enzyme of similar size to pJG317 (Fig.3.28).
Heterologous sequences have been known to interfere with 
cleavage of the a-factor pro-region (section 1.6.4), and
inefficient cleavage may contribute to the lower than expected 
levels of activity seen in this strain. This proposal, however, 
assumes that retention of the a-factor signal interferes with 
/3-glucanase activity and that inefficient cleavage is a feature 
of this construct.
The fact that these problems are not apparent in pJG317, may be 
due to the signal in question being the natural /3-glucanase 
signal sequence. Sequences around the cleavage site are likely 
to be ideal for processing in B.subtilis. That they present no
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obvious problem for the yeast signal peptidase, combined with 
the secretion levels observed, suggests that this signal may be 
useful for the production of other foreign proteins in yeast. 
How the signal fares in conjunction with other sequences, 
however, remains to be seen.
(4.7) Conclusion.
The B.subtilis /3-glucanase enzyme is secreted in yeast using 
its own bacterial signal peptide. Western analysis showed that 
the bacterial signal is recognized and cleaved by the yeast 
signal peptidase. Comparisons to the yeast a-factor signal 
sequence suggests that the bacterial signal is at least ¡is 
efficient as the yeast signal peptide. These studies show that 
the B.subtilis signal has definite potential for use as a 
general secretion signal in yeast. Removal of the bacterial 
signal peptide resulted in a loss of /3-glucanase activity. This 
was shown to be associated with stability of the enzyme in the 
yeast cytoplasm and demonstrated the importance of optimizing 
sequences around the translational initiation site in the 
generation of fusion constructs. Analysis of a mutant form of 
the signal peptide showed that a truncated version of the 
bacterial signal sequence can still translocate /3-glucanase, 
although with reduced efficiency.
Analysis of /9-glucanase secretion was obstructed somewhat by 
the inhibitory effects of glycosylation on activity of the 
enzyme. On one level this caused problems in assessing the 
relative efficiencies of the signal peptides used. 
Glycosylation also interfered with Western analysis in that the 
antibody raised against the B.subtilis /3-glucanase enzyme did 
not recognize glycosylated forms of the enzyme produced in 
yeast. This is likely to be a result of the widely spread 
glycosylation sites preventing recognition of the antigenic 
sites in this relatively small (22KDa) protein. Activity gel 
analysis circumvented this problem to some extent, but 
examination of extensively glycosylated forms of the enzyme 
was still difficult.
Glycosylation also affects the activity of /3-glucuronidase, the
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other bacterial enzyme examined in this work. This enzyme was 
chosen for investigation due to its attractive assaying 
procedures. Although translocation of /?-glucuronidase was not 
achieved in this study, it may be possible to secrete the 
protein, or a truncated version of the protein, using another 
signal sequence. The antibody raised against E.coli 
/3-glucuronidase is less likely to have problems in recognizing 
modified forms of the enzyme in yeast than the 0 -glucana.se 
antibody . The larger size of the protein (72KDa) , and the 
presence of only two glycosylation sites in close proximity to 
each other, should not prevent recognition of the antibody at 
other antigenic sites in the enzyme. These glycosylation sites 
could possibly be removed by the introduction of conservative 
amino acid substitutions. If this did not interfere with 
activity of the enzyme, the problem of reduced activity due to 
glycosylation would also be removed.
171
CHAPTER 5 
REFERENCES
172
Akita, M., Sasaki, S., Matsuyama, S., Mizushimi, S.
(1990) J. Biol. Chem. 265, 8164-8169.
SecA interacts with secretory proteins by recognizing the +ve 
charge at the amino terminus of the signal peptide.
Ammerer, G. (1983) Meths. Enzymol. 101, 192-201.
Expression of genes in yeast using the ADC1 promoter.
Ammerer, G., Hunter, C.P., Rothman, J.H., Saari, G.C., Vails, 
L.A., Stevens, T.H. (1986) Mol. Cell. Biol. 6 , 2490-2499.
PEP4 gene of S.cerevisiae encodes proteinase A, a vacuolar 
enzyme required for processing of vacuolar precursors.
Andrews, D.W., Perera, E., Lesser, C., Lingappa, V.R.
(1989) J. Biol. Chem. 263, 15791-15798.
Sequences beyond the cleavage site influence signal function.
Bachmair, A., Finley, D., Varshavsky, A.
(1986) Science 234, 179-186.
The in vivo half life of a protein is a function of its amino 
terminal residue.
Baker, R.K., Lively, M.D. (1987) Biochemistry 26, 8561-8567. 
Purification and characterization of hen oviduct microsomal 
signal peptidase.
Ballou, C.E., Kern, K.A., Raschke, W.C.
(1973) J. Biol. Chem. 248, 4667-4673.
Genetic control of yeast mannan structure.
Bankaitis, V.A., Johnson, L.M., Emr, S.D.
(1986) Proc. Nat. Acad. Sci. USA 83, 9075-9079.
Isolation of yeast mutants defective in protein targeting to 
the vacuole.
173
Banta, L.M., Robinson, J.S., Klionski, D.J., Emr, S.D.
(1988) J. Cell Biol. 107, 1369-1383.
Organelle assembly in yeast : characterization of yeast mutants 
defective in vacuolar biogenesis and protein sorting.
Barnes, G., Hansen, W. , Holcomb, C.L., Rine, J.,
(1984) Mol. Cell. Biol. 4, 2381-2388.
Bathurst, I.C., Brennan, S.O., Carrel, R.W., Cousens, L.S.,
Brake, A.J., Barr, P.J. (1987) Science 235, 348-351.
Yeast KEX2 protease has the properties of a human proalbumin
converting enzyme.
Bedoulle, H., Bassford, P.J., Fowler, A.V., Zabin, I., et al. 
(1980) Nature 285, 78-81.
Mutations that alter the function of the signal sequence of the 
maltose binding protein of E.coli.
Ben-Bassat, A., Bauer, K. , Chang, S.Y., Myambo, K. , Boosman,
A., Chang, S. (1987) J. Bact. 169, 751-757.
Processing of the initiation methionine from proteins: 
properties of the E.coli methionine aminopeptidase.
Benson, S.A., Hall, M.N., Silhavy, T.J.
(1985) Ann. Rev. Biochem. 54, 101-134.
Genetic analysis of protein export in E.coli.
Bernstein, H.D., Poritz, M.A., Strub, K., Hoben, P.J., Brenner, 
S., Walter, P. (1989) Nature 340, 482-486.
Model for signal sequence recognition from amino acid sequence 
of the 54K subunit of Srp.
Bernstein, M . , Kepes, F., Schekman, R.
(1989) Mol. Cell. Biol. 9, 1191-1199.
SEC59 encodes a membrane protein required for core 
glycosylation in S .cerevisiae.
174
Birnboim, H.C., Doly, J., (1979) Nuc. Acid Res.7, 1513-1523.
A rapid alkaline extraction procedure for screening recombinant 
plasmid DNA.
Bitter, G.A., Egan, K.M. (1984) Gene 32, 263-274.
Expression of heterologous genes in S .cerevisiae from vectors 
utilizing the GAPDH promoter.
Bitter, G.A., Egan, K.M., (1988) Gene 69, 193-207.
Expression of human interferon-7 from hybrid yeast GPD 
promoters containing upstream regulatory sequences from the 
GAL1-GAL10 intergenic region.
Blobel, G., Dobberstein, B., (1975a) J. Cell Biol. 67, 83 
Transfer of proteins across membranes I: Presence of
proteolytically processed and unprocessed nascent 
immunoglobulin light chains on membrane bound ribosomes of 
murine myeloma.
Blobel, G., Dobberstein, B., (1975b) J.Cell Biol. 67, 852 
Transfer of proteins across membranes II: Recognition of
functional rough microsomes from heterologous components.
Bohni, P.C., Deshaies, R.J., Schekman, R.W.
(1988) J. Cell Biol. 106, 1035-1042.
SECll is required for signal peptide processing and yeast cell 
growth.
Bole, D.G., Hendershot, L.M., Kearny, J.F.,
(1986) J. Cell Biol. 102, 1558-1566.
Post-translational association of immunoglobulin heavy chain 
binding protein with nascent heavy chains in nonsecreting and 
secreting hybridomas.
Bradshaw, R.A., (1989) TIBS 14, 276-279.
Protein translocation and turnover in eukaryotic cells.
175
Brake, A.J., Merryweather, J.P., Coit, D.G., Heberlein, U.A., 
Masiartz, F.R., Mullenbach, G.T., Urdea, M.S., et al.
(1984) Proc. Nat. Acad. Sei. USA. 81,4642-4646.
a-factor directed synthesis and secretion of mature foreign 
proteins in S.cerevisiae.
Bussey, M., (1988) Yeast 4, 17-26.
Proteases and the processing of precursors to secreted proteins 
in yeast.
Byrd, J.C., Tarentino, A.L., Maley, F., Atkinson, P.H., 
Trimble, R.B., (1982) J. Biol. Chem. 257, 14657-14666. 
Glycoprotein synthesis in yeast.
Cantwell, B., Brazil, G., Hurley, J., McConnell, D.J.
(1985) Procceedings of the European Brewery Convention Congress 
(Helsinki), pp259-166.
Expression of the gene for endo-ß-1,3,-1,4-glucanase from
B .subtilis in S .cerevisiae.
Cantwell, B., Brazil, G., Murphy, N,, McConnell. D.J.
(1986) Curr. Genet. 11, 65-70.
Comparison of expression of the endo-/3-l, 3-1,4-glucanase gene 
from B. subtilis in S.cerevisiae from the CYC1 and ADH1 
promoters.
Cantwell, B., McConnell, D.J., (1983) Gene 23, 211-219. 
Molecular cloning and expression of a B .subtilis ß -glucanase in 
E .coli .
Chang, C.N., Matteuci, M., Perry, J., Wulf, J.J., Chen, C.Y., 
Hitzeman, R., (1986) Mol. Cell. Biol. 6, 1812-1819.
S.cerevisiae secretes and correctly processes human interferon 
hybrid proteins containing yeast invertase signal peptide.
Chou, P.Y., Fasman, G.D.
(1978) Ann. Rev. Biochem. 47, 251-276.
176
Chirico, W.J., Waters, M.G., Blobel, G.
(1988) Nature 332, 805-810.
70K heat shock related proteins stimulate protein translocation 
into microsomes.
Cigan, A.M., Donahue, T.F., (1987) Gene 59, 1-10.
Sequence and structural features associated with translational 
initiator regions in yeast - a review.
Cigan, A.M., Donahue, T.F.
(1988) Mol. Cell. Biol. 8, 2964-2975.
Mutational analysis of the HIS4 translational initiator region 
in S .cerevisiae.
Collier, D.N., Bankaitis, V.A., Weiss, J.B., Bassford, P.J.
(1988) Cell 53, 273-283.
The antifolding activity of SecB promotes the export of the 
E.coli MBP.
Connolly, T., Gilmore, R., (1989) Cell 57, 599-610.
The SRP receptor mediates the GTP dependant displacement of SRP 
from the signal sequence of the nascent polypeptide.
Crooke, E., Guthrie, B., Lecker, S., Lill, R., Wickner, W.
(1988) Cell 54, 1003-1011.
ProOmpA is stabilized for membrane translocation by either 
purified E.coli trigger factor or canine Srp.
Crooke, E., Wickner, W.
(1987) Proc. Nat. Acad. Sci. 84, 5216-5220.
Trigger factor: a soluble protein that folds proOmpA into a
membrane assembly competent form.
Dalbey, R.E., Wickner, W.
(1985) J. Biol. Chem. 260, 15925-15931.
Leader peptidase catalyzes the release of exported proteins 
from the outer surface of the E.coli plasma membrane.
177
Dean, N., Pelham, H.R.B.,
(1990) J. Cell. Biol. Ill, 369-377.
Deshaies, R.J., Kepes, F., Bohni, P.C. (1989) TIGS 5, 87-93. 
Genetic disection of the early stages of protein secretion in 
yeast.
Deshaies, R.J., Sanders, S.L., Feidheim, D.A., Schekman, R.
(1991) Nature 349, 806-808.
Assembly of yeast secretory proteins involved in translocation 
into the ER, into a membrane bound multisubunit complex.
Deshaies, R.J., Schekman, R. (1987) J. Cell Biol. 105, 633-645.
A yeast mutant defective at an early stage in import of 
secretory protein precursors into the ER.
Deshaies, R.J., Schekman, R.
(1989) J. Cell Biol. 109, 2653-2644.
SEC62 encodes a putative membrane protein required for protein 
translocation into the yeast ER,
Deshaies, R.J., Schekman, R.
(1990) Mol. Cell. Biol. 10, 6024-6035.
Structural and functional disection of Sec62p, a membrane bound 
component of the yeast ER protein import machinery.
Donahue, T.F., Cigan, A.M.,
(1988) Mol. Cell. Biol. 8, 2955-2963.
Genetic selection for mutations that reduce or abolish 
ribosomal recognition of the HIS4 translational initiator 
region.
Eakle, K., Bernstein, M . , Emr, S.D.
(1988) Mol. Cell. Biol. 8, 4098-4109.
Cloning of SEC18 gene product necessary for transport from the 
ER to Golgi.
178
Ecker, D.J., Stadel, J.M., Butt, T.R., Marsh, J.A., Moira, B.P. 
(1989) J. Biol. Chem. 264, 7715-7719.
Increasing gene expression in yeast by fusion to ubiquitin.
Eliers, M., Schatz, G. (1986) Nature 322, 228-232.
Binding of a specific ligand inhibits import of a purified 
precursor protein into mitochondria.
Emr, S.D., Silhavy, T.J., (1980) J. Mol. Biol. 141, 63-90. 
Mutations affecting localization of an E.coli outer membrane 
protein, the bacteriophage A receptor.
Emr, S.D., Hedgpeth, J., Clement, J .M.,Silhavy, T.J.,Hofnung,M.
(1980) Nature 285, 82-85.
Sequence analysis of mutations that prevent export of A 
receptor, an E.coli outer membrane protein.
Englemen, D.M., Steitz, T .A. (1981) Cell 23, 411-422.
The spontaneous insertion of proteins into and across
membranes: the helical hypothesis.
Erhart, E., Hollenberg, C.P. (1983) J. Bact. 156, 625-635.
The presence of defective LEU2 gene on 2 p DNA recombinnant 
plasmids of S .cerevisiae is responsible for curing and high 
copy number.
Erikson, A.H., Blobel, G., (1985) J. Biol. Chem. 254, 11771-74. 
Early events in the biosynthesis of the lysosomal enzyme 
cathepsin D.
Ernst, J.F. (1986) DNA 5, 483-491.
Improved secretion of heterologous proteins by S .cerevisiae: 
effects of promoter substitutions in a-factor fusions.
Ernst, J.F., Mermod, J.J., mattaliano, R., Moonen, P.,
(1987) Bio/technology 5, 831-834.
0-glycosylation and novel processing events during secretion of
179
a-factor / GM-CSF fusions by S.cerevisiae.
Esmon, B., Novick, P., Schekman, R. (1981) Cell 25, 451-460. 
Compartmentalized assembly of oligosaccharides on exported 
glycoproteins in yeast.
Esmon, B., Esmon, P.C., Schekman, R.
(1984) J.Biol. Chem. 259, 10322-10327.
Early steps in processing of glycoproteins.
Esmon, P.C.,Esmon, B.E., Schauer, I.E., Taylor, A.,Schekman, R.
(1987) J. Biol. Chem. 262, 4387-4394.
Structure, assembly and secretion of octameric invertase.
Etcheverry, T., Forrester, W., Hitzeman, R.A.
(1986) Bio/technology 4, 726-730.
Regulation of the chelatin promoter during expression of human 
serum albumin or yeast phosphoglycerate kinase.
Evans, E.A., Gilmore, R., Blobel, G.
(1986) Proc. Natl. Acad. Sci. USA. (1986) 83, 581-585. 
Purification of microsomal signal peptidase as a complex.
Fandle, J.P., Canbelli, R. , Oliver, D., Tai, P.C.
(1988) Proc. Natl. Acad. Sci. USA. 85, 8953-8957.
SecA suppresses the temperature sensitive SecY24 defect in 
protein translocation in E.coli membrane vesicles.
Feldman, R.I., Bernstein, M., Schekman, R.
(1987) J. Biol. Chem. 262, 9332-9339.
Product of SEC53 is required for folding and glycosylation of 
secretory proteins in the lumen of the ER.
Ferro-Novick, S., Novick, P., Fields, C., Schekman, R.
(1984) J. Cell. Biol. 98, 35-43.
Yeast secretory mutants that block the formation of active cell 
surface enzymes.
180
Fieschko, J.L., Egan, K.M. , Ritch, T., Koski, R.A. , Jones, 
M.D., Bitter, G.A. (1987) Biotech. Bioeng. 29, 1113-1121. 
Controlled expression and purification of human immune 
interferon from high cell density fermentations of 
S .cerevisiae.
Fikes, J.D., Bassford, P.J.(Jr). (1989) J.Bact. 171, 402-409. 
Novel alleles of SecA improve export of MBP synthesized with a 
defective signal peptide.
Fujii, T., Kondo, K., Shimizu, F., Sone, H., Tanaka, J .,Inoue,
T. (1990) Appl. Env. Micro. 56, 997-1003.
Application of a ribosomal DNA integration vector in the 
construction of a brewers yeast having a-acetolactate 
decarboxylase activity.
Gething, M.J., Sambrook, J., (1982) Nature 300, 598-603. 
Construction of influenza hemagglutinin genes that code for 
intracellular and secreted forms of the protein.
Gething, M-J., McCammon, K., Sambrook, J.
(1986) Cell 46, 939-950.
Expression of wild type and mutant forms of influenza virus 
hemagglutinin: the role of folding in intracellular transport.
Green, R., Kramer, R.A., Shields, D.
(1989) J. Biol. Chem. 264, 2963-2968.
Misplacement of the amino-terminal positive charge in the 
prepro a-factor signal peptide disrupts membrane translocation 
in vivo.
Guisez, Y., Tison, B., Vanderkockhove, J., Demolder, J., Bauw,
G., Haegeman, G., Fiers, W., Contreras, R.
(1991) Eur. J. Biochem. 198, 217-222.
Production and purification of recombinant human interleukin-6 
secreted by the yeast S .cerevisiae.
181
Haguenauer-Tsapis, R. , Nagy, M. , Ryter, A.(1986) Mol, Cell. 
Biol. 6, 723-729.
A deletion that includes the segment coding for the signal 
peptidase cleavage site delays release of S.cerevisiae : acid
phosphatase from the ER.
Hann, B.C., Poritz, M.A., Walter, P.,
(1989) J. Cell Biol. 109, 3228-3230.
S.cerevisiae and Sz.pombe contain a homologue to the 54KDa 
subunit of the Srp that in S.cerevisiae is essential for 
growth.
Hartley, J.L., Donelson, J.E. (1980) Nature 286, 860-864. 
Nucleotide sequence of the yeast plasmid.
Hartmann, E., Weidmann, M., Rapoport, T.
(1989) EMBO, J. 8, 2225-2229.
A membrane component of the ER that may be essential for 
protein translocation.
Hasilik, A., Tanner, W. (1978) Eur. J. Biochem. 85, 599-608. 
Biosynthesis of the vacuolar glycoprotein carboxypeptidase Y. 
Conversion of the precursor into the enzyme.
Hardwick, K.G., Lewis, L.M., Semenza, J., Dean, N. , Pelham, 
H.R.B., (1990) EMBO J. 9, 623-630.
ERD1, a yeast gene required for the retention of luminal ER 
proteins, affects glycoprotein processing in the ER.
Herman, P.K., Stack, J.H., DeModena, J.A., Emr, S.D.
(1991) Cell 64, 425-437.
A novel protein kinase homologue essential for protein sorting 
to the yeast lysosome-like vacuole.
182
Hernandez, L.M., Ballou, L., Alvardo, E., Gilece-Castro, B.L., 
Burlingame, A.L., Ballou, C.E.
(1989) J. Biol. Chem. 264, 11849-11856.
A new S .cerevisiae mnn mutant N-linked oligosaccharide 
structure.
Hitzeman, R., Leung, D.W., Perry, L.J., Kohr, W.J.
(1983) Science 219, 620-625.
Secretion of human interferon by yeast.
Hitzeman, R.A., Hagie, F.E., Hayflick, J.S., Chen, C . Y . ,  
Seeburg, P.H., Derynck, R. (1982) Nuc. Acid Res. 10, 7791-1808. 
The primary structure of the S .cerevisiae gene for 
3-phosphoglycerate kinase.
Hitzeman, R.A., Leung, D.W., Perry, L.J., Kohr, W.J., Levine,
H.L., Goeddel, P.V., (1983) Science 219, 620-625.
Secretion of human interferons by yeast.
Hitzeman, R.A., Chen, C.Y., Dowbenko, D.J., Renz, M.E., et al.
(1990) Meths. in Enzymol. 185, 421-440.
Use of heterologous and homologous signal sequences for 
secretion of heterologous proteins from yeast.
Holmes, D.S., Quigley, M. (1981) Anal. Biochem. 114, 193-197.
A rapid boiling method for the preparation of bacterial 
plasmids.
Hortin, G., Boime, I., (1981) Cell 24, 453-461.
Miscleavage at the presequence of rat preprolactin synthesized 
in pituitary cells incubated with a threonine analog.
Huffaker, T.C., Robbins, P.W.
(1982) J. Biol. Chem. 257, 3203-3210.
Temperature-sensitive yeast mutants deficient in asparagine 
linked glycosylation.
183
Huffaker, T.C., Robbins, P.W.
(1983) Proc. Natl. Acad. Sci. USA. 80, 7466-7470.
Yeast mutants deficient in protein glycosylation.
Inhohara, T., Shimomura, S., Fukiji, T., Futai, M.
(1989) Proc. Natl. Acad. Sci. USA. 86, 3564-3568.
Auxin binding protein located in the ER of maize shoots, 
molecular cloning and complete primary structure.
Inouye, H., Beckwith, J.
(1977) Proc. Natl. Acad. Sci. USA. 74, 1440-1444.
Synthesis and processing of an E.coli alkaline phosphatase 
precursor in vitro.
Inouye, S., Soberon, X. , Franceschini, K., Nakamura, K,, 
Itakura, K., Inouye, M.
(1982) Proc. Natl. Acad. Sci. USA. 79, 3438.
Role of positive charge at the amino terminal region of the 
signal peptide for protein secretion across the membrane.
Inouye, S., Vlasuk, G., Hsuing, H., Inouye, M.
(1984) J. Biol. Chem. 259, 3729
Effects of mutations at glycine residues in the hydrophobic 
region of E.coli prolipoprotein signal peptide on secretion 
across the membrane.
Ito, K., Bassford, P.J.Jr., Beckwith, J.
(1981) Cell 24, 707-717.
Protein localization in E.coli: is there a common step in the 
secretion of periplasmic and outer membrane proteins.
Ittaguria, G., Jefferson, R.A., Bevan, M.W.
(1989) The Plant Cell 1, 381-390.
ER targeting and glycosylation of hybrid proteins in transgenic 
tobacco.
184
Jamieson, J., Palade, G. (1967a) J. Cell Biol. 34, 577-596. 
Intracellular transport of secretory proteins in the pancreatic 
exocrine cell 1: role of peripheral elements of the Golgi
apparatus.
Jamieson, J., Palade, G. (1967b) J. Cell Biol. 34, 597-615. 
Intracellular transport of secretory proteins in the pancreatic 
exocrine cell 2: transport of condensing vacuoles and zymogen
granules.
Jamieson, J., Palade, G. (1968) J. Cell Biol. 39, 580-588. 
Intracellular transport of secretory proteins in the pancreatic 
exocrine cell 3: dissociation of intracellular transport from
protein synthesis.
Jayaram, M., Sutton, A., Broach, J.R.,
(1985) Mol. Cell. Biol. 5, 2466-2472.
Jefferson, R.A., Burgess, S.M., Hirsch, D.
(1986) Proc. Natl. Acad. Sci. USA. 83, 8447-8451.
/3-glucuronidase from E.coli as a gene fusion marker.
Jefferson, R.A., Kavanagh, T., Bevan, M.W.
(1987) EMBO, J. 6, 3901-3907.
GUS fusions: glucuronidase as a sensitive and versatile gene
fusion marker.
Johnston, M. , Dans, R.W., (1984) Mol. Cell. Biol. 4, 1440-1448. 
Sequences that regulate the divergent GAL1-GA110 promoter in 
S .cerevis Lae.
Jones, E.W., (1984) Ann. Rev. Genet. 18, 223-240.
The synthesis and function of proteases in Saccharomyces : 
genetic approaches,
185
Julius, D., Blair, L., Brake, A., Sprague, G., Thorner, J.
(1983) Cell 32, 839-852.
Yeast a-factor is processed from a larger precursor 
polypeptide: the essential role of a membrane bound dipeptidvl 
aminopeptidase.
Julius, D., Brake, A., Blair, L., Kunisawa, R., Thorner, J. 
(1984a) Cell 37, 1075-1098.
Isolation of the putative structural gene for the 
lysine-arginine cleaving endopeptidase required for the 
processing of yeast prepro-a-factor.
Julius, D., Schekman, R., Thorner, J.
(1984b) Cell 36, 309-318.
Glycosylation and processing of prepro-a-factor through the 
yeast secretory pathway.
Kaplan, H.A., Welphy, J.K., Lennarz, W.J.
(1987) Biochem. Biophys. Acta. 906, 161-173.
Oligosaccharyl transferase: the central enzyme in the pathway
of glycoprotein assembly.
Kaiser, C., Botstein, D.,
(1986) Mol. Cell. Biol. 6, 2382-2391.
Kaiser, C.A., Preuss, D., Grisafi, P., Botstein, D.
(1987) Science 235, 321-317
Many random sequences functionally replace the secretion signal 
sequence of yeast invertase.
Kepes, F. , Schekman, R., (1988) J. Biol. Chem. 263, 9155-9161. 
The yeast SEC53 gene encodes a phosphomannomutase.
Klionski, D.J., Banta, L.M., Emr, S,D.
(1988) Mol. Cell. Biol. 8, 2105-2166.
Intracellular sorting and processing of a yeast vacuolar 
hydrolase: proteinase A propeptide contains vacuolar targeting
186
information.
Kniskern, P.J., Hagopian, A., Montgomery, D.L., Burke, P., 
Dunn, N.R., Hofman, K.J., Miller, W.J., Ellis, R.W.
(1986) Gene 46, 135-141.
Unusually high expression of a foreign (hepatitis B core 
antigen) in S .cerevisiae.
Kozutsumi, Y., Segal, M., Normington, K., Gething, M-J.,
Sambrook, J., (1988) Nature 332, 462-464.
The presence of malfolded proteins in the ER signals the
induction of glucose regulated proteins.
Kornfield, R., Kornfield, S.
(1985) Ann. Rev. Biochem. 54, 631-664.
Assembly of asparagine linked oligosaccharides.
Krieg, U.C., Walter, P., Johnston, A.E.
(1986) Proc. Natl. Acad. Sci. 83, 6804-6808.
Photocrosslinking of the signal sequence of nascent
preprolactin to the 54KDa polypeptide of the Srp.
Kumamoto, C.A., Gannon, P.M.
(1988) J. Biol. Chem. 263, 11554-11558.
Effects of E.coli secB mutations on pre-maltose binding protein 
conformation and export kinetics.
Kumamoto, C.A., Chen, L., Fandel, J., Tai, P.C.
(1989) J. Biol. Chem. 264, 2242-2249.
Purification of the E.coli SECB gene product and demonstration
of its activity in an in vitro protein translocation system.
Kurzchalia, T.V., Weidmann, M. , Girshovich, A.S., Bochkareva, 
E.S., Bielka, H., Rapoport, T.A. (1986) Nature 320, 634-636.
The signal sequence of nascent preprolactin interacts with the 
54K polypeptide of the SRP.
187
Kurkurzinska, M.A., Bergh, M.L.E., Jackson, B.J.,
(1987) Ann. Rev. Biochem. 56, 915-944.
Protein glycosylation in yeast.
Kurjan, J., Hrskowitz, I., (1982) Cell 30, 933-943,
Structure of a yeast pheromone gene (MFa): A putative a-factor 
precursor contains four tandem copies of mature a-factor.
Lecker, S., Lill, R., Ziegelhoffer, T., Georgopoulos, C., 
Basford, P.J.Jr., eCal. (1989) EMBO J . 8, 2703-2709.
Three pure chaperone proteins of E.coli SecB, trigger factor 
and GroEL - form soluble complexes with precursor proteins in 
vitro.
Lehle, L., Tanner, W., (1976) FEBS Lett. 71, 167-170.
The specific site of tunicamycin inhibition in the formation of 
dolichol-bound-N-acetylglucosamine derivatives.
Lehle, L., Bause, E.,
(1984) Biochim. Biophys. Acta. 799, 246-251.
Primary structural requirements for N and 0- glycosylation of 
yeast mannoproteins.
Lewis, M.J., Sweet, D.J., Pelham, H.R.B.,
(1990) Cell 61, 1359-1363.
The ERD2 gene determines the specificity the luminal ER protein 
retention system.
Lewis, M.J., Pelham, H.R.B., (1990) Nature 348, 162-163.
A human horaologue of the yeast HDEL receptor.
Li, P., Beckwith, J., Inouye, H.,
(1988) Proc. Natl. Acad. Sci. USA. 85, 7685-7689.
Alteration of the amino terminus of the mature sequence of a 
periplasmic protein can severely affect protein export in 
E .coli.
188
Lingappa, V.R., Chaidez, J., Yost, S.C., Hedgpeth, J.,
(1984) Proc. Natl. Acad. Sci. USA. 81, 456-460.
Deteminants for protein localization : /3-lactamase
signal-sequence directs globin across microsomal membranes.
Linnemans, W.A.M., Boer, P., Elbers, P.F.,
(1977) J. Bact. 131, 638-644.
Localization of acid phosphatase in S.cerevisiae : a clue to
cell wall formation.
Lin, G., Topping, T.B., Randall, L.L.,
(1989) Proc.. Natl. Acad. Sci. USA. 86, 9213-9217.
Physiological role during export for the retardation of folding 
by the leader peptide of MBP.
Loison, G., Findeli, A., Bernard, S., Nguyen-Juilleret, M. , et 
al. (1988) Bio/technology 6, 72-77.
Expression and secretion in S .cerevisiae of biologically active 
leech hirudin.
Lunn, C.A., Inouye, M., (1987) J.Biol. Chem. 262, 8318-8324. 
Effects of prolipoprotein signal peptide mutations of secretion 
of hybrid prolipo-/3-lactamase in E.coli.
Mazzerella, R.A., Srinivasan, M., Haugejorden, S.M., Green, M.,
(1990) J. Biol. Chem. 265, 1094-1101.
ERp72, an abundant luminal ER protein, contains three copies of 
the active site sequences of protein disulphide isomerase.
Mellor, J., Dobson, M.J., Roberts, N. , Kingsman, A.J., 
Kingsman, S.M., (1985) Gene 33, 215-226.
Factors affecting heterologous gene expression in S .cerevisiae.
Melnick, L.M., Turner, B.G., Puma, P., Price-Tillotson, B., et 
al. (1990) J. Biol. Chem. 265, 801-807.
Characterization of a non-, glycosylated single chain urinary 
plasminogen activator secreted from yeast.
189
Meyer, D.I., Dobberstein, B., (1980) J. Cell. Biol. 87, 503-507 
Identification and characterization of a membrane component 
essential for the translocation of nascent proteins across the 
membrane of the ER.
Miller, G.L., (1959) Anal. Chem. 31, 426-428.
Use of dinitrosalicyclic acid reagent for determination of 
reducing sugars.
Milstein, C., Brownlee, G.G., Harrison, T.M., Mathews, M.B., 
(1972) Nature New Biol. 239, 117.
A possible precursor of immunoglobulin light chains.
Moir, D.T., Dumais, D.R., (1987) Gene 56, 209-217.
Glycosylation and secretion of human a-l-antitrypsin by yeast.
Muller, M., Ibrahimi, I., Chang, C.N., Walter, P., Blobel, G.,
(1982) J. Biol. Chem. 257, 11860-11863.
A bacterial secretory protein requires SRP for translocation 
across mammalian ER.
Munro, S., Pelham, H.R.B., (1987) Cell 48, 499-507.
A C-terminal signal prevents secretion of luminal ER proteins.
Murphy, N., McConnell, D. J., Cantwell, B.,
(1984) Nuc. Acid Res. 12, 5355-5367.
The DNA sequence of the gene and genetic control sites for the 
exreted B . subtilis enzyme ¿9-glucanase .
Murray, A.W., Szostak, J.W., (1983) Cell 34, 961-970.
Pedigree analysis of plasmid segregation in yeast.
Myajima, A., Otsu, K., Schreurs, J., Bond, M.W., Abrams, J.S., 
Arai, K., (1986) EMBO J . 5, 1193-1197.
Expression of murine and human GM-CSF in S .cerevlsiae : 
mutagenesis of the potential glycosylation sites.
190
Nakamura, Y. , Sato, T., Emi, M. , Miyanohara, A., Nishide, T,, 
Matsubara, K., (1986) Gene 50, 239-245.
Expression of human salivary amylase gene in S .cerevisiae.
Normington, K., Kohno, K., Kozutsumi, Y . , Gething, M-J . , 
Sambrook, J., (1989) Cell 57, 1223-1236.
S .cerevisiae encodes an essential protein homologous in 
sequence and function to mammalian BiP.
Novick, P., Schekman, R.,
(1979) Proc. Natl. Acad. Sci. USA. 76, 1858-1862.
Secretion and cell surface growth are blocked in a temperature 
sensitive mutant of S .cerevisiae.
Novick, P., Field, C., Schekman, R., (1980) Cell 21, 205-215. 
Identification of 23 complementation groups required for 
post-translational events in the yeast secretory pathway.
Novick, P., Ferro, S., Schekman, R., (1981) Cell 25, 461-469. 
Order of events in the yeast secretory pathway.
Oleson, 0., Thomsen, T.K., (1991) J. Gen. Micro. 137, 579-585. 
Improvement of bacterial /9-glucanase thermostability by 
glycosylation.
Ozkaynak, E., Finlay, D., Varshavsky, A.,
(1987) EMBO J. 6, 1429-1439.
The yeast ubiquitin genes : a family of natural fusions.
Palade, G.E., (1975) Science 189, 347-358.
Intracellular aspects of the process of protein synthesis. 
Pelham, H.R.B., (1988) EMBO J . 7, 913-918.
Evidence that luminal ER proteins are sorted from secreted 
proteins in a post-ER compartment.
191
Pelham, H.R.B.
(1989) Ann. Rev. Cell Biol. 61, 723-733.
Perlman, D., Halvorson, H.D., Cannon, L.E.,
(1982) Proc. Natl. Acad. Sci. USA. 79, 781-785.
Presecretory and cytoplasmic invertase ploypeptides encoded by 
distinct mRNAs derived from the same structural gene differ by 
a signal sequence.
Perlman, D., Halvorson, H.D.,
(1983) J. Mol. Biol. 167, 391-409.
Perlman, D., Raney, P., Halvorson, H.D.,
(1986) Proc. Natl. Acad. Sci. USA. 83, 5033-5037.
Mutations affecting the signal sequence alter synthesis and 
secretion of yeast invertase.
Preuss, D., Botstein, D., (1989) Mol. Cell Biol. 9, 1452-1464. 
Intragenic revertants of yeast invertase variants with 
secretion defective leader sequences.
Puziss, J., Fides, J.D., Bassford, P.J.,
(1989) J. Bact. 171, 2303-2311.
Asalysis of mutational alterations in the hydrophillic segment 
of the maltose-binding protein signal peptide.
Randall, L.L., Hardy, S.J.S., (1986) Cell 46, 921-928. 
Correlation of competence for export with lack of tertiary 
structure of the mature species : a study in vivo of MBP.
Randall, L.L., Hardy, S.J.S., (1989) Science 243, 1156-1159. 
Unity of function in the absence of consensus in sequence : 
role of leader peptides in export.
192
Ribes, V., Römisch, K., Giner, A., Dobberstein, B., Tellervey,
D. , (1990) Cell 63, 591-600.
E. coli 4.5 SRNA is part of a ribonucleoprotein particle that 
has properties related to SRP.
Rine, J., Hansen, W., Hardeman, E., Davis, R.W.,
(1983) Proc. Natl. Acad. Sei. USA. 80, 6750-6754.
Targeted selection of recombinant clones through gene dosage 
effects.
Rome, L.H., Garvin, A.J., Allietta, M.M., Neufeld, E.T.,
(1979) Cell 17, 143-153.
Two species of lysosomal organelles in cultured human 
fibroblasts.
Römisch, K., Webb, J., Herz, J., Prehn, S., Frank, R., Vingion, 
M., Dobberstein, B., (1989) Nature 340, 478-482.
Homology of 54K protein of Srp, docking protein and two E.coli 
proteins with putative GTP-binding domains.
Rose, M.D., Misra, L.M., Vogel, J.P., (1989) Cell 57, 1211-1221 
KAR2, a karyogamy gene, is the yeast homologue of the mammalian 
BiP/GRP 78 gene.
Rothblatt, J.A., Deshaies, R. J., Sanders, S.L., Daum, G., 
Schekman, R., (1989) J. Cell Biol. 109, 2641-2652.
Multiple genes are required for proper insertion of secretory 
proteins into the ER in yeast.
Rothman, J.E., Kornberg, R.D., (1986) Nature 322, 209-210.
An unfolding story of protein translocation.
Rothstein, S.J., Lahners, K.N., Lazarus, C.M., Baulcombe, D.C., 
Gatenby, A.A., (1987) Gene 55, 353-356.
Synthesis and secretion of wheat a-amylase in S .cervisiae.
193
Runge, K.W., Huffaker, T.C., Robbins, P.W.,
(1984) J. Biol. Chem. 259, 412-417.
Two yeast mutations in glucosylation steps of the N-linked
glycosylation pathway.
Runge, K., Robbins, P.W., (1986) J. Biol. Chem. 261, 15582-90.
A new yeast mutation in the glucosylation steps of N-linked 
glycosylation pathway.
Ruohonen, L. , Hackman, P., Lehtovaara, P., Knowles, J.K.C.,
Keranen, S., (1987) Gene 59, 161-170.
Efficient secretion of B .amyloliquefaciens a-amylase by its o^ \m 
signal peptide from S .cerevisiae host.
Sabin, E., Lee-Ng, C.T., Shuster, J.R., Barr, P.J.,
(1989) Bio/technology 7, 705-709.
High levels of expression and in vivo processing of chimeric 
ubiquitin fusion proteins in S .cervisiae.
Sadler, I., Chaing, A., Kurihara, T., Rothblatt, J., Way, J., 
et al, (1989) J. Cell Biol. 109, 2665-2675.
A yeast gene important for protein assembly into the ER and 
nucleus has homology to DnaJ, an E.colL heat shock protein.
Sanz, P., Meyer, D.I., (1988) EMB0 J. 7, 3553-3557.
Signal recognition particle (SRP) stabilizes the translocation 
competent conformation of pre-secretory proteins.
Schauer, I., Emr, S., Gross, C., Schekman, R . ,
(1985) J. Cell Biol. 100, 1664-1675.
Invertase signal and mature sequence substitutions that delat 
intercompartmental transport of active enzyme.
Schechter, I., McKean, D.J., Gryer, R., Terry, W.,
(1975) Science 188, 160.
Partial amino acid sequence of the precursor of immunoglobulin 
light chain programmed by mRNA in vitro.
194
Schekman, R., (1982) Trends in Biochemical Sei. 7, 243.
The secretory pathway in yeast.
Schwaiger, H., Hasilik, A., Von Figura, K., Wiemken, A., 
Tanner, W., (1982) Bioch. Biophys. Res. Comm. 104, 950-956. 
Carbohydrate free CpY is transferred into the lysosome-like 
yeast vacuole.
Semenza, J.C., Harrwick, K.G., Dean, N., Pelham, H.R.B.,
(1990) Cell 61, 1349-1357.
ERD2, a yeast gene required for the receptor mediated retrieval 
of luminal ER proteins from the secretory pathway.
Sharma, C.B., Lehle, L., Tanner, W.,
(1987) Biochim. Biophys. Acta. 906, 161-173.
Shaw, K.J., Frommer, B.R., Anagnost, J.A., Narula, S.,
Leibowitz, P.J., (1988) DNA 7, 117-126.
Regulated secretion of MuGM-CSF in S .cerevis iae via GALl : MFul 
prepro sequences.
Shelness, G., Kanwar, Y., Blobel, G.,
(1988) J. Biol. Chem. 263, 17063-17070.
cDNA-derived primary structure of the glycoprotein component of 
canine microsomal signal peptidase complex.
Sherman, F., Fink, G.R., Hicks, J.B.,
(1986) Cold Spring Harbour, Laboratory Course Manual for
Methods in Yeast Genetics. ppl43.
Shore, G.C., (1979) J. Cell Science 38, 137-153.
Synthesis of intracellular membrane proteins in vitro relation
between rough ER and mitochondrial outer membrane.
Shortle, D., Haber, J.E., Botstein, D.,
(1982) Science 217, 371-373.
Lethal disruption of the yeast actin gene by integrative DNA
195
Siegel, V., Walter, P., (1988a) TIBS 13, 314-316.
Functional dissection of the signal recognition particle.
Siegel, V., Walter, P., (1988b) EMBO J. 7, 1769-1775.
The affinity of SRP for presecretory proteins is dependant 
nascent chain length.
Silve, S., Monod, M., Hinnen, A., Haguenauer-Tsapis, R.,
(1987) Mol. Cell. Biol. 7, 3306-3314.
The yeast acid phosphatase can enter the secretory pathway 
without its N-terminal signal sequence.
Singh, A., Lugowoy, J.M., Hohr, W, J., Perry, L.J.,
(1984) Nuc. Acid Res. 12, 8927-8938.
Synthesis, secretion and processing of a-factor interferon 
fusion proteins from yeast.
Sleep, D., Belfield, G.P., Goodey, A.R.,
(1990) Bio/technology 8, 42-46.
The secretion of human serum albumin from the yeast 
S .cerevisiae using five different leader sequences.
Sly, W.S., Fischer, H.D., (1982) J. Cell. Biochem. 18, 67-85. 
The phosphomannlsyl recognition system for intracellular and 
intercellular transport of lysosomal enzymes.
Smith, R.A., Duncan, M.J., Moir, D.T.,
(1985) Science 229, 1219-1224.
Heterologous protein secretion from yeast.
Snider, M.D., Rogers, O.C., (1984) Cell 36, 753-761. 
Transmembrane movement of oligosaccharide-lipids during 
glycoprotein synthesis.
Start, M.J.R., Boyd, A., (1988) EMBO J . 5, 1995-2002.
The killer toxin of K.lactis : characterization of the toxin
subunits and identification of the genes which encode them.
196
Stevens, T., Esmon, B. , Schekman, R., (1982) Cell 30, 439-448. 
Early stages in the yeast secretory pathway are required for 
transport of carboxypeptidase Y to the vacuole.
Stevens, T.H., Rothman, J.H., Payne, G.S., Schekman, R.,
(1986) J. Cell Biol. 102, 1551-1557.
Gene dosage dependant secretion of yeast vacuolor CpY.
Summers, R.G., Knowles, J.R.,
(1989) J. Biol. Chem. 264, 20074-20081.
Illicit secretion of a cytoplasmic protein into the periplasm 
of E.coli requires a signal-peptide plus a portion of the 
cognate secreted protein.
Talmadge, K., Stahl, S., Gilbert, W. ,
(1980) Proc. Natl. Acad. Sci. USA. 77, 3369-3373.
Eukaryotic signal sequence transports insulin antigen in E.coli
Thim, L., Hansen, M.T., Norris, K., Hoegh, I., Bell, E., 
Forstrom, J., Ammerer, G., Filil, N.P.,
(1986) Proc. Natl. Acad. Sci. USA. 83, 6766-6770.
Secretion and processing of insulin precursors in yeast.
Tokunaga, M., Tokunaga, H., Wu, H.C.,
(1982) Proc. Natl. Acad. Sci. USA. 79, 2255-2259.
Post translational modification and processing of E.coli 
prolipoprotein in vitro.
Townsend, A.R., Bastin, J., Gould, K., Brownlee, G.G.,
(1986) Nature 324, 575-577.
Cytotoxic T-lymphocytes recognize influenza hemagglutinin that 
lacks a signal sequence.
Trimble, R.B., Atkinson, P.H.,
(1986) J.Biol. Chem. 261, 9815-9824.
Structure of yeast external invertase Man0 GlcNAC processing 
intermediates by 500 MHz Hi NMR spectroscopy.
197
Tsai, P.K., Ballou, L., Esmon, B., Schekman, R., Ballou, C.E.,
(1984) Proc. Natl. Acad. Sci. USA. 81, 6340-6343.
Isolation of glucose-containing high-mannose glycoprotein core 
oligosaccharides.
Tschumper, G., Carbon, J., (1983) Gene 23, 221-232.
Copy number control by a yeast centromere.
Ulane, R.E., Cabib, E., (1976) J. Biol. Chem. 251, 3367-3372.
The activating system of chitin synthetase from S.cerivisiae.
Vails, L.A., Hunter, C.P., Rothman, J.H., Stevens, T.H.,
(1987) Cell 48, 887-897.
Protein sorting in yeast : the localization determinant of
yeast vacuolar CpY resides in the propeptide.
Vernet, T., Dignard, d., Thomas, D.Y., (1987) Gene 52, 225-233. 
A family of yeast expression vectors containing the phage fl 
intergenic region.
Vlasuk, G.P., Inouye, S., Ito, H., Itakura, K., Inouye M. ,
(1983) J. Biol. Chem. 258, 7141-7148.
Effects of the complete removal of basic amino acid residues 
from the signal peptide on secretion of lipoprotein in E.coli.
Von Heijne, G., (1983) Eur. J. Biochem. 133, 17-21.
Patterns of amino acids near signal-sequence cleavage sites.
Von Heijne, G., (1984a) EMBO J . 3, 2315-2318.
Analysis of the distribution of charge residues in the 
N-terminal region of signal sequences : implications for
protein export in prokaryotic and eukaryotic cells.
Von Heijne, G., (1984b) J. Mol. Biol. 173, 243-281.
How signal sequences maintain their cleavage specificity.
198
Von Heijne, G., (1985) J. Mol. Biol. 184, 99-105.
Signal sequences : the limits of variation.
Von Heijne, G., (1986) J. Mol. Biol. 192, 287-290.
Net N-C charge imbalance may be important for signal sequence 
function in bacteria.
Walter, P., Blobel, G.,
(1980) Proc. Natl. Acad. Sci. USA. 77, 7112.
Purification of a membrane associated protein complex required 
for protein translocation across the ER.
Walter, P., Blobel, G., (1981) J. Cell. Biol. 91, 557-561. 
Translocation of proteins across the ER III : signal
recognition protein (SRP) causes signal sequence dependant and 
site specific arrest of chain elongation that is released by 
microsomal membranes.
Walter, P., Gilmore, R., Blobel, G., (1984) Cell 38, 5-8. 
Protein translocation across the ER.
Watson, M.E.E., (1984) Nuc. Acid Res. 12, 5145-5152.
Computation of published signal sequences.
Watts, C., Wickner, W., Zimmerman, R.,
(1983) 80, 2809-2813.
M13 procoat and preimmunoglobulin share processing secificity 
but use different membrane receptor mechanisms.
Werner-Washburner, M., Stone, D.E., Craig, E.A.,
(1987) Mol. Cell. Biol. 7, 2568-2577.
Wickner, W. (1980) Science 210, 861-868.
Assembly of proteins into membranes.
199
Wiedmann, M., Huth, A., Rapoport, T.A.,
(1984) Nature 309, 637-639.
Xenopus eocytes can secrete bacterial ß-lactamase.
Wiedmann, M., Kurzchalia, T.V., Hartman, N.E., Rapoport, T.,
(1987) Nature 328, 830-833.
A Signal sequence receptor in the ER membrane.
Wu, L.C.C., Fisher, P.A., Broach, I.R.,
(1987) J. Biol. Chem. 262, 883-891.
A yeast plasmid partitioning protein is a karyoskeletal 
component.
Ya Deau, J., Blobel, G., (1989) J. Biol. Chem. 264, 2928-2934. 
Solubilization and characterization of yeast signal peptidase.
Yamamoto, Y., Kikuchi, M., (1989) Eur. J. Biochem. 184, 233-236 
Synthesis processing and degradation in yeast of precursor 
human lysozyme with newly designed signal sequences.
Yu, M., Donoviel, S., Young, T.,
(1989) Mol. Cell. Biol. 9, 34-42.
Adjacent upstream activation sequence elements synergistically 
regulate transcription of ADH2 in S .cerevisiae.
Zaret, K.S., Sherman, F., (1982) J. Mol. Biol. 177, 107-135. 
Mutationally altered 31 ends of yeast CYC1 MRNA affect 
transcript stability and translation efficiency.
Zhang, Y., Broome-Smith, J.K.,
(1989) Mol. Microbiol. 3, 1361-1391.
Identification of amino acid sequences that can function as 
translocators of /3-lactamase in E.coli.
200
Zimmerman, R., Sagstetter, M., Lewis, M.J., Pelham, H.R.B.,
(1988) EMBO J. 7, 2875-2880.
70KDa heat shock proteins and an additional component from 
reticulocyte lysate stimulate import of M13 procoat protein 
into microsomes.
Zsebo, K.M., Lu, H.S., Fieschko, J.C., Goldstein, L., Davis, 
J., Duker, K., Suggs, S.V., Lai, P.H., Bitter, G.A.,
(1986) J. Biol. Chem. 261, 5858-5865.
Protein secretion from S.cerevisiae directed by the 
prepro-afactor leader region,
Zubenko, G.S., Mitchell, A. P., Jones, E.W.,
(1979) Proc. Natl. Acad. Sei. USA. 76, 2395-2399.
Septum formation, cell division and sporulation in mutants of 
yeast deficient in proteinase B,
Zwizinski, C., Wickner, W., (1980) J. Biol. Chem. 255, 7973-77. 
Purification and characterization of leader peptidase 
from E.coli.
201
APPENDICES
App. 1 Sequence of Che Bacillus subtilis /3-glucanase gene 
(Murphy et al. 1984).
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App,2. Origin of p69A, p69B, p69C, p69D and p69E. 
p69A contains the entire a-factor coding sequence, including 
the signal peptide and structural genes cloned into the BamHl 
site of YEpl3 (Kurjan and Herskowitz, 1983). The structural
genes were removed using the ffindlll restriction site that 
immediatly follows the signal sequence, to give p69B. p69C, D 
and E were made by inserting 8', 10', and 12'meric BamHI 
linkers into the tfindlll site of d 69B (T. Rvan D.C.U.).
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